Class name | Costs of a $10,000 investment |
Costs paid as a percentage of a $10,000 investment |
$ |
|
6-Month Total Returns |
1 Year | 5 Years | 10 Years | ||||
% | % | % | % | ||||
$ |
Sector(a) | Percent of Net Assets |
|
% | ||
Security(b) | Percent of Net Assets |
|
% | ||
|
|
Class name | Costs of a $10,000 investment |
Costs paid as a percentage of a $10,000 investment |
$ |
|
6-Month Total Returns |
1 Year | 5 Years | 10 Years | ||||
% | % | % | % | ||||
$ |
Sector(a) | Percent of Net Assets |
|
% | ||
Security(b) | Percent of Net Assets |
|
% | ||
|
|
Class name | Costs of a $10,000 investment |
Costs paid as a percentage of a $10,000 investment |
$ |
|
6-Month Total Returns |
1 Year | 5 Years | 10 Years | ||||
% | % | % | % | ||||
$ |
Sector(a) | Percent of Net Assets |
|
% | ||
Security(b) | Percent of Net Assets |
|
% | ||
|
|
Class name | Costs of a $10,000 investment |
Costs paid as a percentage of a $10,000 investment |
$ |
|
6-Month Total Returns |
1 Year | 5 Years | 10 Years | ||||
% | % | % | % | ||||
$ |
Sector(a) | Percent of Net Assets |
|
% | ||
Security(b) | Percent of Net Assets |
|
% | ||
|
|
Class name | Costs of a $10,000 investment |
Costs paid as a percentage of a $10,000 investment |
$ |
|
6-Month Total Returns |
1 Year | 5 Years | 10 Years | ||||
% | % | % | % | ||||
$ |
Sector(a) | Percent of Net Assets |
|
% | ||
Security(b) | Percent of Net Assets |
|
% | ||
|
|
(b) Not Applicable
Item 2 – | Code of Ethics – Not Applicable to this semi-annual report |
Item 3 – | Audit Committee Financial Expert – Not Applicable to this semi-annual report |
Item 4 – | Principal Accountant Fees and Services – Not Applicable to this semi-annual report |
Item 5 – | Audit Committee of Listed Registrant – Not Applicable |
Item 6 – | Investments |
(a) The registrant’s Schedule of Investments is included as part of the Financial Statement and Financial Highlights for Open-End Management Investment Companies filed under Item 7 of this Form.
(b) Not Applicable due to no such divestments during the semi-annual period covered since the previous Form N-CSR filing.
Item 7 – | Financial Statements and Financial Highlights for Open-End Management Investment Companies |
(a) The registrant’s Financial Statements are attached herewith.
(b) The registrant’s Financial Highlights are attached herewith.
|
NOVEMBER 30, 2024 |
2024 Semi-Annual Financial Statements and Additional Information (Unaudited) |
BlackRock Capital Appreciation Fund, Inc.
BlackRock FundsSM
· | BlackRock Health Sciences Opportunities Portfolio |
· | BlackRock Infrastructure Sustainable Opportunities Fund |
· | BlackRock Mid-Cap Growth Equity Portfolio |
· | BlackRock Technology Opportunities Fund |
Not FDIC Insured • May Lose Value • No Bank Guarantee |
Table of Contents
Page | ||||
3 | ||||
4 | ||||
19 | ||||
23 | ||||
25 | ||||
28 | ||||
54 | ||||
70 | ||||
72 |
2 |
Derivative Financial Instruments
The Funds may invest in various derivative financial instruments. These instruments are used to obtain exposure to a security, commodity, index, market, and/or other assets without owning or taking physical custody of securities, commodities and/or other referenced assets or to manage market, equity, credit, interest rate, foreign currency exchange rate, commodity and/or other risks. Derivative financial instruments may give rise to a form of economic leverage and involve risks, including the imperfect correlation between the value of a derivative financial instrument and the underlying asset, possible default of the counterparty to the transaction or illiquidity of the instrument. Pursuant to Rule 18f-4 under the 1940 Act, among other things, the Funds must either use derivative financial instruments with embedded leverage in a limited manner or comply with an outer limit on fund leverage risk based on value-at-risk. The Funds’ successful use of a derivative financial instrument depends on the investment adviser’s ability to predict pertinent market movements accurately, which cannot be assured. The use of these instruments may result in losses greater than if they had not been used, may limit the amount of appreciation a Fund can realize on an investment and/or may result in lower distributions paid to shareholders. The Funds’ investments in these instruments, if any, are discussed in detail in the Notes to Financial Statements.
D E R I V A T I V E F I N A N C I A L I N S T R U M E N T S |
3 |
Schedule of Investments (unaudited) November 30, 2024 |
BlackRock Capital Appreciation Fund, Inc. (Percentages shown are based on Net Assets) |
Security | Shares | Value | ||||||
Common Stocks |
||||||||
Aerospace & Defense — 1.7% | ||||||||
TransDigm Group, Inc. |
50,454 | $ | 63,217,348 | |||||
|
|
|||||||
Automobiles — 3.3% | ||||||||
Ferrari NV |
99,628 | 43,254,493 | ||||||
Tesla, Inc.(a) |
235,759 | 81,374,576 | ||||||
|
|
|||||||
124,629,069 | ||||||||
Broadline Retail — 10.1% | ||||||||
Amazon.com, Inc.(a) |
1,822,920 | 378,966,839 | ||||||
|
|
|||||||
Building Products — 0.7% | ||||||||
Trane Technologies PLC |
63,040 | 26,238,509 | ||||||
|
|
|||||||
Capital Markets — 2.7% | ||||||||
Blackstone, Inc., Class A |
272,870 | 52,142,728 | ||||||
S&P Global, Inc. |
92,437 | 48,299,257 | ||||||
|
|
|||||||
100,441,985 | ||||||||
Chemicals — 1.4% | ||||||||
Sherwin-Williams Co. (The) |
133,083 | 52,887,184 | ||||||
|
|
|||||||
Commercial Services & Supplies — 2.1% | ||||||||
Copart, Inc.(a) |
810,169 | 51,356,613 | ||||||
Waste Connections, Inc. |
147,354 | 28,361,224 | ||||||
|
|
|||||||
79,717,837 | ||||||||
Electrical Equipment — 1.6% | ||||||||
Vertiv Holdings Co., Class A |
464,075 | 59,215,970 | ||||||
|
|
|||||||
Entertainment — 3.2% | ||||||||
Netflix, Inc.(a) |
134,239 | 119,044,488 | ||||||
|
|
|||||||
Financial Services — 5.4% | ||||||||
Mastercard, Inc., Class A |
107,777 | 57,438,674 | ||||||
Visa, Inc., Class A |
457,796 | 144,242,364 | ||||||
|
|
|||||||
201,681,038 | ||||||||
Ground Transportation — 1.0% | ||||||||
Old Dominion Freight Line, Inc. |
157,939 | 35,558,387 | ||||||
|
|
|||||||
Health Care Equipment & Supplies — 4.1% | ||||||||
Align Technology, Inc.(a) |
148,152 | 34,485,341 | ||||||
Boston Scientific Corp.(a) |
390,170 | 35,372,812 | ||||||
Intuitive Surgical, Inc.(a) |
153,473 | 83,182,366 | ||||||
|
|
|||||||
153,040,519 | ||||||||
Hotels, Restaurants & Leisure — 0.7% | ||||||||
Chipotle Mexican Grill, Inc.(a) |
443,020 | 27,254,590 | ||||||
|
|
|||||||
Interactive Media & Services — 9.1% | ||||||||
Alphabet, Inc., Class A |
709,218 | 119,822,381 | ||||||
Meta Platforms, Inc., Class A |
381,716 | 219,227,133 | ||||||
|
|
|||||||
339,049,514 |
Security | Shares | Value | ||||||
IT Services — 0.9% | ||||||||
Shopify, Inc., Class A(a) |
296,381 | $ | 34,261,644 | |||||
|
|
|||||||
Life Sciences Tools & Services — 1.0% | ||||||||
Danaher Corp. |
160,915 | 38,569,716 | ||||||
|
|
|||||||
Media — 0.8% | ||||||||
Trade Desk, Inc. (The), Class A(a) |
232,308 | 29,863,194 | ||||||
|
|
|||||||
Pharmaceuticals — 3.5% | ||||||||
Eli Lilly & Co. |
166,481 | 132,410,663 | ||||||
|
|
|||||||
Real Estate Management & Development — 1.1% | ||||||||
CoStar Group, Inc.(a) |
494,494 | 40,222,142 | ||||||
|
|
|||||||
Semiconductors & Semiconductor Equipment — 19.8% | ||||||||
ASML Holding NV, Registered Shares |
122,005 | 83,769,853 | ||||||
Broadcom, Inc. |
885,153 | 143,465,598 | ||||||
NVIDIA Corp. |
3,728,827 | 515,510,333 | ||||||
|
|
|||||||
742,745,784 | ||||||||
Software — 16.5% | ||||||||
Cadence Design Systems, Inc.(a) |
285,912 | 87,720,661 | ||||||
Intuit, Inc. |
143,625 | 92,168,471 | ||||||
Microsoft Corp. |
873,418 | 369,857,586 | ||||||
Synopsys, Inc.(a) |
119,758 | 66,883,646 | ||||||
|
|
|||||||
616,630,364 | ||||||||
Technology Hardware, Storage & Peripherals — 8.3% | ||||||||
Apple Inc. |
1,317,046 | 312,574,527 | ||||||
|
|
|||||||
Total Common Stocks — 99.0% |
3,708,221,311 | |||||||
|
|
|||||||
Preferred Securities | ||||||||
Preferred Stocks — 0.9% | ||||||||
Interactive Media & Services — 0.9% | ||||||||
Bytedance Ltd., Series E-1 (Acquired 11/11/20, cost $19,426,516)(a)(b)(c) |
177,291 | 32,036,484 | ||||||
|
|
|||||||
Total Investments — 99.9% |
3,740,257,795 | |||||||
Other Assets Less Liabilities — 0.1% |
4,659,374 | |||||||
|
|
|||||||
Net Assets — 100.0% |
$ | 3,744,917,169 | ||||||
|
|
(a) | Non-income producing security. |
(b) | Security is valued using significant unobservable inputs and is classified as Level 3 in the fair value hierarchy. |
(c) | Restricted security as to resale, excluding 144A securities. The Fund held restricted securities with a current value of $32,036,484, representing 0.9% of its net assets as of period end, and an original cost of $19,426,516. |
4 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Schedule of Investments (unaudited) (continued) November 30, 2024 |
BlackRock Capital Appreciation Fund, Inc. |
Affiliates
Investments in issuers considered to be affiliate(s) of the Fund during the six months ended November 30, 2024 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:
Affiliated Issuer | Value at 05/31/24 |
Purchases at Cost |
Proceeds from Sales |
Net Realized Gain (Loss) |
Change in Unrealized Appreciation (Depreciation) |
Value at 11/30/24 |
Shares Held at 11/30/24 |
Income | Capital Gain Distributions from Underlying Funds |
|||||||||||||||||||||||||||||||||||||
BlackRock Liquidity Funds, T-Fund, |
$ | 4,697,315 | $ | — | $ | (4,697,315 | )(b) | $ | — | $ | — | $ | — | — | $ | 80,519 | $ | — | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
(a) | As of period end, the entity is no longer held. |
(b) | Represents net amount purchased (sold). |
For purposes of this report, industry and sector sub-classifications may differ from those utilized by the Fund for compliance purposes.
Fair Value Hierarchy as of Period End
Various inputs are used in determining the fair value of financial instruments at the measurement date. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.
The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.
|
||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Assets |
||||||||||||||||||||||||||||
Investments |
||||||||||||||||||||||||||||
Long-Term Investments |
||||||||||||||||||||||||||||
Common Stocks |
$ | 3,708,221,311 | $ | — | $ | — | $ | 3,708,221,311 | ||||||||||||||||||||
Preferred Securities |
— | — | 32,036,484 | 32,036,484 | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
$ | 3,708,221,311 | $ | — | $ | 32,036,484 | $ | 3,740,257,795 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
See notes to financial statements.
S C H E D U L E S O F I N V E S T M E N T S |
5 |
Schedule of Investments (unaudited) November 30, 2024 |
BlackRock Health Sciences Opportunities Portfolio (Percentages shown are based on Net Assets) |
Security | Shares | Value | ||||||
Common Stocks |
||||||||
Biotechnology — 26.1% | ||||||||
4D Molecular Therapeutics, Inc.(a) |
161,488 | $ | 1,266,066 | |||||
AbbVie, Inc. |
1,889,105 | 345,573,978 | ||||||
AC Immune SA(a)(b) |
1,083,340 | 3,683,356 | ||||||
Allogene Therapeutics, Inc.(a) |
1,479,779 | 3,669,852 | ||||||
Alnylam Pharmaceuticals, Inc.(a) |
490,798 | 124,206,250 | ||||||
Amgen, Inc. |
719,625 | 203,560,324 | ||||||
Arcellx, Inc.(a) |
282,233 | 24,856,260 | ||||||
Argenx SE, ADR(a)(b) |
221,539 | 136,589,870 | ||||||
Ascendis Pharma A/S, ADR(a) |
129,952 | 17,683,868 | ||||||
Autolus Therapeutics PLC, ADR(a) |
889,962 | 2,954,674 | ||||||
Avidity Biosciences, Inc.(a) |
245,371 | 10,558,314 | ||||||
Beam Therapeutics, Inc.(a)(b) |
285,429 | 7,812,192 | ||||||
BeiGene Ltd., ADR(a)(b) |
96,865 | 20,825,975 | ||||||
Biogen, Inc.(a) |
450,623 | 72,383,572 | ||||||
Biohaven Ltd.(a) |
337,770 | 15,540,798 | ||||||
BioMarin Pharmaceutical, Inc.(a) |
294,335 | 19,434,940 | ||||||
BioNTech SE, ADR(a) |
104,740 | 12,400,169 | ||||||
Blueprint Medicines Corp.(a) |
366,990 | 35,370,496 | ||||||
Bridgebio Pharma, Inc.(a) |
231,965 | 6,283,932 | ||||||
Cabaletta Bio, Inc.(a) |
419,920 | 1,604,094 | ||||||
CervoMed, Inc.(a)(b) |
62,555 | 675,594 | ||||||
CG oncology, Inc.(a) |
132,962 | 4,620,429 | ||||||
Denali Therapeutics, Inc.(a) |
485,670 | 12,141,750 | ||||||
Disc Medicine, Inc.(a) |
101,255 | 6,424,630 | ||||||
Dyne Therapeutics, Inc.(a) |
337,551 | 10,332,436 | ||||||
Exact Sciences Corp.(a) |
432,373 | 26,841,716 | ||||||
Gilead Sciences, Inc. |
2,088,937 | 193,393,787 | ||||||
Immatics NV(a)(b) |
298,703 | 2,485,209 | ||||||
Immunocore Holdings PLC, ADR(a) |
181,355 | 5,937,563 | ||||||
Incyte Corp.(a) |
212,725 | 15,867,158 | ||||||
Insmed, Inc.(a)(b) |
621,155 | 46,686,010 | ||||||
Ionis Pharmaceuticals, Inc.(a)(b) |
259,920 | 9,286,942 | ||||||
Kyverna Therapeutics, Inc.(a)(b) |
133,243 | 768,812 | ||||||
Legend Biotech Corp., ADR(a) |
146,621 | 6,168,345 | ||||||
Merus NV(a) |
314,737 | 14,112,807 | ||||||
MoonLake Immunotherapeutics(a)(b) |
144,884 | 7,886,036 | ||||||
Natera, Inc.(a) |
378,780 | 63,551,708 | ||||||
Neurocrine Biosciences, Inc.(a) |
141,165 | 17,892,664 | ||||||
Neurogene, Inc.(a) |
284,041 | 7,223,163 | ||||||
Nurix Therapeutics, Inc.(a) |
619,557 | 13,698,405 | ||||||
Nuvalent, Inc., Class A(a) |
384,892 | 37,211,359 | ||||||
Prime Medicine, Inc.(a)(b) |
360,982 | 1,187,631 | ||||||
Protagonist Therapeutics, Inc.(a) |
275,145 | 12,051,351 | ||||||
PTC Therapeutics, Inc.(a) |
287,575 | 12,618,791 | ||||||
Regeneron Pharmaceuticals, Inc.(a) |
101,367 | 76,047,551 | ||||||
REGENXBIO, Inc.(a) |
259,095 | 2,570,222 | ||||||
REVOLUTION Medicines, Inc.(a)(b) |
204,583 | 11,835,126 | ||||||
Rhythm Pharmaceuticals, Inc.(a)(b) |
690,347 | 42,829,128 | ||||||
Rocket Pharmaceuticals, Inc.(a) |
266,176 | 3,830,273 | ||||||
Roivant Sciences Ltd.(a) |
793,275 | 10,082,525 | ||||||
Sagimet Biosciences, Inc., Series A(a)(b) |
302,930 | 1,723,672 | ||||||
Sarepta Therapeutics, Inc.(a) |
475,457 | 63,397,436 | ||||||
Scholar Rock Holding Corp.(a)(b) |
237,470 | 9,475,053 | ||||||
Soleno Therapeutics, Inc.(a) |
168,265 | 8,869,248 | ||||||
Stoke Therapeutics, Inc.(a) |
969,335 | 11,738,647 | ||||||
TScan Therapeutics, Inc.(a) |
681,015 | 3,248,442 | ||||||
Ultragenyx Pharmaceutical, Inc.(a) |
203,611 | 9,697,992 | ||||||
Vaxcyte, Inc.(a) |
218,160 | 20,581,214 | ||||||
Vertex Pharmaceuticals, Inc.(a) |
389,174 | 182,184,025 | ||||||
Viking Therapeutics, Inc.(a) |
124,540 | 6,593,148 | ||||||
Voyager Therapeutics, Inc.(a) |
445,885 | 3,058,771 |
Security | Shares | Value | ||||||
Biotechnology (continued) | ||||||||
Xenon Pharmaceuticals, Inc.(a) |
491,964 | $ | 20,972,425 | |||||
Zealand Pharma A/S(a) |
117,407 | 12,162,905 | ||||||
|
|
|||||||
2,096,221,079 | ||||||||
Financial Services — 0.1% | ||||||||
Helix Acquisition Corp. II, Class A(a) |
850,715 | 8,855,943 | ||||||
|
|
|||||||
Health Care Equipment & Supplies — 27.7% | ||||||||
Abbott Laboratories |
2,549,993 | 302,862,669 | ||||||
Align Technology, Inc.(a) |
112,515 | 26,190,116 | ||||||
Becton Dickinson & Co. |
460,640 | 102,216,016 | ||||||
Boston Scientific Corp.(a) |
6,120,098 | 554,848,085 | ||||||
Cooper Cos., Inc. (The)(a) |
648,303 | 67,721,731 | ||||||
Dexcom, Inc.(a) |
810,440 | 63,206,216 | ||||||
Edwards Lifesciences Corp.(a) |
1,409,720 | 100,583,522 | ||||||
GE HealthCare Technologies, Inc. |
1,029,320 | 85,660,010 | ||||||
Glaukos Corp.(a) |
199,359 | 28,637,920 | ||||||
IDEXX Laboratories, Inc.(a) |
90,825 | 38,305,444 | ||||||
Inari Medical, Inc.(a) |
97,490 | 5,061,681 | ||||||
Inspire Medical Systems, Inc.(a) |
83,905 | 16,173,528 | ||||||
Intuitive Surgical, Inc.(a) |
728,889 | 395,057,838 | ||||||
Medtronic PLC |
1,002,212 | 86,731,426 | ||||||
Novocure Ltd.(a)(b) |
326,090 | 6,534,844 | ||||||
Nyxoah SA(a)(b) |
411,250 | 3,394,869 | ||||||
Orchestra BioMed Holdings, Inc.(a)(b) |
262,308 | 1,476,794 | ||||||
Penumbra, Inc.(a) |
169,035 | 41,264,824 | ||||||
STERIS PLC |
133,060 | 29,148,124 | ||||||
Stryker Corp. |
672,262 | 263,627,543 | ||||||
|
|
|||||||
2,218,703,200 | ||||||||
Health Care Providers & Services — 17.4% | ||||||||
Cencora, Inc. |
377,045 | 94,845,670 | ||||||
Cigna Group (The) |
512,476 | 173,114,393 | ||||||
Elevance Health, Inc. |
323,317 | 131,577,086 | ||||||
Guardant Health, Inc.(a) |
338,156 | 12,041,735 | ||||||
HCA Healthcare, Inc. |
85,166 | 27,868,019 | ||||||
Humana, Inc. |
255,885 | 75,839,196 | ||||||
Labcorp Holdings, Inc. |
93,970 | 22,661,805 | ||||||
McKesson Corp. |
169,605 | 106,596,742 | ||||||
Quest Diagnostics, Inc. |
162,538 | 26,438,431 | ||||||
UnitedHealth Group, Inc. |
1,189,069 | 725,569,904 | ||||||
|
|
|||||||
1,396,552,981 | ||||||||
Life Sciences Tools & Services — 8.9% | ||||||||
Agilent Technologies, Inc. |
210,463 | 29,037,580 | ||||||
Bio-Techne Corp. |
229,860 | 17,322,250 | ||||||
Danaher Corp. |
1,087,477 | 260,657,362 | ||||||
IQVIA Holdings, Inc.(a) |
92,792 | 18,636,345 | ||||||
Mettler-Toledo International, Inc.(a) |
16,205 | 20,275,696 | ||||||
Repligen Corp.(a) |
189,700 | 28,557,438 | ||||||
Thermo Fisher Scientific, Inc. |
421,007 | 222,977,937 | ||||||
Waters Corp.(a) |
179,040 | 68,880,269 | ||||||
West Pharmaceutical Services, Inc. |
141,185 | 45,981,131 | ||||||
|
|
|||||||
712,326,008 | ||||||||
Pharmaceuticals — 17.8% | ||||||||
AstraZeneca PLC |
347,839 | 47,078,117 | ||||||
Daiichi Sankyo Co. Ltd. |
504,500 | 16,020,778 | ||||||
Eli Lilly & Co. |
884,903 | 703,807,601 | ||||||
Johnson & Johnson |
1,144,423 | 177,397,009 | ||||||
Longboard Pharmaceuticals, Inc.(a) |
138,291 | 8,294,694 | ||||||
Merck & Co., Inc. |
1,148,794 | 116,763,422 | ||||||
Novo Nordisk A/S, Class B |
252,665 | 27,078,068 | ||||||
Pfizer, Inc. |
3,037,515 | 79,613,268 | ||||||
Roche Holding AG, NVS |
193,515 | 56,225,947 |
6 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Schedule of Investments (unaudited) (continued) November 30, 2024 |
BlackRock Health Sciences Opportunities Portfolio (Percentages shown are based on Net Assets) |
Security | Shares | Value | ||||||
Pharmaceuticals (continued) | ||||||||
Sanofi SA |
601,216 | $ | 58,394,466 | |||||
Septerna, Inc.(a) |
88,755 | 2,244,614 | ||||||
Structure Therapeutics, Inc., ADR(a)(b) |
196,098 | 6,500,649 | ||||||
UCB SA |
116,815 | 22,907,663 | ||||||
WaVe Life Sciences Ltd.(a) |
263,885 | 3,984,664 | ||||||
Zoetis, Inc., Class A |
557,146 | 97,639,837 | ||||||
|
|
|||||||
1,423,950,797 | ||||||||
|
|
|||||||
Total Common Stocks — 98.0% |
7,856,610,008 | |||||||
|
|
|||||||
Par (000) |
||||||||
Corporate Bonds |
||||||||
Health Care Equipment & Supplies — 0.0% | ||||||||
Exo Imaging, Inc., 8.00%, 07/29/25 (Acquired 07/24/24, |
USD | 541 | 1,450,864 | |||||
|
|
|||||||
Total Corporate Bonds — 0.0% |
1,450,864 | |||||||
|
|
|||||||
Other Interests(a)(c)(d)(e) |
||||||||
Afferent Pharmaceuticals, Inc., Series C (Acquired 06/30/15, cost $0) |
3,421 | 34 | ||||||
Affinivax Inc. (Acquired 08/19/22, cost $0) |
123 | 1,164,372 | ||||||
|
|
|||||||
Total Other Interests — 0.0% |
1,164,406 | |||||||
|
|
|||||||
Shares | ||||||||
Preferred Securities |
||||||||
Preferred Stocks — 0.7% | ||||||||
Biotechnology — 0.4% | ||||||||
Adarx Pharmaceuticals, Inc., Series C (Acquired 08/02/23, cost $6,399,994)(a)(c)(d) |
769,230 | 6,923,070 | ||||||
Cellarity, Inc., Series B (Acquired 01/15/21, cost $5,149,998)(a)(c)(d) |
858,333 | 2,643,666 | ||||||
Genesis Therapeutics, Inc., Series B (Acquired 08/10/23, cost $4,207,998)(a)(c)(d) |
823,870 | 5,190,381 | ||||||
Goldfinch Bio, Inc., Series B (Acquired 06/26/20, cost $4,152,184)(a)(c)(d) |
3,518,800 | 1,372,332 | ||||||
Kartos Therapeutics, Inc., Series C (Acquired 08/22/23, cost $6,974,988)(a)(c)(d) |
1,233,856 | 7,785,631 | ||||||
Laronde, Inc., Series B (Acquired 07/28/21, cost $10,822,560)(a)(c)(d) |
386,520 | 10,822,560 | ||||||
|
|
|||||||
34,737,640 | ||||||||
Health Care Equipment & Supplies — 0.1% | ||||||||
Exo Imaging, Inc., Series C (Acquired 06/24/21, cost $11,178,997)(a)(c)(d) |
1,908,330 | 3,778,493 | ||||||
Swift Health Systems, Inc., Series D (Acquired 08/27/21, cost $5,271,070)(a)(c)(d) |
1,700,345 | 17 | ||||||
|
|
|||||||
3,778,510 | ||||||||
Health Care Providers & Services — 0.1% | ||||||||
Quanta Dialysis Technologies Ltd., Series D (Acquired 06/18/21, cost $9,727,321)(a)(c)(d) |
80,024,425 | 6,516,933 | ||||||
|
|
|||||||
Pharmaceuticals — 0.1% | ||||||||
Insitro, Series C (Acquired 03/10/21, cost $10,839,964)(a)(c)(d) |
592,636 | 5,013,701 | ||||||
|
|
Security | Shares | Value | ||||||
Software — 0.0% | ||||||||
Carbon Health Technologies, Inc. |
||||||||
Series D2 (Acquired 07/09/21, cost $16,855,000)(a)(c)(d) |
1,670,499 | $ | 1,570,269 | |||||
Series D2 (Acquired 02/27/24, cost $1,209,000)(a)(c)(d) |
1,209 | 1,270,538 | ||||||
|
|
|||||||
2,840,807 | ||||||||
|
|
|||||||
Total Preferred Securities — 0.7% |
52,887,591 | |||||||
|
|
|||||||
Rights |
||||||||
Biotechnology — 0.0% | ||||||||
Korro Bio, Inc., CVR(a)(c) |
428,010 | 4 | ||||||
Mirati Therapeutics, Inc., CVR(a)(b)(c) |
228,510 | 171,383 | ||||||
|
|
|||||||
171,387 | ||||||||
Health Care Equipment & Supplies — 0.0% | ||||||||
ABIOMED INC, CVR(a)(c) |
243,643 | 526,269 | ||||||
|
|
|||||||
Total Rights — 0.0% |
697,656 | |||||||
|
|
|||||||
Warrants(a) |
||||||||
Health Care Providers & Services — 0.0% | ||||||||
CareMax, Inc. (Issued/Exercisable 07/21/21, 1 Share for 1 Warrant, Expires 08/06/26, Strike Price USD 0.00) |
88,432 | 442 | ||||||
|
|
|||||||
Pharmaceuticals — 0.0% | ||||||||
Nuvation Bio, Inc. (Issued/Exercisable 08/17/20, 1 Share for 1 Warrant, Expires 07/07/27, Strike Price USD 0.00) |
77,354 | 12,717 | ||||||
|
|
|||||||
Total Warrants — 0.0% |
13,159 | |||||||
|
|
|||||||
Total Long-Term Investments — 98.7% |
7,912,823,684 | |||||||
|
|
|||||||
Short-Term Securities |
||||||||
Money Market Funds — 2.5% | ||||||||
BlackRock Cash Funds: Institutional, SL Agency Shares, 4.79%(f)(g)(h) |
91,556,290 | 91,602,068 | ||||||
BlackRock Liquidity Funds, T-Fund, Institutional Shares, 4.53%(f)(g) |
111,091,333 | 111,091,333 | ||||||
|
|
|||||||
Total Short-Term Securities — 2.5% |
202,693,401 | |||||||
|
|
|||||||
Total Investments — 101.2% |
8,115,517,085 | |||||||
Liabilities in Excess of Other Assets — (1.2)% |
|
(94,823,469 | ) | |||||
|
|
|||||||
Net Assets — 100.0% |
$ | 8,020,693,616 | ||||||
|
|
(a) | Non-income producing security. |
(b) | All or a portion of this security is on loan. |
(c) | Security is valued using significant unobservable inputs and is classified as Level 3 in the fair value hierarchy. |
(d) | Restricted security as to resale, excluding 144A securities. The Fund held restricted securities with a current value of $55,502,861, representing 0.7% of its net assets as of period end, and an original cost of $93,330,441. |
(e) | Other interests represent beneficial interests in liquidation trusts and other reorganization or private entities. |
(f) | Affiliate of the Fund. |
(g) | Annualized 7-day yield as of period end. |
S C H E D U L E S O F I N V E S T M E N T S |
7 |
Schedule of Investments (unaudited) (continued) November 30, 2024 |
BlackRock Health Sciences Opportunities Portfolio |
(h) | All or a portion of this security was purchased with the cash collateral from loaned securities. |
Affiliates
Investments in issuers considered to be affiliate(s) of the Fund during the six months ended November 30, 2024 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:
Affiliated Issuer | Value at 05/31/24 |
Purchases at Cost |
Proceeds from Sales |
Net Realized Gain (Loss) |
Change in Unrealized Appreciation (Depreciation) |
Value at 11/30/24 |
Shares Held at 11/30/24 |
Income | Capital Gain Distributions from Underlying Funds |
|||||||||||||||||||||||||||||||||||||
BlackRock Cash Funds: Institutional, SL Agency Shares |
$ | 77,919,089 | $ | 13,650,656 | (a) | $ | — | $ | 14,283 | $ | 18,040 | $ | 91,602,068 | 91,556,290 | $ | 212,437 | (b) | $ | — | |||||||||||||||||||||||||||
BlackRock Liquidity Funds, T-Fund, Institutional Shares |
90,612,409 | 20,478,924 | (a) | — | — | — | 111,091,333 | 111,091,333 | 3,929,635 | — | ||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
$ | 14,283 | $ | 18,040 | $ | 202,693,401 | $ | 4,142,072 | $ | — | |||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
(a) | Represents net amount purchased (sold). |
(b) | All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of collateral investment fees, and other payments to and from borrowers of securities. |
For purposes of this report, industry and sector sub-classifications may differ from those utilized by the Fund for compliance purposes.
Fair Value Hierarchy as of Period End
Various inputs are used in determining the fair value of financial instruments at the measurement date. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.
The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.
|
||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Assets |
||||||||||||||||||||||||||||
Investments |
||||||||||||||||||||||||||||
Long-Term Investments |
||||||||||||||||||||||||||||
Common Stocks |
||||||||||||||||||||||||||||
Biotechnology |
$ | 2,084,058,174 | $ | 12,162,905 | $ | — | $ | 2,096,221,079 | ||||||||||||||||||||
Financial Services |
8,855,943 | — | — | 8,855,943 | ||||||||||||||||||||||||
Health Care Equipment & Supplies |
2,218,703,200 | — | — | 2,218,703,200 | ||||||||||||||||||||||||
Health Care Providers & Services |
1,396,552,981 | — | — | 1,396,552,981 | ||||||||||||||||||||||||
Life Sciences Tools & Services |
712,326,008 | — | — | 712,326,008 | ||||||||||||||||||||||||
Pharmaceuticals |
1,196,245,758 | 227,705,039 | — | 1,423,950,797 | ||||||||||||||||||||||||
Corporate Bonds |
— | — | 1,450,864 | 1,450,864 | ||||||||||||||||||||||||
Other Interests |
— | — | 1,164,406 | 1,164,406 | ||||||||||||||||||||||||
Preferred Securities |
— | — | 52,887,591 | 52,887,591 | ||||||||||||||||||||||||
Rights |
— | — | 697,656 | 697,656 | ||||||||||||||||||||||||
Warrants |
13,159 | — | — | 13,159 | ||||||||||||||||||||||||
Short-Term Securities |
||||||||||||||||||||||||||||
Money Market Funds |
202,693,401 | — | — | 202,693,401 | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
$ | 7,819,448,624 | $ | 239,867,944 | $ | 56,200,517 | $ | 8,115,517,085 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
See notes to financial statements.
8 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Schedule of Investments (unaudited) November 30, 2024 |
BlackRock Infrastructure Sustainable Opportunities Fund (Percentages shown are based on Net Assets) |
Security | Shares | Value | ||||||
Common Stocks |
||||||||
Construction & Engineering — 2.5% | ||||||||
Ferrovial SE |
5,856 | $ | 241,578 | |||||
|
|
|||||||
Diversified Telecommunication Services — 4.3% | ||||||||
Cellnex Telecom SA(a) |
6,059 | 217,733 | ||||||
Infrastrutture Wireless Italiane SpA(a) |
19,120 | 197,036 | ||||||
|
|
|||||||
414,769 | ||||||||
Electric Utilities — 19.5% | ||||||||
Alliant Energy Corp. |
3,031 | 191,559 | ||||||
Enel SpA |
49,770 | 358,418 | ||||||
Eversource Energy |
1,516 | 97,767 | ||||||
Exelon Corp. |
12,193 | 482,355 | ||||||
Fortis, Inc. |
3,158 | 141,203 | ||||||
PG&E Corp. |
19,235 | 416,053 | ||||||
SSE PLC |
4,248 | 95,806 | ||||||
Terna - Rete Elettrica Nazionale |
11,327 | 95,867 | ||||||
|
|
|||||||
1,879,028 | ||||||||
Ground Transportation — 18.2% | ||||||||
Canadian National Railway Co. |
4,819 | 538,332 | ||||||
Canadian Pacific Kansas City Ltd. |
2,560 | 196,144 | ||||||
CSX Corp. |
12,937 | 472,847 | ||||||
Tokyo Metro Co. Ltd.(b)(c) |
22,700 | 251,860 | ||||||
West Japan Railway Co. |
15,300 | 288,121 | ||||||
|
|
|||||||
1,747,304 | ||||||||
Health Care REITs — 3.4% | ||||||||
Aedifica SA |
1,454 | 89,282 | ||||||
Healthpeak Properties, Inc. |
10,936 | 240,483 | ||||||
|
|
|||||||
329,765 | ||||||||
Independent Power and Renewable Electricity Producers — 6.1% | ||||||||
Boralex, Inc., Class A |
10,101 | 216,226 | ||||||
Clearway Energy, Inc., Class C |
4,281 | 126,247 | ||||||
Innergex Renewable Energy, Inc. |
25,162 | 155,639 | ||||||
Northland Power, Inc. |
6,160 | 88,679 | ||||||
|
|
|||||||
586,791 | ||||||||
IT Services — 1.8% | ||||||||
NEXTDC Ltd.(b) |
16,103 | 171,774 | ||||||
|
|
|||||||
Multi-Utilities — 17.9% | ||||||||
CMS Energy Corp. |
2,043 | 142,418 | ||||||
Consolidated Edison, Inc. |
4,267 | 429,217 | ||||||
E.ON SE, Registered Shares |
38,114 | 491,246 | ||||||
National Grid PLC |
52,172 | 658,549 | ||||||
|
|
|||||||
1,721,430 |
Security | Shares | Value | ||||||
Specialized REITs — 9.6% | ||||||||
American Tower Corp. |
846 | $ | 176,814 | |||||
Equinix, Inc. |
295 | 289,537 | ||||||
SBA Communications Corp. |
2,012 | 455,215 | ||||||
|
|
|||||||
921,566 | ||||||||
Transportation Infrastructure — 11.9% | ||||||||
Aena SME SA(a) |
1,500 | 324,858 | ||||||
Enav SpA(a) |
44,878 | 193,574 | ||||||
Flughafen Zurich AG, Registered Shares |
1,463 | 348,276 | ||||||
Getlink SE |
5,597 | 91,523 | ||||||
Transurban Group |
21,992 | 184,122 | ||||||
|
|
|||||||
1,142,353 | ||||||||
Water Utilities — 4.1% | ||||||||
United Utilities Group PLC |
27,800 | 396,184 | ||||||
|
|
|||||||
Total Long-Term Investments — 99.3% |
9,552,542 | |||||||
|
|
|||||||
Short-Term Securities |
||||||||
Money Market Funds — 3.6% | ||||||||
BlackRock Cash Funds: Institutional, SL Agency Shares, 4.79%(d)(e)(f) |
274,935 | 275,072 | ||||||
BlackRock Liquidity Funds, T-Fund, Institutional Shares, 4.53%(d)(e) |
69,854 | 69,854 | ||||||
|
|
|||||||
Total Short-Term Securities — 3.6% |
344,926 | |||||||
|
|
|||||||
Total Investments — 102.9% |
9,897,468 | |||||||
Liabilities in Excess of Other Assets — (2.9)% |
(276,350 | ) | ||||||
|
|
|||||||
Net Assets — 100.0% |
$ | 9,621,118 | ||||||
|
|
(a) | Security exempt from registration pursuant to Rule 144A under the Securities Act of 1933, as amended. These securities may be resold in transactions exempt from registration to qualified institutional investors. |
(b) | Non-income producing security. |
(c) | All or a portion of this security is on loan. |
(d) | Affiliate of the Fund. |
(e) | Annualized 7-day yield as of period end. |
(f) | All or a portion of this security was purchased with the cash collateral from loaned securities. |
S C H E D U L E S O F I N V E S T M E N T S |
9 |
Schedule of Investments (unaudited) (continued) November 30, 2024 |
BlackRock Infrastructure Sustainable Opportunities Fund |
Affiliates
Investments in issuers considered to be affiliate(s) of the Fund during the six months ended November 30, 2024 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:
Affiliated Issuer | Value at 05/31/24 |
Purchases at Cost |
Proceeds from Sales |
Net Realized Gain (Loss) |
Change in Unrealized Appreciation (Depreciation) |
Value at 11/30/24 |
Shares Held at 11/30/24 |
Income | Capital Gain Distributions from Underlying Funds |
|||||||||||||||||||||||||||||||||||||
BlackRock Cash Funds: Institutional, SL Agency Shares |
$ | — | $ | 275,035 | (a) | $ | — | $ | 37 | $ | — | $ | 275,072 | 274,935 | $ | 35 | (b) | $ | — | |||||||||||||||||||||||||||
BlackRock Liquidity Funds, T-Fund, Institutional Shares |
179,426 | — | (109,572 | )(a) | — | — | 69,854 | 69,854 | 3,518 | — | ||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
$ | 37 | $ | — | $ | 344,926 | $ | 3,553 | $ | — | |||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
(a) | Represents net amount purchased (sold). |
(b) | All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of collateral investment fees, and other payments to and from borrowers of securities. |
For purposes of this report, industry and sector sub-classifications may differ from those utilized by the Fund for compliance purposes.
Derivative Financial Instruments Categorized by Risk Exposure
For the period ended November 30, 2024, the effect of derivative financial instruments in the Statements of Operations was as follows:
Commodity Contracts |
Credit Contracts |
Equity Contracts |
Foreign Currency Exchange Contracts |
Interest Rate Contracts |
Other Contracts |
Total | ||||||||||||||||||||||
Net Realized Gain (Loss) from: |
||||||||||||||||||||||||||||
Swaps |
$ | — | $ | — | $ | 8,662 | $ | — | $ | — | $ | — | $ | 8,662 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Net Change in Unrealized Appreciation (Depreciation) on: |
||||||||||||||||||||||||||||
Swaps |
$ | — | $ | — | $ | 3,171 | $ | — | $ | — | $ | — | $ | 3,171 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average Quarterly Balances of Outstanding Derivative Financial Instruments
|
||||
Total return swaps |
||||
Average notional amount |
$ | 16,464 | ||
|
For more information about the Fund’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.
Fair Value Hierarchy as of Period End
Various inputs are used in determining the fair value of financial instruments at the measurement date. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.
The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.
|
||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Assets |
||||||||||||||||||||||||||||
Investments |
||||||||||||||||||||||||||||
Long-Term Investments |
||||||||||||||||||||||||||||
Common Stocks |
||||||||||||||||||||||||||||
Construction & Engineering |
$ | — | $ | 241,578 | $ | — | $ | 241,578 | ||||||||||||||||||||
Diversified Telecommunication Services |
— | 414,769 | — | 414,769 | ||||||||||||||||||||||||
Electric Utilities |
1,328,937 | 550,091 | — | 1,879,028 | ||||||||||||||||||||||||
Ground Transportation |
1,459,183 | 288,121 | — | 1,747,304 | ||||||||||||||||||||||||
Health Care REITs |
240,483 | 89,282 | — | 329,765 | ||||||||||||||||||||||||
Independent Power and Renewable Electricity Producers |
586,791 | — | — | 586,791 | ||||||||||||||||||||||||
IT Services |
— | 171,774 | — | 171,774 | ||||||||||||||||||||||||
Multi-Utilities |
571,635 | 1,149,795 | — | 1,721,430 | ||||||||||||||||||||||||
Specialized REITs |
921,566 | — | — | 921,566 |
10 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Schedule of Investments (unaudited) (continued) November 30, 2024 |
BlackRock Infrastructure Sustainable Opportunities Fund |
Fair Value Hierarchy as of Period End (continued)
|
||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Common Stocks (continued) |
||||||||||||||||||||||||||||
Transportation Infrastructure |
$ | — | $ | 1,142,353 | $ | — | $ | 1,142,353 | ||||||||||||||||||||
Water Utilities |
— | 396,184 | — | 396,184 | ||||||||||||||||||||||||
Short-Term Securities |
||||||||||||||||||||||||||||
Money Market Funds |
344,926 | — | — | 344,926 | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
$ | 5,453,521 | $ | 4,443,947 | $ | — | $ | 9,897,468 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
See notes to financial statements.
S C H E D U L E S O F I N V E S T M E N T S |
11 |
Schedule of Investments (unaudited) November 30, 2024 |
BlackRock Mid-Cap Growth Equity Portfolio (Percentages shown are based on Net Assets) |
Security | Shares | Value | ||||||
Common Stocks |
| |||||||
Aerospace & Defense — 9.1% | ||||||||
Axon Enterprise, Inc.(a) |
776,029 | $ | 502,059,722 | |||||
HEICO Corp.(b) |
1,050,536 | 287,185,026 | ||||||
Howmet Aerospace, Inc. |
2,150,375 | 254,561,393 | ||||||
|
|
|||||||
1,043,806,141 | ||||||||
Automobiles — 1.8% | ||||||||
Ferrari NV(b) |
464,141 | 201,511,456 | ||||||
|
|
|||||||
Biotechnology — 0.4% | ||||||||
Natera, Inc.(a) |
246,803 | 41,408,607 | ||||||
|
|
|||||||
Building Products — 1.1% | ||||||||
AZEK Co., Inc. (The), Class A(a)(b) |
2,429,827 | 129,072,410 | ||||||
|
|
|||||||
Capital Markets — 8.3% | ||||||||
Ares Management Corp., Class A |
2,038,300 | 360,228,759 | ||||||
MSCI, Inc., Class A |
68,526 | 41,775,505 | ||||||
TPG, Inc., Class A |
3,841,090 | 268,722,656 | ||||||
Tradeweb Markets, Inc., Class A |
2,095,335 | 283,917,893 | ||||||
|
|
|||||||
954,644,813 | ||||||||
Commercial Services & Supplies — 4.3% | ||||||||
Copart, Inc.(a) |
3,870,086 | 245,324,752 | ||||||
Rollins, Inc. |
3,187,265 | 160,415,047 | ||||||
Waste Connections, Inc. |
470,595 | 90,575,420 | ||||||
|
|
|||||||
496,315,219 | ||||||||
Construction & Engineering — 4.1% | ||||||||
Comfort Systems U.S.A., Inc. |
624,295 | 307,945,995 | ||||||
Quanta Services, Inc. |
474,779 | 163,570,861 | ||||||
|
|
|||||||
471,516,856 | ||||||||
Construction Materials — 1.0% | ||||||||
Vulcan Materials Co. |
390,543 | 112,527,155 | ||||||
|
|
|||||||
Electrical Equipment — 4.0% | ||||||||
Vertiv Holdings Co., Class A |
3,553,645 | 453,445,102 | ||||||
|
|
|||||||
Electronic Equipment, Instruments & Components — 0.8% | ||||||||
Coherent Corp.(a) |
948,013 | 94,952,982 | ||||||
|
|
|||||||
Entertainment — 4.7% | ||||||||
Liberty Media Corp. - Liberty Formula One, Class C, NVS(a) |
2,689,167 | 237,614,796 | ||||||
Live Nation Entertainment, Inc.(a)(b) |
2,190,785 | 302,876,026 | ||||||
|
|
|||||||
540,490,822 | ||||||||
Financial Services — 2.4% | ||||||||
Adyen NV(a)(c) |
106,162 | 154,520,258 | ||||||
Affirm Holdings, Inc., Class A(a) |
1,644,888 | 115,158,609 | ||||||
|
|
|||||||
269,678,867 | ||||||||
Ground Transportation — 2.5% | ||||||||
Saia, Inc.(a)(b) |
503,890 | 286,753,721 | ||||||
|
|
|||||||
Health Care Equipment & Supplies — 7.2% | ||||||||
Alcon AG |
1,764,600 | 156,784,710 | ||||||
Align Technology, Inc.(a) |
911,854 | 212,252,255 | ||||||
Dexcom, Inc.(a) |
2,964,432 | 231,196,052 | ||||||
IDEXX Laboratories, Inc.(a) |
125,832 | 53,069,646 | ||||||
Masimo Corp.(a)(b) |
970,331 | 167,420,911 | ||||||
|
|
|||||||
820,723,574 | ||||||||
Hotels, Restaurants & Leisure — 6.1% | ||||||||
Churchill Downs, Inc. |
1,170,248 | 166,303,943 | ||||||
DraftKings, Inc., Class A(a)(b) |
5,291,718 | 230,983,491 | ||||||
Flutter Entertainment PLC(a) |
167,668 | 46,330,022 |
Security | Shares | Value | ||||||
Hotels, Restaurants & Leisure (continued) | ||||||||
Planet Fitness, Inc., Class A(a) |
1,554,953 | $ | 154,795,571 | |||||
Wingstop, Inc. |
287,364 | 94,476,662 | ||||||
|
|
|||||||
692,889,689 | ||||||||
Independent Power and Renewable Electricity Producers — 1.2% | ||||||||
Vistra Corp. |
850,138 | 135,886,058 | ||||||
|
|
|||||||
Interactive Media & Services — 2.1% | ||||||||
Pinterest, Inc., Class A(a) |
4,174,517 | 126,571,355 | ||||||
Reddit, Inc., Class A(a) |
841,043 | 118,326,340 | ||||||
|
|
|||||||
244,897,695 | ||||||||
IT Services — 2.7% | ||||||||
Globant SA(a)(b) |
560,399 | 127,636,476 | ||||||
MongoDB, Inc., Class A(a) |
560,739 | 180,832,720 | ||||||
|
|
|||||||
308,469,196 | ||||||||
Life Sciences Tools & Services — 2.4% | ||||||||
Bio-Techne Corp.(b) |
101,181 | 7,625,000 | ||||||
Mettler-Toledo International, Inc.(a) |
9,151 | 11,449,731 | ||||||
Repligen Corp.(a) |
360,284 | 54,237,154 | ||||||
West Pharmaceutical Services, Inc. |
607,897 | 197,979,895 | ||||||
|
|
|||||||
271,291,780 | ||||||||
Machinery — 0.5% | ||||||||
IDEX Corp. |
234,839 | 54,160,919 | ||||||
|
|
|||||||
Media — 2.3% | ||||||||
Trade Desk, Inc. (The), Class A(a) |
2,068,490 | 265,904,389 | ||||||
|
|
|||||||
Real Estate Management & Development — 2.1% | ||||||||
CoStar Group, Inc.(a)(b) |
2,925,982 | 237,999,376 | ||||||
|
|
|||||||
Semiconductors & Semiconductor Equipment — 7.8% | ||||||||
ASM International NV |
352,023 | 189,450,410 | ||||||
Astera Labs, Inc.(a)(b) |
1,144,227 | 118,141,438 | ||||||
BE Semiconductor Industries NV |
837,315 | 99,557,467 | ||||||
Credo Technology Group Holding Ltd.(a) |
1,731,816 | 84,789,711 | ||||||
Entegris, Inc.(b) |
2,343,229 | 247,515,279 | ||||||
Monolithic Power Systems, Inc. |
269,247 | 152,835,367 | ||||||
|
|
|||||||
892,289,672 | ||||||||
Software — 16.3% | ||||||||
AppLovin Corp., Class A(a) |
1,734,760 | 584,180,430 | ||||||
Aspen Technology, Inc.(a)(b) |
48,911 | 12,227,750 | ||||||
Bentley Systems, Inc., Class B |
2,643,307 | 130,843,697 | ||||||
Cadence Design Systems, Inc.(a) |
875,307 | 268,552,941 | ||||||
Confluent, Inc., Class A(a)(b) |
5,351,686 | 165,045,996 | ||||||
CyberArk Software Ltd.(a) |
195,295 | 63,179,885 | ||||||
Fair Isaac Corp.(a) |
104,642 | 248,527,889 | ||||||
Manhattan Associates, Inc.(a)(b) |
558,365 | 159,379,706 | ||||||
PTC, Inc.(a) |
526,838 | 105,399,210 | ||||||
Roper Technologies, Inc. |
34,995 | 19,822,568 | ||||||
Tyler Technologies, Inc.(a)(b) |
170,490 | 107,267,193 | ||||||
|
|
|||||||
1,864,427,265 | ||||||||
Specialty Retail — 2.4% | ||||||||
Carvana Co., Class A(a) |
526,539 | 137,121,286 | ||||||
Floor & Decor Holdings, Inc., Class A(a)(b) |
1,220,745 | 136,979,797 | ||||||
|
|
|||||||
274,101,083 | ||||||||
Technology Hardware, Storage & Peripherals — 0.8% | ||||||||
Pure Storage, Inc., Class A(a) |
1,757,111 | 93,109,312 | ||||||
|
|
|||||||
Textiles, Apparel & Luxury Goods — 1.2% | ||||||||
On Holding AG, Class A(a)(b) |
2,346,376 | 136,864,112 | ||||||
|
|
12 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Schedule of Investments (unaudited) (continued) November 30, 2024 |
BlackRock Mid-Cap Growth Equity Portfolio (Percentages shown are based on Net Assets) |
Security | Shares |
Value | ||||||
Trading Companies & Distributors — 0.5% | ||||||||
FTAI Aviation Ltd. |
376,924 | $ | 63,632,310 | |||||
|
|
|||||||
Total Common Stocks — 100.1% |
11,452,770,581 | |||||||
|
|
|||||||
Par (000) |
||||||||
Other Interests(a)(d)(e) |
||||||||
GCI Liberty, Inc., Class A |
USD | 1,529 | 15 | |||||
|
|
|||||||
Total Other Interests — 0.0% |
15 | |||||||
|
|
|||||||
Total Long-Term Investments — 100.1% |
|
11,452,770,596 | ||||||
|
|
|||||||
Shares | ||||||||
Short-Term Securities |
||||||||
Money Market Funds — 3.8% | ||||||||
BlackRock Cash Funds: Institutional, SL Agency Shares, 4.79%(f)(g)(h) |
431,367,865 | 431,583,549 | ||||||
|
|
|||||||
Total Short-Term Securities — 3.8% |
431,583,549 | |||||||
|
|
|||||||
Total Investments — 103.9% |
11,884,354,145 | |||||||
Liabilities in Excess of Other Assets — (3.9)% |
|
(446,230,675 | ) | |||||
|
|
|||||||
Net Assets — 100.0% |
$ | 11,438,123,470 | ||||||
|
|
(a) | Non-income producing security. |
(b) | All or a portion of this security is on loan. |
(c) | Security exempt from registration pursuant to Rule 144A under the Securities Act of 1933, as amended. These securities may be resold in transactions exempt from registration to qualified institutional investors. |
(d) | Security is valued using significant unobservable inputs and is classified as Level 3 in the fair value hierarchy. |
(e) | Other interests represent beneficial interests in liquidation trusts and other reorganization or private entities. |
(f) | Affiliate of the Fund. |
(g) | Annualized 7-day yield as of period end. |
(h) | All or a portion of this security was purchased with the cash collateral from loaned securities. |
Affiliates
Investments in issuers considered to be affiliate(s) of the Fund during the six months ended November 30, 2024 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:
Affiliated Issuer | Value at 05/31/24 |
Purchases at Cost |
Proceeds from Sales |
Net Realized Gain (Loss) |
Change in Unrealized Appreciation (Depreciation) |
Value at 11/30/24 |
Shares Held at |
Income | Capital Gain Distributions from Underlying Funds |
|||||||||||||||||||||||||||||||||||||
BlackRock Cash Funds: Institutional, SL Agency Shares |
$ | 462,938,124 | $ | — | $ | (31,574,329 | )(a) | $ | 196,041 | $ | 23,713 | $ | 431,583,549 | 431,367,865 | $ | 454,417 | (b) | $ | — | |||||||||||||||||||||||||||
BlackRock Liquidity Funds, T-Fund, Institutional Shares(c) |
750,097 | — | (750,097 | )(a) | — | — | — | — | 240,458 | — | ||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
$ | 196,041 | $ | 23,713 | $ | 431,583,549 | $ | 694,875 | $ | — | |||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
(a) | Represents net amount purchased (sold). |
(b) | All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of collateral investment fees, and other payments to and from borrowers of securities. |
(c) | As of period end, the entity is no longer held. |
For purposes of this report, industry and sector sub-classifications may differ from those utilized by the Fund for compliance purposes.
S C H E D U L E S O F I N V E S T M E N T S |
13 |
Schedule of Investments (unaudited) (continued) November 30, 2024 |
BlackRock Mid-Cap Growth Equity Portfolio |
Fair Value Hierarchy as of Period End
Various inputs are used in determining the fair value of financial instruments at the measurement date. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.
The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.
|
||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Assets |
||||||||||||||||||||||||||||
Investments |
||||||||||||||||||||||||||||
Long-Term Investments |
||||||||||||||||||||||||||||
Common Stocks |
||||||||||||||||||||||||||||
Aerospace & Defense |
$ | 1,043,806,141 | $ | — | $ | — | $ | 1,043,806,141 | ||||||||||||||||||||
Automobiles |
201,511,456 | — | — | 201,511,456 | ||||||||||||||||||||||||
Biotechnology |
41,408,607 | — | — | 41,408,607 | ||||||||||||||||||||||||
Building Products |
129,072,410 | — | — | 129,072,410 | ||||||||||||||||||||||||
Capital Markets |
954,644,813 | — | — | 954,644,813 | ||||||||||||||||||||||||
Commercial Services & Supplies |
496,315,219 | — | — | 496,315,219 | ||||||||||||||||||||||||
Construction & Engineering |
471,516,856 | — | — | 471,516,856 | ||||||||||||||||||||||||
Construction Materials |
112,527,155 | — | — | 112,527,155 | ||||||||||||||||||||||||
Electrical Equipment |
453,445,102 | — | — | 453,445,102 | ||||||||||||||||||||||||
Electronic Equipment, Instruments & Components |
94,952,982 | — | — | 94,952,982 | ||||||||||||||||||||||||
Entertainment |
540,490,822 | — | — | 540,490,822 | ||||||||||||||||||||||||
Financial Services |
115,158,609 | 154,520,258 | — | 269,678,867 | ||||||||||||||||||||||||
Ground Transportation |
286,753,721 | — | — | 286,753,721 | ||||||||||||||||||||||||
Health Care Equipment & Supplies |
820,723,574 | — | — | 820,723,574 | ||||||||||||||||||||||||
Hotels, Restaurants & Leisure |
692,889,689 | — | — | 692,889,689 | ||||||||||||||||||||||||
Independent Power and Renewable Electricity Producers |
135,886,058 | — | — | 135,886,058 | ||||||||||||||||||||||||
Interactive Media & Services |
244,897,695 | — | — | 244,897,695 | ||||||||||||||||||||||||
IT Services |
308,469,196 | — | — | 308,469,196 | ||||||||||||||||||||||||
Life Sciences Tools & Services |
271,291,780 | — | — | 271,291,780 | ||||||||||||||||||||||||
Machinery |
54,160,919 | — | — | 54,160,919 | ||||||||||||||||||||||||
Media |
265,904,389 | — | — | 265,904,389 | ||||||||||||||||||||||||
Real Estate Management & Development |
237,999,376 | — | — | 237,999,376 | ||||||||||||||||||||||||
Semiconductors & Semiconductor Equipment |
603,281,795 | 289,007,877 | — | 892,289,672 | ||||||||||||||||||||||||
Software |
1,864,427,265 | — | — | 1,864,427,265 | ||||||||||||||||||||||||
Specialty Retail |
274,101,083 | — | — | 274,101,083 | ||||||||||||||||||||||||
Technology Hardware, Storage & Peripherals |
93,109,312 | — | — | 93,109,312 | ||||||||||||||||||||||||
Textiles, Apparel & Luxury Goods |
136,864,112 | — | — | 136,864,112 | ||||||||||||||||||||||||
Trading Companies & Distributors |
63,632,310 | — | — | 63,632,310 | ||||||||||||||||||||||||
Other Interests |
— | — | 15 | 15 | ||||||||||||||||||||||||
Short-Term Securities |
||||||||||||||||||||||||||||
Money Market Funds |
431,583,549 | — | — | 431,583,549 | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
$ | 11,440,825,995 | $ | 443,528,135 | $ | 15 | $ | 11,884,354,145 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
See notes to financial statements.
14 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Schedule of Investments (unaudited) November 30, 2024 |
BlackRock Technology Opportunities Fund (Percentages shown are based on Net Assets) |
Security | Shares | Value | ||||||
Common Stocks |
||||||||
Automobiles — 2.3% | ||||||||
Tesla, Inc.(a) |
416,148 | $ | 143,637,644 | |||||
|
|
|||||||
Banks — 0.4% | ||||||||
NU Holdings Ltd., Class A(a) |
1,720,887 | 21,562,714 | ||||||
|
|
|||||||
Broadline Retail — 4.3% | ||||||||
Amazon.com, Inc.(a) |
776,493 | 161,425,130 | ||||||
MercadoLibre, Inc.(a) |
51,356 | 101,950,390 | ||||||
|
|
|||||||
263,375,520 | ||||||||
Capital Markets — 0.5% | ||||||||
S&P Global, Inc. |
64,329 | 33,612,546 | ||||||
|
|
|||||||
Communications Equipment — 1.7% | ||||||||
Arista Networks, Inc.(a) |
169,037 | 68,598,595 | ||||||
Motorola Solutions, Inc. |
69,230 | 34,594,231 | ||||||
|
|
|||||||
103,192,826 | ||||||||
Consumer Finance — 0.6% | ||||||||
Kaspi.KZ JSC, ADR |
319,978 | 34,045,659 | ||||||
|
|
|||||||
Diversified Consumer Services — 0.0% | ||||||||
Think & Learn Private Ltd. (Acquired 09/30/20, cost $3,427,642)(a)(b)(c) |
2,241 | — | ||||||
|
|
|||||||
Electric Utilities — 0.4% | ||||||||
Constellation Energy Corp. |
103,188 | 26,473,913 | ||||||
|
|
|||||||
Electrical Equipment — 1.1% | ||||||||
Vertiv Holdings Co., Class A |
533,886 | 68,123,854 | ||||||
|
|
|||||||
Electronic Equipment, Instruments & Components — 1.0% | ||||||||
Coherent Corp.(a) |
633,491 | 63,450,458 | ||||||
|
|
|||||||
Entertainment — 4.4% | ||||||||
Electronic Arts, Inc. |
198,202 | 32,439,721 | ||||||
Netflix, Inc.(a) |
59,859 | 53,083,560 | ||||||
Nintendo Co. Ltd. |
696,800 | 40,895,261 | ||||||
Spotify Technology SA(a) |
210,362 | 100,334,259 | ||||||
Take-Two Interactive Software, Inc.(a) |
224,032 | 42,203,148 | ||||||
|
|
|||||||
268,955,949 | ||||||||
Financial Services — 2.1% | ||||||||
Adyen NV(a)(d) |
23,234 | 33,817,408 | ||||||
Mastercard, Inc., Class A |
174,325 | 92,904,765 | ||||||
|
|
|||||||
126,722,173 | ||||||||
Industrial Conglomerates — 1.1% | ||||||||
Hitachi Ltd. |
2,628,000 | 66,227,843 | ||||||
|
|
|||||||
Interactive Media & Services — 5.1% | ||||||||
Alphabet, Inc., Class A |
569,952 | 96,293,391 | ||||||
Meta Platforms, Inc., Class A |
379,185 | 217,773,529 | ||||||
|
|
|||||||
314,066,920 | ||||||||
IT Services — 3.1% | ||||||||
Farmer’s Business Network, Inc.(a)(b) |
194,200 | 514,630 | ||||||
Klarna Holdings AB (Acquired 09/15/20, cost $11,017,172)(a)(b)(c) |
25,600 | 12,614,743 | ||||||
MongoDB, Inc., Class A(a) |
247,774 | 79,904,637 | ||||||
Shopify, Inc., Class A(a) |
304,124 | 35,156,734 | ||||||
Snowflake, Inc., Class A(a) |
350,702 | 61,302,710 | ||||||
|
|
|||||||
189,493,454 | ||||||||
Professional Services — 1.9% | ||||||||
RELX PLC |
1,265,101 | 59,642,064 | ||||||
Thomson Reuters Corp. |
345,555 | 56,212,386 | ||||||
|
|
|||||||
115,854,450 |
Security | Shares | Value | ||||||
Semiconductors & Semiconductor Equipment — 28.8% | ||||||||
Applied Materials, Inc. |
227,461 | $ | 39,739,711 | |||||
ARM Holdings PLC, ADR(a)(e) |
442,121 | 59,372,429 | ||||||
ASM International NV |
76,373 | 41,102,133 | ||||||
ASML Holding NV |
112,892 | 77,140,141 | ||||||
Broadcom, Inc. |
1,680,805 | 272,424,874 | ||||||
Marvell Technology, Inc. |
934,490 | 86,617,878 | ||||||
Micron Technology, Inc. |
1,055,668 | 103,402,681 | ||||||
Monolithic Power Systems, Inc. |
62,497 | 35,475,797 | ||||||
NVIDIA Corp.(e) |
6,671,918 | 922,392,664 | ||||||
Taiwan Semiconductor Manufacturing Co. Ltd., ADR |
668,756 | 123,492,483 | ||||||
|
|
|||||||
1,761,160,791 | ||||||||
Software — 30.3% | ||||||||
AppLovin Corp., Class A(a) |
126,916 | 42,738,963 | ||||||
Atlassian Corp., Class A(a) |
173,488 | 45,727,967 | ||||||
Autodesk, Inc.(a) |
154,393 | 45,067,317 | ||||||
Cadence Design Systems, Inc.(a) |
650,594 | 199,608,745 | ||||||
Constellation Software, Inc. |
22,901 | 76,842,543 | ||||||
Crowdstrike Holdings, Inc., Class A(a) |
194,314 | 67,226,815 | ||||||
CyberArk Software Ltd.(a) |
132,068 | 42,725,319 | ||||||
Databricks, Inc. (Acquired 07/24/20, cost $5,122,891)(a)(b)(c) |
319,983 | 28,142,505 | ||||||
Datadog, Inc., Class A(a) |
309,428 | 47,265,127 | ||||||
Fair Isaac Corp.(a) |
57,128 | 135,680,714 | ||||||
Guidewire Software, Inc.(a) |
210,435 | 42,695,157 | ||||||
Microsoft Corp. |
1,220,392 | 516,787,196 | ||||||
Nutanix, Inc., Class A(a) |
489,750 | 31,970,880 | ||||||
Oracle Corp. |
928,139 | 171,557,213 | ||||||
Palo Alto Networks, Inc.(a) |
131,838 | 51,129,413 | ||||||
Samsara, Inc., Class A(a)(e) |
879,228 | 47,029,906 | ||||||
SAP SE |
406,414 | 96,509,460 | ||||||
ServiceNow, Inc.(a) |
114,142 | 119,785,180 | ||||||
Unqork, Inc. (Acquired 03/05/21, cost $4,093,769)(a)(b)(c) |
149,520 | 822,360 | ||||||
Xero Ltd.(a) |
420,030 | 47,829,752 | ||||||
|
|
|||||||
1,857,142,532 | ||||||||
Specialty Retail — 0.0% | ||||||||
AceVector Ltd. (Acquired 05/07/14, cost $1,414,399)(a)(b)(c) |
304,000 | 115,849 | ||||||
|
|
|||||||
Technology Hardware, Storage & Peripherals — 8.3% | ||||||||
Apple Inc. |
2,014,661 | 478,139,495 | ||||||
Dell Technologies, Inc., Class C |
235,465 | 30,042,979 | ||||||
|
|
|||||||
508,182,474 | ||||||||
|
|
|||||||
Total Common Stocks — 97.4% |
5,965,397,569 | |||||||
|
|
|||||||
Preferred Securities |
||||||||
Preferred Stocks — 1.5% | ||||||||
Diversified Consumer Services — 0.0% | ||||||||
Think & Learn Private Ltd., Series F (Acquired 09/30/20, cost $6,867,746)(a)(b)(c) |
2,371 | — | ||||||
|
|
|||||||
Interactive Media & Services — 0.3% | ||||||||
Bytedance Ltd., Series E-1 (Acquired 11/11/20, cost $10,748,384)(a)(b)(c) |
94,889 | 17,146,442 | ||||||
|
|
S C H E D U L E S O F I N V E S T M E N T S |
15 |
Schedule of Investments (unaudited) (continued) November 30, 2024 |
BlackRock Technology Opportunities Fund (Percentages shown are based on Net Assets) |
Security | Shares | Value | ||||||
Semiconductors & Semiconductor Equipment — 0.5% | ||||||||
PsiQuantum Corp., Series C (Acquired 09/09/19, cost $2,698,454)(a)(b)(c) |
581,814 | $ | 17,815,145 | |||||
SambaNova Systems, Inc., Series C (Acquired 02/20/20, cost $9,804,574)(a)(b)(c) |
184,153 | 10,266,530 | ||||||
|
|
|||||||
28,081,675 | ||||||||
Software — 0.7% | ||||||||
Databricks, Inc. |
||||||||
Series F (Acquired 10/22/19, cost $3,700,005)(a)(b)(c) |
258,450 | 22,730,677 | ||||||
Series G (Acquired 02/01/21, cost $12,500,003)(a)(b)(c) |
211,425 | 18,594,829 | ||||||
Unqork, Inc. |
||||||||
Series A (Acquired 03/05/21, cost $194,941)(a)(b)(c) |
7,120 | 41,296 | ||||||
Series B (Acquired 03/05/21, cost $314,315)(a)(b)(c) |
11,480 | 73,472 | ||||||
Series C (Acquired 09/18/20, cost $8,323,340)(a)(b)(c) |
304,000 | 2,441,120 | ||||||
Series Seed (Acquired 03/05/21, cost $489,544)(a)(b)(c) |
17,880 | 99,592 | ||||||
Series Seed A (Acquired 03/05/21, cost $180,704)(a)(b)(c) |
6,600 | 36,630 | ||||||
|
|
|||||||
44,017,616 | ||||||||
|
|
|||||||
Total Preferred Securities — 1.5% |
89,245,733 | |||||||
|
|
|||||||
Warrants(a)(b) |
||||||||
Software — 0.0% | ||||||||
Constellation Software, Inc. (Issued/Exercisable 08/23/23, 1 Share for 1 Warrant, Expires 03/31/40, Strike Price CAD 0.00) |
22,107 | — | ||||||
|
|
|||||||
Total Warrants — 0.0% |
|
— | ||||||
|
|
|||||||
Total Long-Term Investments — 98.9% |
|
6,054,643,302 | ||||||
|
|
Security | Shares | Value | ||||||
Short-Term Securities |
||||||||
Money Market Funds — 2.0% | ||||||||
BlackRock Cash Funds: Institutional, SL Agency Shares, 4.79%(f)(g)(h) |
51,325,295 | $ | 51,350,958 | |||||
BlackRock Liquidity Funds, T-Fund, Institutional Shares, 4.53%(f)(g) |
74,215,637 | 74,215,637 | ||||||
|
|
|||||||
Total Short-Term Securities — 2.0% |
|
125,566,595 | ||||||
|
|
|||||||
Total Investments — 100.9% |
|
6,180,209,897 | ||||||
Liabilities in Excess of Other Assets — (0.9)% |
|
(57,990,335 | ) | |||||
|
|
|||||||
Net Assets — 100.0% |
$ | 6,122,219,562 | ||||||
|
|
(a) | Non-income producing security. |
(b) | Security is valued using significant unobservable inputs and is classified as Level 3 in the fair value hierarchy. |
(c) | Restricted security as to resale, excluding 144A securities. The Fund held restricted securities with a current value of $130,941,190, representing 2.1% of its net assets as of period end, and an original cost of $80,897,883. |
(d) | Security exempt from registration pursuant to Rule 144A under the Securities Act of 1933, as amended. These securities may be resold in transactions exempt from registration to qualified institutional investors. |
(e) | All or a portion of this security is on loan. |
(f) | Affiliate of the Fund. |
(g) | Annualized 7-day yield as of period end. |
(h) | All or a portion of this security was purchased with the cash collateral from loaned securities. |
Affiliates
Investments in issuers considered to be affiliate(s) of the Fund during the six months ended November 30, 2024 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:
Affiliated Issuer | Value at 05/31/24 |
Purchases at Cost |
Proceeds from Sales |
Net Realized Gain (Loss) |
Change in Unrealized Appreciation (Depreciation) |
Value at 11/30/24 |
Shares Held at 11/30/24 |
Income | Capital Gain Distributions from Underlying Funds |
|||||||||||||||||||||||||||||||||
BlackRock Cash Funds: Institutional, SL Agency Shares |
$ | 42,718,478 | $ | 8,632,283 | (a) | $ | — | $ | 1,768 | $ | (1,571 | ) | $ | 51,350,958 | 51,325,295 | $ | 80,247 | (b) | $ | — | ||||||||||||||||||||||
BlackRock Liquidity Funds, T-Fund, Institutional Shares |
25,083,311 | 49,132,326 | (a) | — | — | — | 74,215,637 | 74,215,637 | 1,298,846 | — | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
$ | 1,768 | $ | (1,571 | ) | $ | 125,566,595 | $ | 1,379,093 | $ | — | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
(a) | Represents net amount purchased (sold). |
(b) | All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of collateral investment fees, and other payments to and from borrowers of securities. |
16 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Schedule of Investments (unaudited) (continued) November 30, 2024 |
BlackRock Technology Opportunities Fund |
For purposes of this report, industry and sector sub-classifications may differ from those utilized by the Fund for compliance purposes.
Fair Value Hierarchy as of Period End
Various inputs are used in determining the fair value of financial instruments at the measurement date. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.
The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.
|
||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Assets |
||||||||||||||||||||||||||||
Investments |
||||||||||||||||||||||||||||
Long-Term Investments |
||||||||||||||||||||||||||||
Common Stocks |
||||||||||||||||||||||||||||
Automobiles |
$ | 143,637,644 | $ | — | $ | — | $ | 143,637,644 | ||||||||||||||||||||
Banks |
21,562,714 | — | — | 21,562,714 | ||||||||||||||||||||||||
Broadline Retail |
263,375,520 | — | — | 263,375,520 | ||||||||||||||||||||||||
Capital Markets |
33,612,546 | — | — | 33,612,546 | ||||||||||||||||||||||||
Communications Equipment |
103,192,826 | — | — | 103,192,826 | ||||||||||||||||||||||||
Consumer Finance |
34,045,659 | — | — | 34,045,659 | ||||||||||||||||||||||||
Diversified Consumer Services |
— | — | — | — | ||||||||||||||||||||||||
Electric Utilities |
26,473,913 | — | — | 26,473,913 | ||||||||||||||||||||||||
Electrical Equipment |
68,123,854 | — | — | 68,123,854 | ||||||||||||||||||||||||
Electronic Equipment, Instruments & Components |
63,450,458 | — | — | 63,450,458 | ||||||||||||||||||||||||
Entertainment |
228,060,688 | 40,895,261 | — | 268,955,949 | ||||||||||||||||||||||||
Financial Services |
92,904,765 | 33,817,408 | — | 126,722,173 | ||||||||||||||||||||||||
Industrial Conglomerates |
— | 66,227,843 | — | 66,227,843 | ||||||||||||||||||||||||
Interactive Media & Services |
314,066,920 | — | — | 314,066,920 | ||||||||||||||||||||||||
IT Services |
176,364,081 | — | 13,129,373 | 189,493,454 | ||||||||||||||||||||||||
Professional Services |
56,212,386 | 59,642,064 | — | 115,854,450 | ||||||||||||||||||||||||
Semiconductors & Semiconductor Equipment |
1,642,918,517 | 118,242,274 | — | 1,761,160,791 | ||||||||||||||||||||||||
Software |
1,683,838,455 | 144,339,212 | 28,964,865 | 1,857,142,532 | ||||||||||||||||||||||||
Specialty Retail |
— | — | 115,849 | 115,849 | ||||||||||||||||||||||||
Technology Hardware, Storage & Peripherals |
508,182,474 | — | — | 508,182,474 | ||||||||||||||||||||||||
Preferred Securities |
— | — | 89,245,733 | 89,245,733 | ||||||||||||||||||||||||
Warrants |
— | — | — | — | ||||||||||||||||||||||||
Short-Term Securities |
||||||||||||||||||||||||||||
Money Market Funds |
125,566,595 | — | — | 125,566,595 | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
$ | 5,585,590,015 | $ | 463,164,062 | $ | 131,455,820 | $ | 6,180,209,897 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
A reconciliation of Level 3 financial instruments is presented when the Fund had a significant amount of Level 3 investments at the beginning and/or end of the year in relation to net assets. The following table is a reconciliation of Level 3 investments for which significant unobservable inputs were used in determining fair value:
Common Stocks |
Preferred Stocks |
Warrants | Total | |||||||||||||
Assets |
||||||||||||||||
Opening Balance, as of May 31, 2024 |
$ | 35,470,366 | $ | 83,769,762 | $ | — | $ | 119,240,128 | ||||||||
Transfers into Level 3 |
— | — | — | — | ||||||||||||
Transfers out of Level 3 |
— | — | — | — | ||||||||||||
Accrued discounts/premiums |
— | — | — | — | ||||||||||||
Net realized gain (loss) |
— | (144,905 | ) | — | (144,905 | ) | ||||||||||
Net change in unrealized appreciation (depreciation)(a)(b) |
6,739,721 | 7,968,231 | — | 14,707,952 | ||||||||||||
Purchases |
— | — | — | — | ||||||||||||
Sales |
— | (2,347,355 | ) | — | (2,347,355 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Closing Balance, as of November 30, 2024 |
$ | 42,210,087 | $ | 89,245,733 | $ | — | (c) | $ | 131,455,820 | |||||||
|
|
|
|
|
|
|
|
|||||||||
Net change in unrealized appreciation (depreciation) on investments still held at November 30, 2024(c) |
$ | 6,739,721 | $ | 7,968,231 | $ | — | $ | 14,707,952 | ||||||||
|
|
|
|
|
|
|
|
(a) | Included in the related net change in unrealized appreciation (depreciation) in the Statements of Operations. |
(b) | Any difference between net change in unrealized appreciation (depreciation) and net change in unrealized appreciation (depreciation) on investments still held at November 30, 2024, is generally due to investments no longer held or categorized as Level 3 at period end. |
(c) | Rounds to less than $1. |
S C H E D U L E S O F I N V E S T M E N T S |
17 |
Schedule of Investments (unaudited) (continued) November 30, 2024 |
BlackRock Technology Opportunities Fund |
The following table summarizes the valuation approaches used and unobservable inputs utilized by the Valuation Committee to determine the value of certain of the Fund’s Level 3 financial instruments as of period end.
Value | Valuation Approach | Unobservable Inputs |
Range of Unobservable Inputs Utilized(a) |
Weighted Average of Unobservable Inputs Based on Fair Value |
||||||||||||||||
Assets |
||||||||||||||||||||
Common Stocks |
$ | 42,210,087 | Market | Revenue Multiple | 2.10x - 23.00x | 17.36x | ||||||||||||||
Volatility | 70% | — | ||||||||||||||||||
Time to Exit | 3.0 years | — | ||||||||||||||||||
Preferred Stocks |
89,245,733 | Market | Revenue Multiple | 1.34x - 23.00x | 15.44x | |||||||||||||||
Volatility | 50% - 90% | 65% | ||||||||||||||||||
Time to Exit | 3.0 - 4.0 years | 3.6 years | ||||||||||||||||||
Market Adjustment Multiple | 1.60x | — | ||||||||||||||||||
|
|
|||||||||||||||||||
$ | 131,455,820 | |||||||||||||||||||
|
|
(a) | A significant change in unobservable input would have resulted in a correlated (inverse) significant change to value. |
See notes to financial statements.
18 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Statements of Assets and Liabilities (unaudited)
November 30, 2024
BlackRock Capital Appreciation Fund, Inc. |
BlackRock Health Sciences Opportunities Portfolio |
BlackRock Infrastructure Sustainable Opportunities Fund |
||||||||||
ASSETS |
||||||||||||
Investments, at value — unaffiliated(a)(b) |
$ | 3,740,257,795 | $ | 7,912,823,684 | $ | 9,552,542 | ||||||
Investments, at value — affiliated(c) |
— | 202,693,401 | 344,926 | |||||||||
Foreign currency, at value(d) |
— | 99,444 | 2,592 | |||||||||
Receivables: |
||||||||||||
Investments sold |
7,614,625 | — | 123,108 | |||||||||
Securities lending income — affiliated |
— | 39,583 | 2 | |||||||||
Capital shares sold |
698,004 | 2,541,913 | — | |||||||||
Dividends — unaffiliated |
1,407,130 | 7,496,969 | 49,362 | |||||||||
Dividends — affiliated |
8,700 | 392,938 | 551 | |||||||||
From the Manager |
— | — | 13,085 | |||||||||
Foreign withholding tax claims |
212,877 | — | — | |||||||||
Prepaid expenses |
80,243 | 105,398 | 33,927 | |||||||||
|
|
|
|
|
|
|||||||
Total assets |
3,750,279,374 | 8,126,193,330 | 10,120,095 | |||||||||
|
|
|
|
|
|
|||||||
LIABILITIES |
||||||||||||
Bank overdraft |
1,184,234 | — | — | |||||||||
Collateral on securities loaned |
— | 91,579,360 | 275,072 | |||||||||
Payables: |
||||||||||||
Investments purchased |
— | — | 138,350 | |||||||||
Administration fees |
— | 361,217 | — | |||||||||
Capital shares redeemed |
1,039,164 | 5,824,691 | — | |||||||||
Investment advisory fees |
1,876,869 | 4,417,669 | — | |||||||||
Directors’ and Officer’s fees |
6,750 | 13,842 | 1,442 | |||||||||
Other accrued expenses |
100,113 | 280,506 | 31,336 | |||||||||
Other affiliate fees |
51,096 | 64,032 | 42 | |||||||||
Professional fees |
19,756 | 22,920 | 52,320 | |||||||||
Service and distribution fees |
505,094 | 907,158 | 46 | |||||||||
Transfer agent fees |
579,129 | 2,028,319 | 369 | |||||||||
|
|
|
|
|
|
|||||||
Total liabilities |
5,362,205 | 105,499,714 | 498,977 | |||||||||
|
|
|
|
|
|
|||||||
Commitments and contingent liabilities |
||||||||||||
NET ASSETS |
$ | 3,744,917,169 | $ | 8,020,693,616 | $ | 9,621,118 | ||||||
|
|
|
|
|
|
|||||||
NET ASSETS CONSIST OF: |
||||||||||||
Paid-in capital |
$ | 1,220,247,273 | $ | 4,264,783,946 | $ | 10,094,653 | ||||||
Accumulated earnings (loss) |
2,524,669,896 | 3,755,909,670 | (473,535 | ) | ||||||||
|
|
|
|
|
|
|||||||
NET ASSETS |
$ | 3,744,917,169 | $ | 8,020,693,616 | $ | 9,621,118 | ||||||
|
|
|
|
|
|
|||||||
(a) Investments, at cost — unaffiliated |
$ | 1,413,710,323 | $ | 4,527,494,558 | $ | 9,126,536 | ||||||
(b) Securities loaned, at value |
$ | — | $ | 90,044,218 | $ | 248,531 | ||||||
(c) Investments, at cost — affiliated |
$ | — | $ | 202,675,361 | $ | 344,926 | ||||||
(d) Foreign currency, at cost |
$ | — | $ | 103,311 | $ | 2,586 |
S T A T E M E N T S O F A S S E T S A N D L I A B I L I T I E S |
19 |
Statements of Assets and Liabilities (unaudited) (continued)
November 30, 2024
BlackRock Capital Appreciation Fund, Inc. |
BlackRock Health Sciences Opportunities Portfolio |
BlackRock Infrastructure Sustainable Opportunities Fund |
||||||||||
NET ASSET VALUE |
||||||||||||
Institutional | ||||||||||||
Net assets |
$ | 853,525,300 | $ | 4,163,988,484 | $ | 110,924 | ||||||
|
|
|
|
|
|
|||||||
Shares outstanding |
19,132,388 | 55,387,784 | 11,723 | |||||||||
|
|
|
|
|
|
|||||||
Net asset value |
$ | 44.61 | $ | 75.18 | $ | 9.46 | ||||||
|
|
|
|
|
|
|||||||
Shares authorized |
300 million | Unlimited | Unlimited | |||||||||
|
|
|
|
|
|
|||||||
Par value |
$ | 0.10 | $ | 0.001 | $ | 0.001 | ||||||
|
|
|
|
|
|
|||||||
Service | ||||||||||||
Net assets |
$ | N/A | $ | 29,920,951 | $ | N/A | ||||||
|
|
|
|
|
|
|||||||
Shares outstanding |
N/A | 425,452 | N/A | |||||||||
|
|
|
|
|
|
|||||||
Net asset value |
$ | N/A | $ | 70.33 | $ | N/A | ||||||
|
|
|
|
|
|
|||||||
Shares authorized |
N/A | Unlimited | N/A | |||||||||
|
|
|
|
|
|
|||||||
Par value |
$ | N/A | $ | 0.001 | $ | N/A | ||||||
|
|
|
|
|
|
|||||||
Investor A | ||||||||||||
Net assets |
$ | 2,262,412,776 | $ | 2,795,605,072 | $ | 230,435 | ||||||
|
|
|
|
|
|
|||||||
Shares outstanding |
58,840,902 | 39,962,984 | 24,392 | |||||||||
|
|
|
|
|
|
|||||||
Net asset value |
$ | 38.45 | $ | 69.95 | $ | 9.45 | ||||||
|
|
|
|
|
|
|||||||
Shares authorized |
300 million | Unlimited | Unlimited | |||||||||
|
|
|
|
|
|
|||||||
Par value |
$ | 0.10 | $ | 0.001 | $ | 0.001 | ||||||
|
|
|
|
|
|
|||||||
Investor C | ||||||||||||
Net assets |
$ | 42,051,895 | $ | 275,601,646 | $ | N/A | ||||||
|
|
|
|
|
|
|||||||
Shares outstanding |
2,182,747 | 4,873,984 | N/A | |||||||||
|
|
|
|
|
|
|||||||
Net asset value |
$ | 19.27 | $ | 56.55 | $ | N/A | ||||||
|
|
|
|
|
|
|||||||
Shares authorized |
300 million | Unlimited | N/A | |||||||||
|
|
|
|
|
|
|||||||
Par value |
$ | 0.10 | $ | 0.001 | $ | N/A | ||||||
|
|
|
|
|
|
|||||||
Class K | ||||||||||||
Net assets |
$ | 561,470,079 | $ | 510,773,724 | $ | 9,279,759 | ||||||
|
|
|
|
|
|
|||||||
Shares outstanding |
12,418,004 | 6,779,798 | 980,507 | |||||||||
|
|
|
|
|
|
|||||||
Net asset value |
$ | 45.21 | $ | 75.34 | $ | 9.46 | ||||||
|
|
|
|
|
|
|||||||
Shares authorized |
300 million | Unlimited | Unlimited | |||||||||
|
|
|
|
|
|
|||||||
Par value |
$ | 0.10 | $ | 0.001 | $ | 0.001 | ||||||
|
|
|
|
|
|
|||||||
Class R | ||||||||||||
Net assets |
$ | 25,457,119 | $ | 244,803,739 | $ | N/A | ||||||
|
|
|
|
|
|
|||||||
Shares outstanding |
976,140 | 3,629,407 | N/A | |||||||||
|
|
|
|
|
|
|||||||
Net asset value |
$ | 26.08 | $ | 67.45 | $ | N/A | ||||||
|
|
|
|
|
|
|||||||
Shares authorized |
500 million | Unlimited | N/A | |||||||||
|
|
|
|
|
|
|||||||
Par value |
$ | 0.10 | $ | 0.001 | $ | N/A | ||||||
|
|
|
|
|
|
See notes to financial statements.
20 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Statements of Assets and Liabilities (unaudited) (continued)
November 30, 2024
BlackRock Mid-Cap Growth Equity Portfolio |
BlackRock Technology Opportunities Fund |
|||||||
ASSETS |
||||||||
Investments, at value — unaffiliated(a)(b) |
$ | 11,452,770,596 | $ | 6,054,643,302 | ||||
Investments, at value — affiliated(c) |
431,583,549 | 125,566,595 | ||||||
Cash |
— | 5,848 | ||||||
Foreign currency, at value(d) |
— | 329,521 | ||||||
Receivables: |
||||||||
Investments sold |
22,755,403 | 3,527,997 | ||||||
Securities lending income — affiliated |
59,524 | 15,836 | ||||||
Capital shares sold |
5,700,245 | 4,022,047 | ||||||
Dividends — unaffiliated |
2,892,967 | 1,531,186 | ||||||
Dividends — affiliated |
33,898 | 64,806 | ||||||
From the Manager |
24,952 | 3,210 | ||||||
Prepaid expenses |
130,542 | 101,105 | ||||||
|
|
|
|
|||||
Total assets |
11,915,951,676 | 6,189,811,453 | ||||||
|
|
|
|
|||||
LIABILITIES |
||||||||
Bank overdraft |
7,085,736 | — | ||||||
Collateral on securities loaned |
431,379,902 | 51,344,691 | ||||||
Payables: |
||||||||
Investments purchased |
11,720,942 | 4,978,824 | ||||||
Administration fees |
384,793 | 261,535 | ||||||
Capital shares redeemed |
18,018,761 | 4,441,841 | ||||||
Investment advisory fees |
5,715,928 | 3,779,670 | ||||||
Directors’ and Officer’s fees |
24,051 | 8,070 | ||||||
Other accrued expenses |
334,840 | 352,543 | ||||||
Other affiliate fees |
25,067 | 25,183 | ||||||
Professional fees |
8,875 | 4,908 | ||||||
Service and distribution fees |
536,777 | 732,604 | ||||||
Transfer agent fees |
2,592,534 | 1,662,022 | ||||||
|
|
|
|
|||||
Total liabilities |
477,828,206 | 67,591,891 | ||||||
|
|
|
|
|||||
Commitments and contingent liabilities |
||||||||
NET ASSETS |
$ | 11,438,123,470 | $ | 6,122,219,562 | ||||
|
|
|
|
|||||
NET ASSETS CONSIST OF: |
||||||||
Paid-in capital |
$ | 7,667,026,297 | $ | 2,760,592,538 | ||||
Accumulated earnings |
3,771,097,173 | 3,361,627,024 | ||||||
|
|
|
|
|||||
NET ASSETS |
$ | 11,438,123,470 | $ | 6,122,219,562 | ||||
|
|
|
|
|||||
(a) Investments, at cost — unaffiliated |
$ | 7,496,122,042 | $ | 2,971,667,102 | ||||
(b) Securities loaned, at value |
$ | 424,224,215 | $ | 50,820,184 | ||||
(c) Investments, at cost — affiliated |
$ | 431,561,589 | $ | 125,568,166 | ||||
(d) Foreign currency, at cost |
$ | — | $ | 323,147 |
S T A T E M E N T S O F A S S E T S A N D L I A B I L I T I E S |
21 |
Statements of Assets and Liabilities (unaudited) (continued)
November 30, 2024
BlackRock Mid-Cap Growth Equity Portfolio |
BlackRock Technology Opportunities Fund |
|||||||
NET ASSET VALUE |
||||||||
Institutional | ||||||||
Net assets |
$ | 4,892,014,678 | $ | 3,165,791,734 | ||||
|
|
|
|
|||||
Shares outstanding |
105,999,726 | 41,794,261 | ||||||
|
|
|
|
|||||
Net asset value |
$ | 46.15 | $ | 75.75 | ||||
|
|
|
|
|||||
Shares authorized |
Unlimited | Unlimited | ||||||
|
|
|
|
|||||
Par value |
$ | 0.001 | $ | 0.001 | ||||
|
|
|
|
|||||
Service | ||||||||
Net assets |
$ | 59,903,820 | $ | 56,019,061 | ||||
|
|
|
|
|||||
Shares outstanding |
1,461,414 | 797,150 | ||||||
|
|
|
|
|||||
Net asset value |
$ | 40.99 | $ | 70.27 | ||||
|
|
|
|
|||||
Shares authorized |
Unlimited | Unlimited | ||||||
|
|
|
|
|||||
Par value |
$ | 0.001 | $ | 0.001 | ||||
|
|
|
|
|||||
Investor A | ||||||||
Net assets |
$ | 1,733,971,135 | $ | 2,188,541,317 | ||||
|
|
|
|
|||||
Shares outstanding |
44,396,888 | 31,923,886 | ||||||
|
|
|
|
|||||
Net asset value |
$ | 39.06 | $ | 68.55 | ||||
|
|
|
|
|||||
Shares authorized |
Unlimited | Unlimited | ||||||
|
|
|
|
|||||
Par value |
$ | 0.001 | $ | 0.001 | ||||
|
|
|
|
|||||
Investor C | ||||||||
Net assets |
$ | 186,860,194 | $ | 312,838,920 | ||||
|
|
|
|
|||||
Shares outstanding |
6,512,213 | 5,786,942 | ||||||
|
|
|
|
|||||
Net asset value |
$ | 28.69 | $ | 54.06 | ||||
|
|
|
|
|||||
Shares authorized |
Unlimited | Unlimited | ||||||
|
|
|
|
|||||
Par value |
$ | 0.001 | $ | 0.001 | ||||
|
|
|
|
|||||
Class K | ||||||||
Net assets |
$ | 4,474,464,016 | $ | 349,268,574 | ||||
|
|
|
|
|||||
Shares outstanding |
96,336,054 | 4,596,656 | ||||||
|
|
|
|
|||||
Net asset value |
$ | 46.45 | $ | 75.98 | ||||
|
|
|
|
|||||
Shares authorized |
Unlimited | Unlimited | ||||||
|
|
|
|
|||||
Par value |
$ | 0.001 | $ | 0.001 | ||||
|
|
|
|
|||||
Class R | ||||||||
Net assets |
$ | 90,909,627 | $ | 49,759,956 | ||||
|
|
|
|
|||||
Shares outstanding |
2,400,723 | 727,310 | ||||||
|
|
|
|
|||||
Net asset value |
$ | 37.87 | $ | 68.42 | ||||
|
|
|
|
|||||
Shares authorized |
Unlimited | Unlimited | ||||||
|
|
|
|
|||||
Par value |
$ | 0.001 | $ | 0.001 | ||||
|
|
|
|
See notes to financial statements.
22 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Statements of Operations (unaudited)
Six Months Ended November 30, 2024
BlackRock Capital Appreciation Fund, Inc. |
BlackRock Health Sciences Opportunities Portfolio |
BlackRock Infrastructure Sustainable Opportunities Fund |
||||||||||
INVESTMENT INCOME |
||||||||||||
Dividends — unaffiliated |
$ | 10,855,123 | (a) | $ | 42,095,280 | $ | 154,795 | |||||
Dividends — affiliated |
80,519 | 3,929,635 | 3,518 | |||||||||
Securities lending income — affiliated — net |
— | 212,437 | 35 | |||||||||
Other income |
10,484 | — | — | |||||||||
Foreign taxes withheld |
(73,814 | ) | (36,082 | ) | (7,750 | ) | ||||||
Foreign withholding tax claims |
300,549 | — | — | |||||||||
|
|
|
|
|
|
|||||||
Total investment income |
11,172,861 | 46,201,270 | 150,598 | |||||||||
|
|
|
|
|
|
|||||||
EXPENSES |
||||||||||||
Investment advisory |
11,176,768 | 28,230,850 | 37,588 | |||||||||
Service and distribution — class specific |
3,009,266 | 5,799,197 | 285 | |||||||||
Transfer agent — class specific |
1,355,178 | 3,828,562 | 638 | |||||||||
Accounting services |
117,014 | 247,746 | 18,556 | |||||||||
Professional |
95,082 | 43,476 | 55,388 | |||||||||
Registration |
41,781 | 67,564 | 25,250 | |||||||||
Printing and postage |
30,085 | 34,918 | 18,905 | |||||||||
Custodian |
22,058 | 65,531 | 8,709 | |||||||||
Directors and Officer |
15,924 | 35,637 | 3,320 | |||||||||
Administration |
— | 1,461,679 | 1,997 | |||||||||
Administration — class specific |
— | 842,015 | 940 | |||||||||
Miscellaneous |
18,084 | 143,481 | 6,028 | |||||||||
|
|
|
|
|
|
|||||||
Total expenses excluding interest expense |
15,881,240 | 40,800,656 | 177,604 | |||||||||
Interest expense |
8,871 | 697 | 1 | |||||||||
|
|
|
|
|
|
|||||||
Total expenses |
15,890,111 | 40,801,353 | 177,605 | |||||||||
|
|
|
|
|
|
|||||||
Less: |
||||||||||||
Administration fees waived |
— | — | (1,997 | ) | ||||||||
Administration fees waived by the Manager — class specific |
— | — | (940 | ) | ||||||||
Fees waived and/or reimbursed by the Manager |
(1,223 | ) | (58,232 | ) | (129,048 | ) | ||||||
Transfer agent fees waived and/or reimbursed by the Manager — class specific |
— | — | (554 | ) | ||||||||
|
|
|
|
|
|
|||||||
Total expenses after fees waived and/or reimbursed |
15,888,888 | 40,743,121 | 45,066 | |||||||||
|
|
|
|
|
|
|||||||
Net investment income (loss) |
(4,716,027 | ) | 5,458,149 | 105,532 | ||||||||
|
|
|
|
|
|
|||||||
REALIZED AND UNREALIZED GAIN (LOSS) |
||||||||||||
Net realized gain (loss) from: |
||||||||||||
Investments — unaffiliated |
214,582,315 | 397,159,486 | 105,641 | |||||||||
Investments — affiliated |
— | 14,283 | 37 | |||||||||
Foreign currency transactions |
(10,327 | ) | 126,216 | 2,246 | ||||||||
Swaps |
— | — | 8,662 | |||||||||
|
|
|
|
|
|
|||||||
$ | 214,571,988 | $ | 397,299,985 | $ | 116,586 | |||||||
|
|
|
|
|
|
|||||||
Net change in unrealized appreciation (depreciation) on: |
||||||||||||
Investments — unaffiliated |
264,419,127 | (89,361,091 | ) | 461,346 | ||||||||
Investments — affiliated |
— | 18,040 | — | |||||||||
Foreign currency translations |
(8,392 | ) | (2,994 | ) | (447 | ) | ||||||
Swaps |
— | — | 3,171 | |||||||||
|
|
|
|
|
|
|||||||
264,410,735 | (89,346,045 | ) | 464,070 | |||||||||
|
|
|
|
|
|
|||||||
Net realized and unrealized gain |
478,982,723 | 307,953,940 | 580,656 | |||||||||
|
|
|
|
|
|
|||||||
NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS |
$ | 474,266,696 | $ | 313,412,089 | $ | 686,188 | ||||||
|
|
|
|
|
|
(a) | Includes $3,851,625 related to a special distribution from TransDigm Group, Inc. |
See notes to financial statements.
S T A T E M E N T S O F O P E R A T I O N S |
23 |
Statements of Operations (unaudited) (continued)
Six Months Ended November 30, 2024
BlackRock Mid-Cap Growth Equity Portfolio |
BlackRock Technology Opportunities Fund |
|||||||
INVESTMENT INCOME |
||||||||
Dividends — unaffiliated |
$ | 16,622,971 | $ | 12,186,488 | ||||
Dividends — affiliated |
240,458 | 1,298,846 | ||||||
Securities lending income — affiliated — net |
454,417 | 80,247 | ||||||
Foreign taxes withheld |
— | (333,326 | ) | |||||
|
|
|
|
|||||
Total investment income |
17,317,846 | 13,232,255 | ||||||
|
|
|
|
|||||
EXPENSES |
||||||||
Investment advisory |
34,954,003 | 22,120,205 | ||||||
Transfer agent — class specific |
4,680,358 | 2,844,988 | ||||||
Service and distribution — class specific |
3,150,732 | 4,308,582 | ||||||
Administration |
1,897,729 | 1,039,996 | ||||||
Administration — class specific |
1,110,777 | 582,231 | ||||||
Accounting services |
320,896 | 176,992 | ||||||
Registration |
95,158 | 81,004 | ||||||
Custodian |
83,882 | 46,507 | ||||||
Directors and Officer |
50,707 | 24,381 | ||||||
Printing and postage |
46,920 | 30,942 | ||||||
Professional |
30,611 | 28,129 | ||||||
Miscellaneous |
47,074 | 45,408 | ||||||
|
|
|
|
|||||
Total expenses excluding interest expense |
46,468,847 | 31,329,365 | ||||||
Interest expense |
222,576 | 8,125 | ||||||
|
|
|
|
|||||
Total expenses |
46,691,423 | 31,337,490 | ||||||
|
|
|
|
|||||
Less: |
||||||||
Administration fees waived by the Manager — class specific |
(653,175 | ) | (322,352 | ) | ||||
Fees waived and/or reimbursed by the Manager |
(3,615 | ) | (18,880 | ) | ||||
Transfer agent fees waived and/or reimbursed by the Manager — class specific |
(459,575 | ) | (49,098 | ) | ||||
|
|
|
|
|||||
Total expenses after fees waived and/or reimbursed |
45,575,058 | 30,947,160 | ||||||
|
|
|
|
|||||
Net investment loss |
(28,257,212 | ) | (17,714,905 | ) | ||||
|
|
|
|
|||||
REALIZED AND UNREALIZED GAIN (LOSS) |
||||||||
Net realized gain from: |
||||||||
Investments — unaffiliated |
1,169,966,125 | 751,481,879 | ||||||
Investments — affiliated |
196,041 | 1,768 | ||||||
Foreign currency transactions |
2,754 | (12,976 | ) | |||||
|
|
|
|
|||||
$ | 1,170,164,920 | $ | 751,470,671 | |||||
|
|
|
|
|||||
Net change in unrealized appreciation (depreciation) on: |
||||||||
Investments — unaffiliated |
649,803,191 | 97,825,408 | ||||||
Investments — affiliated |
23,713 | (1,571 | ) | |||||
Foreign currency translations |
(14,111 | ) | 6,850 | |||||
|
|
|
|
|||||
649,812,793 | 97,830,687 | |||||||
|
|
|
|
|||||
Net realized and unrealized gain |
1,819,977,713 | 849,301,358 | ||||||
|
|
|
|
|||||
NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS |
$ | 1,791,720,501 | $ | 831,586,453 | ||||
|
|
|
|
See notes to financial statements.
24 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Statements of Changes in Net Assets
BlackRock Capital Appreciation Fund, Inc. | BlackRock Health Sciences Opportunities Portfolio |
|||||||||||||||||||
Six Months Ended 11/30/24 (unaudited) |
Year Ended 05/31/24 |
Six Months Ended 11/30/24 (unaudited) |
Year Ended 05/31/24 |
|||||||||||||||||
INCREASE (DECREASE) IN NET ASSETS |
||||||||||||||||||||
OPERATIONS |
||||||||||||||||||||
Net investment income (loss) |
$ | (4,716,027 | ) | $ | (10,611,713 | ) | $ | 5,458,149 | $ | 25,316,530 | ||||||||||
Net realized gain |
214,571,988 | 341,112,234 | 397,299,985 | 395,305,992 | ||||||||||||||||
Net change in unrealized appreciation (depreciation) |
264,410,735 | 713,790,114 | (89,346,045 | ) | 615,065,988 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Net increase in net assets resulting from operations |
474,266,696 | 1,044,290,635 | 313,412,089 | 1,035,688,510 | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
DISTRIBUTIONS TO SHAREHOLDERS(a) |
||||||||||||||||||||
Institutional |
(54,180,906 | ) | (24,574,161 | ) | (142,791,970 | ) | (165,666,116 | ) | ||||||||||||
Service |
— | — | (1,061,471 | ) | (1,218,171 | ) | ||||||||||||||
Investor A |
(167,569,969 | ) | (69,431,098 | ) | (100,438,873 | ) | (108,961,191 | ) | ||||||||||||
Investor C |
(5,759,646 | ) | (2,509,299 | ) | (13,002,667 | ) | (16,034,475 | ) | ||||||||||||
Class K |
(35,917,298 | ) | (22,193,494 | ) | (16,517,766 | ) | (17,980,192 | ) | ||||||||||||
Class R |
(2,697,452 | ) | (1,215,316 | ) | (9,050,426 | ) | (8,884,277 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Decrease in net assets resulting from distributions to shareholders |
(266,125,271 | ) | (119,923,368 | ) | (282,863,173 | ) | (318,744,422 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
CAPITAL SHARE TRANSACTIONS |
||||||||||||||||||||
Net increase (decrease) in net assets derived from capital share transactions |
51,825,482 | (551,525,947 | ) | (323,988,605 | ) | (872,061,789 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
NET ASSETS |
||||||||||||||||||||
Total increase (decrease) in net assets |
259,966,907 | 372,841,320 | (293,439,689 | ) | (155,117,701 | ) | ||||||||||||||
Beginning of period |
3,484,950,262 | 3,112,108,942 | 8,314,133,305 | 8,469,251,006 | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
End of period |
$ | 3,744,917,169 | $ | 3,484,950,262 | $ | 8,020,693,616 | $ | 8,314,133,305 | ||||||||||||
|
|
|
|
|
|
|
|
(a) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
See notes to financial statements.
S T A T E M E N T S O F C H A N G E S I N N E T A S S E T S |
25 |
Statements of Changes in Net Assets (continued)
BlackRock Infrastructure Sustainable Opportunities Fund | BlackRock Mid-Cap Growth Equity Portfolio |
|||||||||||||||||||
Six Months Ended 11/30/24 (unaudited) |
Year Ended 05/31/24 |
Six Months Ended 11/30/24 (unaudited) |
Year Ended 05/31/24 |
|||||||||||||||||
INCREASE (DECREASE) IN NET ASSETS |
||||||||||||||||||||
OPERATIONS |
||||||||||||||||||||
Net investment income (loss) |
$ | 105,532 | $ | 198,809 | $ | (28,257,212 | ) | $ | (47,778,831 | ) | ||||||||||
Net realized gain (loss) |
116,586 | (375,488 | ) | 1,170,164,920 | 1,006,857,842 | |||||||||||||||
Net change in unrealized appreciation (depreciation) |
464,070 | 200,297 | 649,812,793 | 1,133,709,179 | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Net increase in net assets resulting from operations |
686,188 | 23,618 | 1,791,720,501 | 2,092,788,190 | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
DISTRIBUTIONS TO SHAREHOLDERS(a) |
||||||||||||||||||||
Institutional |
(654 | ) | (2,409 | ) | — | — | ||||||||||||||
Investor A |
(1,137 | ) | (3,809 | ) | — | — | ||||||||||||||
Class K |
(57,026 | ) | (214,945 | ) | — | — | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Decrease in net assets resulting from distributions to shareholders |
(58,817 | ) | (221,163 | ) | — | — | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
CAPITAL SHARE TRANSACTIONS |
||||||||||||||||||||
Net increase (decrease) in net assets derived from capital share transactions |
(35,124 | ) | 102,034 | (2,020,736,553 | ) | (1,914,227,253 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
NET ASSETS |
||||||||||||||||||||
Total increase (decrease) in net assets |
592,247 | (95,511 | ) | (229,016,052 | ) | 178,560,937 | ||||||||||||||
Beginning of period |
9,028,871 | 9,124,382 | 11,667,139,522 | 11,488,578,585 | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
End of period |
$ | 9,621,118 | $ | 9,028,871 | $ | 11,438,123,470 | $ | 11,667,139,522 | ||||||||||||
|
|
|
|
|
|
|
|
(a) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
See notes to financial statements.
26 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Statements of Changes in Net Assets (continued)
BlackRock Technology Opportunities Fund | ||||||||
Six Months Ended 11/30/24 (unaudited) |
Year Ended 05/31/24 |
|||||||
INCREASE (DECREASE) IN NET ASSETS |
||||||||
OPERATIONS |
||||||||
Net investment loss |
$ | (17,714,905 | ) | $ | (27,099,028 | ) | ||
Net realized gain |
751,470,671 | 280,429,599 | ||||||
Net change in unrealized appreciation (depreciation) |
97,830,687 | 1,259,756,995 | ||||||
|
|
|
|
|||||
Net increase in net assets resulting from operations |
831,586,453 | 1,513,087,566 | ||||||
|
|
|
|
|||||
CAPITAL SHARE TRANSACTIONS |
||||||||
Net decrease in net assets derived from capital share transactions |
(44,924,865 | ) | (566,590,067 | ) | ||||
|
|
|
|
|||||
NET ASSETS |
||||||||
Total increase in net assets |
786,661,588 | 946,497,499 | ||||||
Beginning of period |
5,335,557,974 | 4,389,060,475 | ||||||
|
|
|
|
|||||
End of period |
$ | 6,122,219,562 | $ | 5,335,557,974 | ||||
|
|
|
|
See notes to financial statements.
S T A T E M E N T S O F C H A N G E S I N N E T A S S E T S |
27 |
Financial Highlights
(For a share outstanding throughout each period)
BlackRock Capital Appreciation Fund, Inc. | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Institutional | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Six Months Ended 11/30/24 (unaudited |
) |
|
Year Ended 05/31/24 |
|
|
Year Ended 05/31/23 |
|
|
Year Ended 05/31/22 |
|
|
Period from 10/01/20 to 05/31/21 |
|
|
Year Ended 09/30/20 |
|
|
Year Ended 09/30/19 |
| ||||||||||||||||||||||||||||||||
Net asset value, beginning of period |
$ | 41.93 | $ | 31.69 | $ | 31.98 | $ | 43.32 | $ | 38.32 | $ | 30.52 | $ | 33.72 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment income (loss)(a) |
(0.02 | )(b) | (0.06 | ) | 0.00 | (c) | (0.09 | ) | (0.06 | ) | (0.07 | ) | (0.05 | ) | ||||||||||||||||||||||||||||||||||||||
Net realized and unrealized gain (loss) |
5.67 | 11.51 | 1.82 | (6.14 | ) | 7.06 | 10.81 | 0.23 | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net increase (decrease) from investment operations |
5.65 | 11.45 | 1.82 | (6.23 | ) | 7.00 | 10.74 | 0.18 | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Distributions from net realized gain(d) |
(2.97 | ) | (1.21 | ) | (2.11 | ) | (5.11 | ) | (2.00 | ) | (2.94 | ) | (3.38 | ) | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net asset value, end of period |
$ | 44.61 | $ | 41.93 | $ | 31.69 | $ | 31.98 | $ | 43.32 | $ | 38.32 | $ | 30.52 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total Return(e) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Based on net asset value |
14.10 | %(f) | 37.03 | % | 6.81 | % | (17.30 | )% | 18.72 | %(f) | 38.17 | % | 1.77 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Ratios to Average Net Assets(g) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total expenses |
0.72 | %(h) | 0.75 | % | 0.73 | % | 0.70 | % | 0.72 | %(h) | 0.75 | % | 0.75 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total expenses after fees waived and/or reimbursed |
0.72 | %(h) | 0.74 | % | 0.73 | % | 0.70 | % | 0.72 | %(h) | 0.75 | % | 0.75 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment income (loss) |
(0.10 | )%(h) | (0.17 | )% | 0.01 | % | (0.21 | )% | (0.21 | )%(h) | (0.22 | )% | (0.17 | )% | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Supplemental Data |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Net assets, end of period (000) |
$ | 853,525 | $ | 784,361 | $ | 678,965 | $ | 943,275 | $ | 1,072,833 | $ | 911,484 | $ | 644,983 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Portfolio turnover rate |
10 | % | 21 | % | 43 | % | 55 | % | 25 | % | 42 | % | 48 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) | Based on average shares outstanding. |
(b) | Includes a one-time special distribution from TransDigm Group, Inc. Excluding such special distribution, the net investment income would have been $(0.07) per share and 0.21% of average net assets. |
(c) | Amount is less than $0.005 per share. |
(d) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(e) | Where applicable, assumes the reinvestment of distributions. |
(f) | Not annualized. |
(g) | Excludes fees and expenses incurred indirectly as a result of investments in underlying funds. |
(h) | Annualized. |
See notes to financial statements.
28 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BlackRock Capital Appreciation Fund, Inc. (continued) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investor A | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Six Months Ended 11/30/24 (unaudited |
) |
|
Year Ended 05/31/24 |
|
|
Year Ended 05/31/23 |
|
|
Year Ended 05/31/22 |
|
|
Period from 10/01/20 to 05/31/21 |
|
|
Year Ended 09/30/20 |
|
|
Year Ended 09/30/19 |
| ||||||||||||||||||||||||||||||||
Net asset value, beginning of period |
$ | 36.54 | $ | 27.77 | $ | 28.38 | $ | 39.00 | $ | 34.74 | $ | 27.99 | $ | 31.25 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss(a) |
(0.07 | )(b) | (0.13 | ) | (0.07 | ) | (0.18 | ) | (0.11 | ) | (0.14 | ) | (0.12 | ) | ||||||||||||||||||||||||||||||||||||||
Net realized and unrealized gain (loss) |
4.91 | 10.04 | 1.57 | (5.39 | ) | 6.37 | 9.83 | 0.18 | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net increase (decrease) from investment operations |
4.84 | 9.91 | 1.50 | (5.57 | ) | 6.26 | 9.69 | 0.06 | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Distributions from net realized gain(c) |
(2.93 | ) | (1.14 | ) | (2.11 | ) | (5.05 | ) | (2.00 | ) | (2.94 | ) | (3.32 | ) | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net asset value, end of period |
$ | 38.45 | $ | 36.54 | $ | 27.77 | $ | 28.38 | $ | 39.00 | $ | 34.74 | $ | 27.99 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total Return(d) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Based on net asset value |
13.95 | %(e) | 36.66 | % | 6.53 | % | (17.51 | )% | 18.51 | %(e) | 37.84 | % | 1.48 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Ratios to Average Net Assets(f) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total expenses |
0.97 | %(g) | 1.00 | % | 1.00 | % | 0.97 | % | 0.97 | %(g) | 1.01 | % | 1.01 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total expenses after fees waived and/or reimbursed |
0.97 | %(g) | 0.99 | % | 1.00 | % | 0.97 | % | 0.97 | %(g) | 1.01 | % | 1.01 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss |
(0.35 | )%(g) | (0.42 | )% | (0.27 | )% | (0.48 | )% | (0.46 | )%(g) | (0.48 | )% | (0.43 | )% | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Supplemental Data |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Net assets, end of period (000) |
$ | 2,262,413 | $ | 2,117,888 | $ | 1,723,973 | $ | 1,871,340 | $ | 2,551,211 | $ | 2,195,906 | $ | 1,692,630 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Portfolio turnover rate |
10 | % | 21 | % | 43 | % | 55 | % | 25 | % | 42 | % | 48 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) | Based on average shares outstanding. |
(b) | Includes a one-time special distribution from TransDigm Group, Inc. Excluding such special distribution, the net investment income would have been $(0.10) per share and 0.21% of average net assets. |
(c) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(d) | Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions. |
(e) | Not annualized. |
(f) | Excludes fees and expenses incurred indirectly as a result of investments in underlying funds. |
(g) | Annualized. |
See notes to financial statements.
F I N A N C I A L H I G H L I G H T S |
29 |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BlackRock Capital Appreciation Fund, Inc. (continued) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investor C | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Six Months Ended 11/30/24 (unaudited |
) |
|
Year Ended 05/31/24 |
|
|
Year Ended 05/31/23 |
|
|
Year Ended 05/31/22 |
|
|
Period from 10/01/20 to 05/31/21 |
|
|
Year Ended 09/30/20 |
|
|
Year Ended 09/30/19 |
| ||||||||||||||||||||||||||||||||
Net asset value, beginning of period |
$ | 19.74 | $ | 15.52 | $ | 17.01 | $ | 25.27 | $ | 23.27 | $ | 19.81 | $ | 23.29 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss(a) |
(0.11 | )(b) | (0.22 | ) | (0.16 | ) | (0.29 | ) | (0.20 | ) | (0.25 | ) | (0.24 | ) | ||||||||||||||||||||||||||||||||||||||
Net realized and unrealized gain (loss) |
2.53 | 5.50 | 0.78 | (3.05 | ) | 4.20 | 6.65 | 0.04 | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net increase (decrease) from investment operations |
2.42 | 5.28 | 0.62 | (3.34 | ) | 4.00 | 6.40 | (0.20 | ) | |||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Distributions from net realized gain(c) |
(2.89 | ) | (1.06 | ) | (2.11 | ) | (4.92 | ) | (2.00 | ) | (2.94 | ) | (3.28 | ) | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net asset value, end of period |
$ | 19.27 | $ | 19.74 | $ | 15.52 | $ | 17.01 | $ | 25.27 | $ | 23.27 | $ | 19.81 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total Return(d) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Based on net asset value |
13.48 | %(e) | 35.61 | % | 5.62 | % | (18.18 | )% | 17.89 | %(e) | 36.73 | % | 0.72 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Ratios to Average Net Assets(f) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total expenses |
1.79 | %(g) | 1.84 | % | 1.84 | % | 1.76 | % | 1.77 | %(g) | 1.79 | % | 1.81 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total expenses after fees waived and/or reimbursed |
1.79 | %(g) | 1.83 | % | 1.84 | % | 1.76 | % | 1.77 | %(g) | 1.79 | % | 1.81 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss |
(1.18 | )%(g) | (1.26 | )% | (1.11 | )% | (1.28 | )% | (1.27 | )%(g) | (1.26 | )% | (1.23 | )% | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Supplemental Data |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Net assets, end of period (000) |
$ | 42,052 | $ | 40,228 | $ | 39,581 | $ | 48,332 | $ | 72,075 | $ | 89,336 | $ | 195,908 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Portfolio turnover rate |
10 | % | 21 | % | 43 | % | 55 | % | 25 | % | 42 | % | 48 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) | Based on average shares outstanding. |
(b) | Includes a one-time special distribution from TransDigm Group, Inc. Excluding such special distribution, the net investment income would have been $(0.13) per share and 0.21% of average net assets. |
(c) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(d) | Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions. |
(e) | Not annualized. |
(f) | Excludes fees and expenses incurred indirectly as a result of investments in underlying funds. |
(g) | Annualized. |
See notes to financial statements.
30 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BlackRock Capital Appreciation Fund, Inc. (continued) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Class K | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Six Months Ended 11/30/24 (unaudited |
) |
|
Year Ended 05/31/24 |
|
|
Year Ended 05/31/23 |
|
|
Year Ended 05/31/22 |
|
|
Period from 10/01/20 to 05/31/21 |
|
|
Year Ended 09/30/20 |
|
|
Year Ended 09/30/19 |
| ||||||||||||||||||||||||||||||||
Net asset value, beginning of period |
$ | 42.46 | $ | 32.08 | $ | 32.32 | $ | 43.71 | $ | 38.63 | $ | 30.71 | $ | 33.91 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment income (loss)(a) |
(0.01 | )(b) | (0.03 | ) | 0.02 | (0.06 | ) | (0.03 | ) | (0.04 | ) | (0.02 | ) | |||||||||||||||||||||||||||||||||||||||
Net realized and unrealized gain (loss) |
5.74 | 11.65 | 1.85 | (6.20 | ) | 7.11 | 10.90 | 0.23 | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net increase (decrease) from investment operations |
5.73 | 11.62 | 1.87 | (6.26 | ) | 7.08 | 10.86 | 0.21 | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Distributions from net realized gain(c) |
(2.98 | ) | (1.24 | ) | (2.11 | ) | (5.13 | ) | (2.00 | ) | (2.94 | ) | (3.41 | ) | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net asset value, end of period |
$ | 45.21 | $ | 42.46 | $ | 32.08 | $ | 32.32 | $ | 43.71 | $ | 38.63 | $ | 30.71 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total Return(d) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Based on net asset value |
14.13 | %(e) | 37.14 | % | 6.90 | % | (17.22 | )% | 18.78 | %(e) | 38.33 | % | 1.86 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Ratios to Average Net Assets(f) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total expenses |
0.65 | %(g) | 0.65 | % | 0.65 | % | 0.64 | % | 0.63 | %(g) | 0.64 | % | 0.65 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total expenses after fees waived and/or reimbursed |
0.65 | %(g) | 0.65 | % | 0.65 | % | 0.63 | % | 0.63 | %(g) | 0.64 | % | 0.64 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment income (loss) |
(0.03 | )%(g) | (0.08 | )% | 0.08 | % | (0.15 | )% | (0.13 | )%(g) | (0.11 | )% | (0.06 | )% | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Supplemental Data |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Net assets, end of period (000) |
$ | 561,470 | $ | 517,123 | $ | 645,860 | $ | 646,115 | $ | 845,106 | $ | 682,107 | $ | 552,523 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Portfolio turnover rate |
10 | % | 21 | % | 43 | % | 55 | % | 25 | % | 42 | % | 48 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) | Based on average shares outstanding. |
(b) | Includes a one-time special distribution from TransDigm Group, Inc. Excluding such special distribution, the net investment income would have been $(0.05) per share and 0.21% of average net assets. |
(c) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(d) | Where applicable, assumes the reinvestment of distributions. |
(e) | Not annualized. |
(f) | Excludes fees and expenses incurred indirectly as a result of investments in underlying funds. |
(g) | Annualized. |
See notes to financial statements.
F I N A N C I A L H I G H L I G H T S |
31 |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BlackRock Capital Appreciation Fund, Inc. (continued) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Class R | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Six Months Ended 11/30/24 (unaudited |
) |
|
Year Ended 05/31/24 |
|
|
Year Ended 05/31/23 |
|
|
Year Ended 05/31/22 |
|
|
Period from 10/01/20 to 05/31/21 |
|
|
Year Ended 09/30/20 |
|
|
Year Ended 09/30/19 |
| ||||||||||||||||||||||||||||||||
Net asset value, beginning of period |
$ | 25.70 | $ | 19.86 | $ | 21.02 | $ | 30.12 | $ | 27.30 | $ | 22.65 | $ | 26.00 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss(a) |
(0.09 | )(b) | (0.17 | ) | (0.11 | ) | (0.23 | ) | (0.15 | ) | (0.17 | ) | (0.16 | ) | ||||||||||||||||||||||||||||||||||||||
Net realized and unrealized gain (loss) |
3.37 | 7.10 | 1.06 | (3.88 | ) | 4.97 | 7.76 | 0.09 | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net increase (decrease) from investment operations |
3.28 | 6.93 | 0.95 | (4.11 | ) | 4.82 | 7.59 | (0.07 | ) | |||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Distributions from net realized gain(c) |
(2.90 | ) | (1.09 | ) | (2.11 | ) | (4.99 | ) | (2.00 | ) | (2.94 | ) | (3.28 | ) | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net asset value, end of period |
$ | 26.08 | $ | 25.70 | $ | 19.86 | $ | 21.02 | $ | 30.12 | $ | 27.30 | $ | 22.65 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total Return(d) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Based on net asset value |
13.76 | %(e) | 36.14 | % | 6.17 | % | (17.82 | )% | 18.26 | %(e) | 37.45 | % | 1.19 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Ratios to Average Net Assets(f) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total expenses |
1.35 | %(g) | 1.36 | % | 1.37 | % | 1.33 | % | 1.30 | %(g) | 1.28 | % | 1.29 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total expenses after fees waived and/or reimbursed |
1.35 | %(g) | 1.35 | % | 1.36 | % | 1.33 | % | 1.30 | %(g) | 1.28 | % | 1.29 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss |
(0.74 | )%(g) | (0.78 | )% | (0.63 | )% | (0.85 | )% | (0.80 | )%(g) | (0.75 | )% | (0.71 | )% | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Supplemental Data |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Net assets, end of period (000) |
$ | 25,457 | $ | 25,350 | $ | 23,731 | $ | 24,371 | $ | 36,933 | $ | 37,741 | $ | 54,828 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Portfolio turnover rate |
10 | % | 21 | % | 43 | % | 55 | % | 25 | % | 42 | % | 48 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) | Based on average shares outstanding. |
(b) | Includes a one-time special distribution from TransDigm Group, Inc. Excluding such special distribution, the net investment income would have been $(0.12) per share and 0.21% of average net assets. |
(c) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(d) | Where applicable, assumes the reinvestment of distributions. |
(e) | Not annualized. |
(f) | Excludes fees and expenses incurred indirectly as a result of investments in underlying funds. |
(g) | Annualized. |
See notes to financial statements.
32 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Financial Highlights
(For a share outstanding throughout each period)
BlackRock Health Sciences Opportunities Portfolio | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Institutional | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Six Months (unaudited) |
Year Ended 05/31/24 |
Year Ended 05/31/23 |
Year Ended 05/31/22 |
Period from 10/01/20 to 05/31/21 |
Year Ended 09/30/20 |
Year Ended 09/30/19 |
||||||||||||||||||||||||||||||||||||||||||||||
Net asset value, beginning of period |
$ | 74.83 | $ | 68.47 | $ | 72.10 | $ | 81.77 | $ | 75.37 | $ | 61.55 | $ | 67.67 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment income(a) |
0.10 | 0.32 | 0.34 | 0.24 | 0.13 | 0.19 | 0.28 | |||||||||||||||||||||||||||||||||||||||||||||
Net realized and unrealized gain (loss) |
2.74 | 8.71 | 1.07 | (2.75 | ) | 9.66 | 16.26 | (1.64 | ) | |||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net increase (decrease) from investment operations |
2.84 | 9.03 | 1.41 | (2.51 | ) | 9.79 | 16.45 | (1.36 | ) | |||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Distributions(b) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
From net investment income |
— | (0.33 | ) | (0.38 | ) | (0.16 | ) | (0.13 | ) | (0.32 | ) | (0.23 | ) | |||||||||||||||||||||||||||||||||||||||
From net realized gain |
(2.49 | ) | (2.34 | ) | (4.66 | ) | (7.00 | ) | (3.26 | ) | (2.31 | ) | (4.53 | ) | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total distributions |
(2.49 | ) | (2.67 | ) | (5.04 | ) | (7.16 | ) | (3.39 | ) | (2.63 | ) | (4.76 | ) | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net asset value, end of period |
$ | 75.18 | $ | 74.83 | $ | 68.47 | $ | 72.10 | $ | 81.77 | $ | 75.37 | $ | 61.55 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total Return(c) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Based on net asset value |
3.83 | %(d) | 13.57 | % | 2.25 | % | (3.55 | )%(e) | 13.37 | %(d) | 27.34 | %(f) | (1.84 | )% | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Ratios to Average Net Assets(g) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total expenses |
0.83 | %(h) | 0.84 | % | 0.84 | % | 0.85 | % | 0.84 | %(h) | 0.85 | % | 0.85 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total expenses after fees waived and/or reimbursed |
0.83 | %(h) | 0.84 | % | 0.84 | % | 0.85 | % | 0.84 | %(h) | 0.85 | % | 0.84 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment income |
0.27 | %(h) | 0.45 | % | 0.49 | % | 0.31 | % | 0.24 | %(h) | 0.28 | % | 0.45 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Supplemental Data |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Net assets, end of period (000) |
$ | 4,163,988 | $ | 4,374,721 | $ | 4,436,816 | $ | 5,062,514 | $ | 5,990,131 | $ | 5,133,191 | $ | 3,095,352 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Portfolio turnover rate |
16 | % | 27 | % | 29 | % | 51 | % | 19 | % | 28 | % | 41 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) | Based on average shares outstanding. |
(b) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(c) | Where applicable, assumes the reinvestment of distributions. |
(d) | Not annualized. |
(e) | Includes a capital contribution from affiliate, which had no impact on the Fund’s total return. |
(f) | Includes a payment received from an affiliate, which had no impact on the Fund’s total return. |
(g) | Excludes fees and expenses incurred indirectly as a result of investments in underlying funds. |
(h) | Annualized. |
See notes to financial statements.
F I N A N C I A L H I G H L I G H T S |
33 |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BlackRock Health Sciences Opportunities Portfolio (continued) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Service | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Six Months (unaudited) |
Year Ended 05/31/24 |
Year Ended 05/31/23 |
Year Ended 05/31/22 |
Period from 10/01/20 to 05/31/21 |
Year Ended 09/30/20 |
Year Ended 09/30/19 |
||||||||||||||||||||||||||||||||||||||||||||||
Net asset value, beginning of period |
$ | 70.27 | $ | 64.44 | $ | 68.16 | $ | 77.63 | $ | 71.63 | $ | 58.66 | $ | 64.73 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment income (loss)(a) |
(0.02 | ) | 0.10 | 0.13 | 0.01 | (0.03 | ) | (0.01 | ) | 0.08 | ||||||||||||||||||||||||||||||||||||||||||
Net realized and unrealized gain (loss) |
2.57 | 8.20 | 1.00 | (2.61 | ) | 9.18 | 15.48 | (1.57 | ) | |||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net increase (decrease) from investment operations |
2.55 | 8.30 | 1.13 | (2.60 | ) | 9.15 | 15.47 | (1.49 | ) | |||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Distributions(b) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
From net investment income |
— | (0.13 | ) | (0.19 | ) | — | — | (0.19 | ) | (0.05 | ) | |||||||||||||||||||||||||||||||||||||||||
From net realized gain |
(2.49 | ) | (2.34 | ) | (4.66 | ) | (6.87 | ) | (3.15 | ) | (2.31 | ) | (4.53 | ) | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total distributions |
(2.49 | ) | (2.47 | ) | (4.85 | ) | (6.87 | ) | (3.15 | ) | (2.50 | ) | (4.58 | ) | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net asset value, end of period |
$ | 70.33 | $ | 70.27 | $ | 64.44 | $ | 68.16 | $ | 77.63 | $ | 71.63 | $ | 58.66 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total Return(c) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Based on net asset value |
3.66 | %(d) | 13.24 | % | 1.94 | % | (3.83 | )%(e) | 13.15 | %(d) | 26.96 | %(f) | (2.16 | )% | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Ratios to Average Net Assets(g) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total expenses |
1.15 | %(h) | 1.14 | % | 1.14 | % | 1.14 | % | 1.14 | %(h) | 1.15 | % | 1.15 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total expenses after fees waived and/or reimbursed |
1.15 | %(h) | 1.14 | % | 1.14 | % | 1.14 | % | 1.14 | %(h) | 1.15 | % | 1.15 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment income (loss) |
(0.05 | )%(h) | 0.15 | % | 0.19 | % | 0.02 | % | (0.07 | )%(h) | (0.02 | )% | 0.14 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Supplemental Data |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Net assets, end of period (000) |
$ | 29,921 | $ | 31,141 | $ | 33,055 | $ | 36,625 | $ | 43,825 | $ | 40,252 | $ | 34,708 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Portfolio turnover rate |
16 | % | 27 | % | 29 | % | 51 | % | 19 | % | 28 | % | 41 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) | Based on average shares outstanding. |
(b) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(c) | Where applicable, assumes the reinvestment of distributions. |
(d) | Not annualized. |
(e) | Includes a capital contribution from affiliate, which had no impact on the Fund’s total return. |
(f) | Includes a payment received from an affiliate, which had no impact on the Fund’s total return. |
(g) | Excludes fees and expenses incurred indirectly as a result of investments in underlying funds. |
(h) | Annualized. |
See notes to financial statements.
34 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BlackRock Health Sciences Opportunities Portfolio (continued) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investor A | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Six Months (unaudited) |
Year Ended 05/31/24 |
Year Ended 05/31/23 |
Year Ended 05/31/22 |
Period from 10/01/20 to 05/31/21 |
Year Ended 09/30/20 |
Year Ended 09/30/19 |
||||||||||||||||||||||||||||||||||||||||||||||
Net asset value, beginning of period |
$ | 69.88 | $ | 64.11 | $ | 67.84 | $ | 77.31 | $ | 71.37 | $ | 58.45 | $ | 64.50 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment income |
0.01 | 0.13 | 0.16 | 0.05 | (0.01 | ) | 0.01 | 0.10 | ||||||||||||||||||||||||||||||||||||||||||||
Net realized and unrealized gain (loss) |
2.55 | 8.15 | 0.99 | (2.59 | ) | 9.15 | 15.42 | (1.56 | ) | |||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net increase (decrease) from investment operations |
2.56 | 8.28 | 1.15 | (2.54 | ) | 9.14 | 15.43 | (1.46 | ) | |||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Distributions(b) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
From net investment income |
— | (0.17 | ) | (0.22 | ) | — | — | (0.20 | ) | (0.06 | ) | |||||||||||||||||||||||||||||||||||||||||
From net realized gain |
(2.49 | ) | (2.34 | ) | (4.66 | ) | (6.93 | ) | (3.20 | ) | (2.31 | ) | (4.53 | ) | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total distributions |
(2.49 | ) | (2.51 | ) | (4.88 | ) | (6.93 | ) | (3.20 | ) | (2.51 | ) | (4.59 | ) | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net asset value, end of period |
$ | 69.95 | $ | 69.88 | $ | 64.11 | $ | 67.84 | $ | 77.31 | $ | 71.37 | $ | 58.45 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total Return(c) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Based on net asset value |
3.69 | %(d) | 13.28 | % | 1.99 | % | (3.78 | )%(e) | 13.18 | %(d) | 26.99 | %(f) | (2.11 | )% | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Ratios to Average Net Assets(g) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total expenses |
1.08 | %(h) | 1.09 | % | 1.09 | % | 1.09 | % | 1.10 | %(h) | 1.11 | % | 1.12 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total expenses after fees waived and/or reimbursed |
1.08 | %(h) | 1.09 | % | 1.09 | % | 1.09 | % | 1.10 | %(h) | 1.11 | % | 1.12 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment income (loss) |
0.02 | %(h) | 0.20 | % | 0.24 | % | 0.07 | % | (0.02 | )%(h) | 0.01 | % | 0.17 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Supplemental Data |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Net assets, end of period (000) |
$ | 2,795,605 | $ | 2,851,925 | $ | 2,865,706 | $ | 3,151,912 | $ | 3,496,818 | $ | 3,135,882 | $ | 2,598,888 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Portfolio turnover rate |
16 | % | 27 | % | 29 | % | 51 | % | 19 | % | 28 | % | 41 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) | Based on average shares outstanding. |
(b) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(c) | Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions. |
(d) | Not annualized. |
(e) | Includes a capital contribution from affiliate, which had no impact on the Fund’s total return. |
(f) | Includes a payment received from an affiliate, which had no impact on the Fund’s total return. |
(g) | Excludes fees and expenses incurred indirectly as a result of investments in underlying funds. |
(h) | Annualized. |
See notes to financial statements.
F I N A N C I A L H I G H L I G H T S |
35 |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BlackRock Health Sciences Opportunities Portfolio (continued) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investor C | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Six Months Ended 11/30/24 (unaudited |
) |
|
Year Ended 05/31/24 |
|
|
Year Ended 05/31/23 |
|
|
Year Ended 05/31/22 |
|
|
Period from 10/01/20 to 05/31/21 |
|
|
Year Ended 09/30/20 |
|
|
Year Ended 09/30/19 |
| ||||||||||||||||||||||||||||||||
Net asset value, beginning of period |
$ | 57.16 | $ | 53.11 | $ | 57.24 | $ | 66.15 | $ | 61.38 | $ | 50.74 | $ | 56.55 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss(a) |
(0.21 | ) | (0.31 | ) | (0.27 | ) | (0.43 | ) | (0.33 | ) | (0.40 | ) | (0.28 | ) | ||||||||||||||||||||||||||||||||||||||
Net realized and unrealized gain (loss) |
2.09 | 6.70 | 0.80 | (2.17 | ) | 7.85 | 13.34 | (1.38 | ) | |||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net increase (decrease) from investment operations |
1.88 | 6.39 | 0.53 | (2.60 | ) | 7.52 | 12.94 | (1.66 | ) | |||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Distributions from net realized gain(b) |
(2.49 | ) | (2.34 | ) | (4.66 | ) | (6.31 | ) | (2.75 | ) | (2.30 | ) | (4.15 | ) | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net asset value, end of period |
$ | 56.55 | $ | 57.16 | $ | 53.11 | $ | 57.24 | $ | 66.15 | $ | 61.38 | $ | 50.74 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total Return(c) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Based on net asset value |
3.32 | %(d) | 12.42 | % | 1.22 | % | (4.50 | )%(e) | 12.61 | %(d) | 26.09 | %(f) | (2.82 | )% | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Ratios to Average Net Assets(g) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total expenses |
1.84 | %(h) | 1.86 | % | 1.85 | % | 1.84 | % | 1.84 | %(h) | 1.85 | % | 1.85 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total expenses after fees waived and/or reimbursed |
1.84 | %(h) | 1.86 | % | 1.85 | % | 1.84 | % | 1.84 | %(h) | 1.85 | % | 1.85 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss |
(0.74 | )%(h) | (0.57 | )% | (0.51 | )% | (0.68 | )% | (0.77 | )%(h) | (0.72 | )% | (0.56 | )% | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Supplemental Data |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Net assets, end of period (000) |
$ | 275,602 | $ | 311,994 | $ | 404,306 | $ | 542,880 | $ | 719,525 | $ | 773,522 | $ | 745,636 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Portfolio turnover rate |
16 | % | 27 | % | 29 | % | 51 | % | 19 | % | 28 | % | 41 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) | Based on average shares outstanding. |
(b) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(c) | Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions. |
(d) | Not annualized. |
(e) | Includes a capital contribution from affiliate, which had no impact on the Fund’s total return. |
(f) | Includes a payment received from an affiliate, which had no impact on the Fund’s total return. |
(g) | Excludes fees and expenses incurred indirectly as a result of investments in underlying funds. |
(h) | Annualized. |
See notes to financial statements.
36 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BlackRock Health Sciences Opportunities Portfolio (continued) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Class K | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Six Months (unaudited) |
Year Ended 05/31/24 |
Year Ended 05/31/23 |
Year Ended 05/31/22 |
Period from 10/01/20 to 05/31/21 |
Year Ended 09/30/20 |
Year Ended 09/30/19 |
||||||||||||||||||||||||||||||||||||||||||||||
Net asset value, beginning of period |
$ | 74.95 | $ | 68.58 | $ | 72.21 | $ | 81.91 | $ | 75.50 | $ | 61.63 | $ | 67.75 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment income(a) |
0.13 | 0.39 | 0.40 | 0.33 | 0.18 | 0.27 | 0.34 | |||||||||||||||||||||||||||||||||||||||||||||
Net realized and unrealized gain (loss) |
2.75 | 8.72 | 1.08 | (2.77 | ) | 9.68 | 16.28 | (1.65 | ) | |||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net increase (decrease) from investment operations |
2.88 | 9.11 | 1.48 | (2.44 | ) | 9.86 | 16.55 | (1.31 | ) | |||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Distributions(b) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
From net investment income |
— | (0.40 | ) | (0.45 | ) | (0.26 | ) | (0.19 | ) | (0.37 | ) | (0.28 | ) | |||||||||||||||||||||||||||||||||||||||
From net realized gain |
(2.49 | ) | (2.34 | ) | (4.66 | ) | (7.00 | ) | (3.26 | ) | (2.31 | ) | (4.53 | ) | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total distributions |
(2.49 | ) | (2.74 | ) | (5.11 | ) | (7.26 | ) | (3.45 | ) | (2.68 | ) | (4.81 | ) | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net asset value, end of period |
$ | 75.34 | $ | 74.95 | $ | 68.58 | $ | 72.21 | $ | 81.91 | $ | 75.50 | $ | 61.63 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total Return(c) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Based on net asset value |
3.87 | %(d) | 13.68 | % | 2.34 | % | (3.44 | )%(e) | 13.45 | %(d) | 27.47 | %(f) | (1.75 | )% | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Ratios to Average Net Assets(g) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total expenses |
0.75 | %(h) | 0.75 | % | 0.75 | % | 0.74 | % | 0.74 | %(h) | 0.75 | % | 0.75 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total expenses after fees waived and/or reimbursed |
0.74 | %(h) | 0.75 | % | 0.75 | % | 0.74 | % | 0.74 | %(h) | 0.75 | % | 0.75 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment income |
0.35 | %(h) | 0.54 | % | 0.59 | % | 0.42 | % | 0.34 | %(h) | 0.39 | % | 0.55 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Supplemental Data |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Net assets, end of period (000) |
$ | 510,774 | $ | 496,504 | $ | 487,287 | $ | 436,984 | $ | 464,179 | $ | 344,822 | $ | 171,517 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Portfolio turnover rate |
16 | % | 27 | % | 29 | % | 51 | % | 19 | % | 28 | % | 41 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) | Based on average shares outstanding. |
(b) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(c) | Where applicable, assumes the reinvestment of distributions. |
(d) | Not annualized. |
(e) | Includes a capital contribution from affiliate, which had no impact on the Fund’s total return. |
(f) | Includes a payment received from an affiliate, which had no impact on the Fund’s total return. |
(g) | Excludes fees and expenses incurred indirectly as a result of investments in underlying funds. |
(h) | Annualized. |
See notes to financial statements.
F I N A N C I A L H I G H L I G H T S |
37 |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BlackRock Health Sciences Opportunities Portfolio (continued) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Class R | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Six Months (unaudited) |
Year Ended 05/31/24 |
Year Ended 05/31/23 |
Year Ended 05/31/22 |
Period from 10/01/20 to 05/31/21 |
Year Ended 09/30/20 |
Year Ended 09/30/19 |
||||||||||||||||||||||||||||||||||||||||||||||
Net asset value, beginning of period |
$ | 67.59 | $ | 62.14 | $ | 65.94 | $ | 75.28 | $ | 69.54 | $ | 57.05 | $ | 63.09 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss(a) |
(0.12 | ) | (0.11 | ) | (0.08 | ) | (0.21 | ) | (0.18 | ) | (0.20 | ) | (0.09 | ) | ||||||||||||||||||||||||||||||||||||||
Net realized and unrealized gain (loss) |
2.47 | 7.90 | 0.96 | (2.52 | ) | 8.91 | 15.05 | (1.53 | ) | |||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net increase (decrease) from investment operations |
2.35 | 7.79 | 0.88 | (2.73 | ) | 8.73 | 14.85 | (1.62 | ) | |||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Distributions(b) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
From net investment income |
— | — | (0.02 | ) | — | — | (0.05 | ) | — | |||||||||||||||||||||||||||||||||||||||||||
From net realized gain |
(2.49 | ) | (2.34 | ) | (4.66 | ) | (6.61 | ) | (2.99 | ) | (2.31 | ) | (4.42 | ) | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total distributions |
(2.49 | ) | (2.34 | ) | (4.68 | ) | (6.61 | ) | (2.99 | ) | (2.36 | ) | (4.42 | ) | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net asset value, end of period |
$ | 67.45 | $ | 67.59 | $ | 62.14 | $ | 65.94 | $ | 75.28 | $ | 69.54 | $ | 57.05 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total Return(c) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Based on net asset value |
3.50 | %(d) | 12.88 | % | 1.62 | % | (4.12 | )%(e) | 12.91 | %(d) | 26.60 | %(f) | (2.44 | )% | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Ratios to Average Net Assets(g) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total expenses |
1.44 | %(h) | 1.46 | % | 1.46 | % | 1.45 | % | 1.44 | %(h) | 1.45 | % | 1.45 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total expenses after fees waived and/or reimbursed |
1.44 | %(h) | 1.46 | % | 1.46 | % | 1.45 | % | 1.44 | %(h) | 1.45 | % | 1.45 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss |
(0.34 | )%(h) | (0.17 | )% | (0.13 | )% | (0.29 | )% | (0.37 | )%(h) | (0.32 | )% | (0.15 | )% | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Supplemental Data |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Net assets, end of period (000) |
$ | 244,804 | $ | 247,848 | $ | 242,080 | $ | 263,195 | $ | 289,676 | $ | 260,488 | $ | 224,862 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Portfolio turnover rate |
16 | % | 27 | % | 29 | % | 51 | % | 19 | % | 28 | % | 41 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) | Based on average shares outstanding. |
(b) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(c) | Where applicable, assumes the reinvestment of distributions. |
(d) | Not annualized. |
(e) | Includes a capital contribution from affiliate, which had no impact on the Fund’s total return. |
(f) | Includes a payment received from an affiliate, which had no impact on the Fund’s total return. |
(g) | Excludes fees and expenses incurred indirectly as a result of investments in underlying funds. |
(h) | Annualized. |
See notes to financial statements.
38 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Financial Highlights
(For a share outstanding throughout each period)
BlackRock Infrastructure Sustainable Opportunities Fund | ||||||||||||||||||||||||||||
Institutional | ||||||||||||||||||||||||||||
|
Six Months Ended 11/30/24 (unaudited |
) |
|
Year Ended 05/31/24 |
|
|
Year Ended 05/31/23 |
|
|
Period from 09/30/21 to 05/31/22 |
(a)
| |||||||||||||||||
Net asset value, beginning of period |
$ | 8.84 | $ | 9.04 | $ | 9.97 | $ | 10.00 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net investment income(b) |
0.10 | 0.19 | 0.14 | 0.07 | ||||||||||||||||||||||||
Net realized and unrealized gain (loss) |
0.58 | (0.18 | ) | (0.68 | ) | (0.02 | ) | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net increase (decrease) from investment operations |
0.68 | 0.01 | (0.54 | ) | 0.05 | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Distributions(c) |
||||||||||||||||||||||||||||
From net investment income |
(0.06 | ) | (0.21 | ) | (0.13 | ) | (0.04 | ) | ||||||||||||||||||||
From net realized gain |
— | — | (0.26 | ) | (0.04 | ) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total distributions |
(0.06 | ) | (0.21 | ) | (0.39 | ) | (0.08 | ) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net asset value, end of period |
$ | 9.46 | $ | 8.84 | $ | 9.04 | $ | 9.97 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total Return(d) |
||||||||||||||||||||||||||||
Based on net asset value |
7.69 | %(e) | 0.13 | % | (5.32 | )% | 0.45 | %(e) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Ratios to Average Net Assets(f) |
||||||||||||||||||||||||||||
Total expenses |
3.93 | %(g) | 4.73 | % | 4.54 | % | 3.62 | %(g)(h) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total expenses after fees waived and/or reimbursed |
1.00 | %(g) | 1.00 | % | 1.00 | % | 1.00 | %(g) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net investment income |
2.20 | %(g) | 2.22 | % | 1.60 | % | 1.09 | %(g) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Supplemental Data |
||||||||||||||||||||||||||||
Net assets, end of period (000) |
$ | 111 | $ | 102 | $ | 102 | $ | 107 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Portfolio turnover rate |
59 | % | 57 | %(i) | 104 | %(i) | 70 | %(i) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
(a) | Commencement of operations. |
(b) | Based on average shares outstanding. |
(c) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(d) | Where applicable, assumes the reinvestment of distributions. |
(e) | Not annualized. |
(f) | Excludes fees and expenses incurred indirectly as a result of investments in underlying funds. |
(g) | Annualized. |
(h) | Audit, offering, organization and printing costs were not annualized in the calculation of the expense ratios. If these expenses were annualized, the total expenses would have been 4.45%. |
(i) | Excludes underlying investments in total return swaps. |
See notes to financial statements.
F I N A N C I A L H I G H L I G H T S |
39 |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BlackRock Infrastructure Sustainable Opportunities Fund (continued) | ||||||||||||||||||||||||||||
Investor A | ||||||||||||||||||||||||||||
|
Six Months Ended 11/30/24 (unaudited |
) |
|
Year Ended 05/31/24 |
|
|
Year Ended 05/31/23 |
|
|
Period from 09/30/21 to 05/31/22 |
(a)
| |||||||||||||||||
Net asset value, beginning of period |
$ | 8.83 | $ | 9.03 | $ | 9.96 | $ | 10.00 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net investment income(b) |
0.09 | 0.17 | 0.13 | 0.06 | ||||||||||||||||||||||||
Net realized and unrealized gain (loss) |
0.58 | (0.17 | ) | (0.69 | ) | (0.03 | ) | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net increase (decrease) from investment operations |
0.67 | 0.00 | (c) | (0.56 | ) | 0.03 | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Distributions(d) |
||||||||||||||||||||||||||||
From net investment income |
(0.05 | ) | (0.20 | ) | (0.11 | ) | (0.03 | ) | ||||||||||||||||||||
From net realized gain |
— | — | (0.26 | ) | (0.04 | ) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total distributions |
(0.05 | ) | (0.20 | ) | (0.37 | ) | (0.07 | ) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net asset value, end of period |
$ | 9.45 | $ | 8.83 | $ | 9.03 | $ | 9.96 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total Return(e) |
||||||||||||||||||||||||||||
Based on net asset value |
7.58 | %(f) | (0.08 | )% | (5.55 | )% | 0.29 | %(f) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Ratios to Average Net Assets(g) |
||||||||||||||||||||||||||||
Total expenses |
4.32 | %(h) | 5.05 | % | 4.75 | % | 3.88 | %(h)(i) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total expenses after fees waived and/or reimbursed |
1.25 | %(h) | 1.25 | % | 1.25 | % | 1.25 | %(h) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net investment income |
2.03 | %(h) | 1.97 | % | 1.41 | % | 0.84 | %(h) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Supplemental Data |
||||||||||||||||||||||||||||
Net assets, end of period (000) |
$ | 230 | $ | 253 | $ | 156 | $ | 109 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Portfolio turnover rate |
59 | % | 57 | %(j) | 104 | %(j) | 70 | %(j) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
(a) | Commencement of operations. |
(b) | Based on average shares outstanding. |
(c) | Amount is less than $0.005 per share. |
(d) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(e) | Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions. |
(f) | Not annualized. |
(g) | Excludes fees and expenses incurred indirectly as a result of investments in underlying funds. |
(h) | Annualized. |
(i) | Audit, offering, organization and printing costs were not annualized in the calculation of the expense ratios. If these expenses were annualized, the total expenses would have been 4.71%. |
(j) | Excludes underlying investments in total return swaps. |
See notes to financial statements.
40 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BlackRock Infrastructure Sustainable Opportunities Fund (continued) | ||||||||||||||||||||||||||||
Class K | ||||||||||||||||||||||||||||
|
Six Months Ended 11/30/24 (unaudited |
) |
|
Year Ended 05/31/24 |
|
|
Year Ended 05/31/23 |
|
|
Period from 09/30/21 to 05/31/22 |
(a)
| |||||||||||||||||
Net asset value, beginning of period |
$ | 8.85 | $ | 9.04 | $ | 9.97 | $ | 10.00 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net investment income(b) |
0.10 | 0.20 | 0.15 | 0.08 | ||||||||||||||||||||||||
Net realized and unrealized gain (loss) |
0.57 | (0.17 | ) | (0.69 | ) | (0.03 | ) | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net increase (decrease) from investment operations |
0.67 | 0.03 | (0.54 | ) | 0.05 | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Distributions(c) |
||||||||||||||||||||||||||||
From net investment income |
(0.06 | ) | (0.22 | ) | (0.13 | ) | (0.04 | ) | ||||||||||||||||||||
From net realized gain |
— | — | (0.26 | ) | (0.04 | ) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total distributions |
(0.06 | ) | (0.22 | ) | (0.39 | ) | (0.08 | ) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net asset value, end of period |
$ | 9.46 | $ | 8.85 | $ | 9.04 | $ | 9.97 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total Return(d) |
||||||||||||||||||||||||||||
Based on net asset value |
7.58 | %(e) | 0.29 | % | (5.27 | )% | 0.46 | %(e) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Ratios to Average Net Assets(f) |
||||||||||||||||||||||||||||
Total expenses |
3.76 | %(g) | 4.41 | % | 4.33 | % | 3.36 | %(g)(h) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total expenses after fees waived and/or reimbursed |
0.95 | %(g) | 0.95 | % | 0.95 | % | 0.95 | %(g) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net investment income |
2.25 | %(g) | 2.27 | % | 1.65 | % | 1.13 | %(g) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Supplemental Data |
||||||||||||||||||||||||||||
Net assets, end of period (000) |
$ | 9,280 | $ | 8,674 | $ | 8,866 | $ | 9,777 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Portfolio turnover rate |
59 | % | 57 | %(i) | 104 | %(i) | 70 | %(i) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
(a) | Commencement of operations. |
(b) | Based on average shares outstanding. |
(c) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(d) | Where applicable, assumes the reinvestment of distributions. |
(e) | Not annualized. |
(f) | Excludes fees and expenses incurred indirectly as a result of investments in underlying funds. |
(g) | Annualized. |
(h) | Audit, offering, organization and printing costs were not annualized in the calculation of the expense ratios. If these expenses were annualized, the total expenses would have been 4.21%. |
(i) | Excludes underlying investments in total return swaps. |
See notes to financial statements.
F I N A N C I A L H I G H L I G H T S |
41 |
Financial Highlights
(For a share outstanding throughout each period)
BlackRock Mid-Cap Growth Equity Portfolio | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Institutional | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Six Months Ended 11/30/24 (unaudited |
) |
|
Year Ended 05/31/24 |
|
|
Year Ended 05/31/23 |
|
|
Year Ended 05/31/22 |
|
|
Period from 10/01/20 to 05/31/21 |
|
|
Year Ended 09/30/20 |
|
|
Year Ended 09/30/19 |
| ||||||||||||||||||||||||||||||||
Net asset value, beginning of period |
$ | 39.18 | $ | 32.79 | $ | 32.83 | $ | 45.95 | $ | 36.56 | $ | 28.68 | $ | 27.87 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss(a) |
(0.10 | ) | (0.14 | ) | (0.08 | ) | (0.23 | ) | (0.15 | ) | (0.14 | ) | (0.09 | ) | ||||||||||||||||||||||||||||||||||||||
Net realized and unrealized gain (loss) |
7.07 | 6.53 | 0.04 | (10.52 | ) | 9.54 | 8.14 | 1.95 | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net increase (decrease) from investment operations |
6.97 | 6.39 | (0.04 | ) | (10.75 | ) | 9.39 | 8.00 | 1.86 | |||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Distributions from net realized gain(b) |
— | — | — | (2.37 | ) | — | (0.12 | ) | (1.05 | ) | ||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net asset value, end of period |
$ | 46.15 | $ | 39.18 | $ | 32.79 | $ | 32.83 | $ | 45.95 | $ | 36.56 | $ | 28.68 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total Return(c) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Based on net asset value |
17.79 | %(d) | 19.49 | % | (0.12 | )% | (24.87 | )% | 25.68 | %(d) | 27.98 | % | 7.43 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Ratios to Average Net Assets(e) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total expenses |
0.83 | %(f) | 0.85 | % | 0.84 | % | 0.81 | % | 0.80 | %(f) | 0.85 | % | 0.87 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total expenses after fees waived and/or reimbursed |
0.80 | %(f) | 0.80 | % | 0.80 | % | 0.80 | % | 0.80 | %(f) | 0.80 | % | 0.80 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss |
(0.49 | )%(f) | (0.38 | )% | (0.25 | )% | (0.52 | )% | (0.52 | )%(f) | (0.43 | )% | (0.34 | )% | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Supplemental Data |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Net assets, end of period (000) |
$ | 4,892,015 | $ | 5,194,320 | $ | 5,266,832 | $ | 7,095,644 | $ | 9,260,191 | $ | 6,003,280 | $ | 2,700,531 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Portfolio turnover rate |
38 | % | 48 | % | 46 | % | 28 | % | 22 | % | 35 | % | 38 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) | Based on average shares outstanding. |
(b) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(c) | Where applicable, assumes the reinvestment of distributions. |
(d) | Not annualized. |
(e) | Excludes fees and expenses incurred indirectly as a result of investments in underlying funds. |
(f) | Annualized. |
See notes to financial statements.
42 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BlackRock Mid-Cap Growth Equity Portfolio (continued) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Service | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Six Months Ended 11/30/24 (unaudited |
) |
|
Year Ended 05/31/24 |
|
|
Year Ended 05/31/23 |
|
|
Year Ended 05/31/22 |
|
|
Period from 10/01/20 to 05/31/21 |
|
|
Year Ended 09/30/20 |
|
|
Year Ended 09/30/19 |
| ||||||||||||||||||||||||||||||||
Net asset value, beginning of period |
$ | 34.85 | $ | 29.23 | $ | 29.34 | $ | 41.34 | $ | 32.95 | $ | 25.92 | $ | 25.30 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss(a) |
(0.13 | ) | (0.21 | ) | (0.14 | ) | (0.31 | ) | (0.20 | ) | (0.19 | ) | (0.15 | ) | ||||||||||||||||||||||||||||||||||||||
Net realized and unrealized gain (loss) |
6.27 | 5.83 | 0.03 | (9.39 | ) | 8.59 | 7.34 | 1.76 | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net increase (decrease) from investment operations |
6.14 | 5.62 | (0.11 | ) | (9.70 | ) | 8.39 | 7.15 | 1.61 | |||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Distributions from net realized gain(b) |
— | — | — | (2.30 | ) | — | (0.12 | ) | (0.99 | ) | ||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net asset value, end of period |
$ | 40.99 | $ | 34.85 | $ | 29.23 | $ | 29.34 | $ | 41.34 | $ | 32.95 | $ | 25.92 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total Return(c) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Based on net asset value |
17.62 | %(d) | 19.23 | % | (0.38 | )% | (25.06 | )% | 25.46 | %(d) | 27.68 | % | 7.15 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Ratios to Average Net Assets(e) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total expenses |
1.14 | %(f) | 1.12 | % | 1.10 | % | 1.09 | % | 1.10 | %(f) | 1.11 | % | 1.16 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total expenses after fees waived and/or reimbursed |
1.05 | %(f) | 1.05 | % | 1.05 | % | 1.05 | % | 1.05 | %(f) | 1.05 | % | 1.05 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss |
(0.74 | )%(f) | (0.63 | )% | (0.50 | )% | (0.77 | )% | (0.78 | )%(f) | (0.67 | )% | (0.59 | )% | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Supplemental Data |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Net assets, end of period (000) |
$ | 59,904 | $ | 59,731 | $ | 62,693 | $ | 81,276 | $ | 104,997 | $ | 83,680 | $ | 61,293 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Portfolio turnover rate |
38 | % | 48 | % | 46 | % | 28 | % | 22 | % | 35 | % | 38 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) | Based on average shares outstanding. |
(b) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(c) | Where applicable, assumes the reinvestment of distributions. |
(d) | Not annualized. |
(e) | Excludes fees and expenses incurred indirectly as a result of investments in underlying funds. |
(f) | Annualized. |
See notes to financial statements.
F I N A N C I A L H I G H L I G H T S |
43 |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BlackRock Mid-Cap Growth Equity Portfolio (continued) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investor A | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Six Months Ended 11/30/24 (unaudited |
) |
|
Year Ended 05/31/24 |
|
|
Year Ended 05/31/23 |
|
|
Year Ended 05/31/22 |
|
|
Period from 10/01/20 to 05/31/21 |
|
|
Year Ended 09/30/20 |
|
|
Year Ended 09/30/19 |
| ||||||||||||||||||||||||||||||||
Net asset value, beginning of period |
$ | 33.20 | $ | 27.85 | $ | 27.96 | $ | 39.50 | $ | 31.48 | $ | 24.78 | $ | 24.22 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss(a) |
(0.13 | ) | (0.20 | ) | (0.14 | ) | (0.29 | ) | (0.19 | ) | (0.18 | ) | (0.14 | ) | ||||||||||||||||||||||||||||||||||||||
Net realized and unrealized gain (loss) |
5.99 | 5.55 | 0.03 | (8.94 | ) | 8.21 | 7.00 | 1.68 | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net increase (decrease) from investment operations |
5.86 | 5.35 | (0.11 | ) | (9.23 | ) | 8.02 | 6.82 | 1.54 | |||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Distributions from net realized gain(b) |
— | — | — | (2.31 | ) | — | (0.12 | ) | (0.98 | ) | ||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net asset value, end of period |
$ | 39.06 | $ | 33.20 | $ | 27.85 | $ | 27.96 | $ | 39.50 | $ | 31.48 | $ | 24.78 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total Return(c) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Based on net asset value |
17.65 | %(d) | 19.21 | % | (0.39 | )% | (25.05 | )% | 25.48 | %(d) | 27.61 | % | 7.17 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Ratios to Average Net Assets(e) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total expenses |
1.11 | %(f) | 1.13 | % | 1.13 | % | 1.09 | % | 1.09 | %(f) | 1.14 | % | 1.16 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total expenses after fees waived and/or reimbursed |
1.05 | %(f) | 1.05 | % | 1.05 | % | 1.05 | % | 1.05 | %(f) | 1.05 | % | 1.05 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss |
(0.74 | )%(f) | (0.63 | )% | (0.50 | )% | (0.78 | )% | (0.78 | )%(f) | (0.67 | )% | (0.58 | )% | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Supplemental Data |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Net assets, end of period (000) |
$ | 1,733,971 | $ | 1,622,438 | $ | 1,637,289 | $ | 1,913,190 | $ | 2,577,151 | $ | 1,917,773 | $ | 1,335,467 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Portfolio turnover rate |
38 | % | 48 | % | 46 | % | 28 | % | 22 | % | 35 | % | 38 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) | Based on average shares outstanding. |
(b) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(c) | Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions. |
(d) | Not annualized. |
(e) | Excludes fees and expenses incurred indirectly as a result of investments in underlying funds. |
(f) | Annualized. |
See notes to financial statements.
44 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BlackRock Mid-Cap Growth Equity Portfolio (continued) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investor C | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Six Months Ended 11/30/24 (unaudited |
) |
|
Year Ended 05/31/24 |
|
|
Year Ended 05/31/23 |
|
|
Year Ended 05/31/22 |
|
|
Period from 10/01/20 to 05/31/21 |
|
|
Year Ended 09/30/20 |
|
|
Year Ended 09/30/19 |
| ||||||||||||||||||||||||||||||||
Net asset value, beginning of period |
$ | 24.48 | $ | 20.69 | $ | 20.93 | $ | 30.22 | $ | 24.20 | $ | 19.21 | $ | 19.04 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss(a) |
(0.19 | ) | (0.32 | ) | (0.25 | ) | (0.43 | ) | (0.29 | ) | (0.30 | ) | (0.24 | ) | ||||||||||||||||||||||||||||||||||||||
Net realized and unrealized gain (loss) |
4.40 | 4.11 | 0.01 | (6.67 | ) | 6.31 | 5.41 | 1.28 | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net increase (decrease) from investment operations |
4.21 | 3.79 | (0.24 | ) | (7.10 | ) | 6.02 | 5.11 | 1.04 | |||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Distributions from net realized gain(b) |
— | — | — | (2.19 | ) | — | (0.12 | ) | (0.87 | ) | ||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net asset value, end of period |
$ | 28.69 | $ | 24.48 | $ | 20.69 | $ | 20.93 | $ | 30.22 | $ | 24.20 | $ | 19.21 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total Return(c) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Based on net asset value |
17.20 | %(d) | 18.32 | % | (1.15 | )% | (25.61 | )% | 24.88 | %(d) | 26.72 | % | 6.33 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Ratios to Average Net Assets(e) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total expenses |
1.81 | %(f) | 1.84 | % | 1.83 | % | 1.78 | % | 1.80 | %(f) | 1.84 | % | 1.86 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total expenses after fees waived and/or reimbursed |
1.80 | %(f) | 1.80 | % | 1.80 | % | 1.78 | % | 1.79 | %(f) | 1.80 | % | 1.80 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss |
(1.49 | )%(f) | (1.38 | )% | (1.25 | )% | (1.51 | )% | (1.52 | )%(f) | (1.42 | )% | (1.33 | )% | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Supplemental Data |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Net assets, end of period (000) |
$ | 186,860 | $ | 184,966 | $ | 194,849 | $ | 243,284 | $ | 357,360 | $ | 280,143 | $ | 209,923 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Portfolio turnover rate |
38 | % | 48 | % | 46 | % | 28 | % | 22 | % | 35 | % | 38 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) | Based on average shares outstanding. |
(b) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(c) | Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions. |
(d) | Not annualized. |
(e) | Excludes fees and expenses incurred indirectly as a result of investments in underlying funds. |
(f) | Annualized. |
See notes to financial statements.
F I N A N C I A L H I G H L I G H T S |
45 |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BlackRock Mid-Cap Growth Equity Portfolio (continued) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Class K | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Six Months Ended 11/30/24 (unaudited |
) |
|
Year Ended 05/31/24 |
|
|
Year Ended 05/31/23 |
|
|
Year Ended 05/31/22 |
|
|
Period from 10/01/20 to 05/31/21 |
|
|
Year Ended 09/30/20 |
|
|
Year Ended 09/30/19 |
| ||||||||||||||||||||||||||||||||
Net asset value, beginning of period |
$ | 39.42 | $ | 32.95 | $ | 32.96 | $ | 46.10 | $ | 36.66 | $ | 28.74 | $ | 27.93 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss(a) |
(0.08 | ) | (0.11 | ) | (0.05 | ) | (0.17 | ) | (0.12 | ) | (0.12 | ) | (0.09 | ) | ||||||||||||||||||||||||||||||||||||||
Net realized and unrealized gain (loss) |
7.11 | 6.58 | 0.04 | (10.58 | ) | 9.56 | 8.16 | 1.96 | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net increase (decrease) from investment operations |
7.03 | 6.47 | (0.01 | ) | (10.75 | ) | 9.44 | 8.04 | 1.87 | |||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Distributions from net realized gain(b) |
— | — | — | (2.39 | ) | — | (0.12 | ) | (1.06 | ) | ||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net asset value, end of period |
$ | 46.45 | $ | 39.42 | $ | 32.95 | $ | 32.96 | $ | 46.10 | $ | 36.66 | $ | 28.74 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total Return(c) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Based on net asset value |
17.83 | %(d) | 19.64 | % | (0.03 | )% | (24.79 | )% | 25.75 | %(d) | 28.06 | % | 7.47 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Ratios to Average Net Assets(e) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total expenses |
0.70 | %(f) | 0.71 | % | 0.71 | % | 0.70 | % | 0.70 | %(f) | 0.73 | %(g) | 0.76 | %(h) | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total expenses after fees waived and/or reimbursed |
0.70 | %(f) | 0.71 | % | 0.71 | % | 0.70 | % | 0.70 | %(f) | 0.73 | % | 0.75 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss |
(0.39 | )%(f) | (0.29 | )% | (0.15 | )% | (0.40 | )% | (0.42 | )%(f) | (0.36 | )% | (0.31 | )% | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Supplemental Data |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Net assets, end of period (000) |
$ | 4,474,464 | $ | 4,520,357 | $ | 4,233,488 | $ | 4,376,642 | $ | 3,674,402 | $ | 2,011,727 | $ | 652,138 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Portfolio turnover rate |
38 | % | 48 | % | 46 | % | 28 | % | 22 | % | 35 | % | 38 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) | Based on average shares outstanding. |
(b) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(c) | Where applicable, assumes the reinvestment of distributions. |
(d) | Not annualized. |
(e) | Excludes fees and expenses incurred indirectly as a result of investments in underlying funds. |
(f) | Annualized. |
(g) | Includes recoupment of past waived and/or reimbursed fees with no financial impact to the expense ratios. |
(h) | Includes recoupment of past waived and/or reimbursed fees. Excluding the recoupment of past waived and/or reimbursed fees for the year ended September 30, 2019, the expense ratio would have been 0.75%. |
See notes to financial statements.
46 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BlackRock Mid-Cap Growth Equity Portfolio (continued) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Class R | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Six Months Ended 11/30/24 (unaudited |
) |
|
Year Ended 05/31/24 |
|
|
Year Ended 05/31/23 |
|
|
Year Ended 05/31/22 |
|
|
Period from 10/01/20 to 05/31/21 |
|
|
Year Ended 09/30/20 |
|
|
Year Ended 09/30/19 |
| ||||||||||||||||||||||||||||||||
Net asset value, beginning of period |
$ | 32.23 | $ | 27.11 | $ | 27.28 | $ | 38.65 | $ | 30.85 | $ | 24.34 | $ | 23.83 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss(a) |
(0.17 | ) | (0.26 | ) | (0.20 | ) | (0.37 | ) | (0.25 | ) | (0.24 | ) | (0.19 | ) | ||||||||||||||||||||||||||||||||||||||
Net realized and unrealized gain (loss) |
5.81 | 5.38 | 0.03 | (8.73 | ) | 8.05 | 6.87 | 1.65 | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net increase (decrease) from investment operations |
5.64 | 5.12 | (0.17 | ) | (9.10 | ) | 7.80 | 6.63 | 1.46 | |||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Distributions from net realized gain(b) |
— | — | — | (2.27 | ) | — | (0.12 | ) | (0.95 | ) | ||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net asset value, end of period |
$ | 37.87 | $ | 32.23 | $ | 27.11 | $ | 27.28 | $ | 38.65 | $ | 30.85 | $ | 24.34 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total Return(c) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Based on net asset value |
17.50 | %(d) | 18.89 | % | (0.62 | )% | (25.24 | )% | 25.28 | %(d) | 27.33 | % | 6.89 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Ratios to Average Net Assets(e) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total expenses |
1.42 | %(f) | 1.41 | % | 1.42 | % | 1.40 | % | 1.39 | %(f) | 1.45 | % | 1.47 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total expenses after fees waived and/or reimbursed |
1.30 | %(f) | 1.30 | % | 1.30 | % | 1.30 | % | 1.30 | %(f) | 1.30 | % | 1.30 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss |
(0.99 | )%(f) | (0.88 | )% | (0.75 | )% | (1.02 | )% | (1.03 | )%(f) | (0.92 | )% | (0.83 | )% | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Supplemental Data |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Net assets, end of period (000) |
$ | 90,910 | $ | 85,328 | $ | 93,427 | $ | 93,527 | $ | 98,300 | $ | 59,411 | $ | 40,999 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Portfolio turnover rate |
38 | % | 48 | % | 46 | % | 28 | % | 22 | % | 35 | % | 38 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) | Based on average shares outstanding. |
(b) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(c) | Where applicable, assumes the reinvestment of distributions. |
(d) | Not annualized. |
(e) | Excludes fees and expenses incurred indirectly as a result of investments in underlying funds. |
(f) | Annualized. |
See notes to financial statements.
F I N A N C I A L H I G H L I G H T S |
47 |
Financial Highlights
(For a share outstanding throughout each period)
BlackRock Technology Opportunities Fund | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Institutional | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Six Months Ended 11/30/24 (unaudited |
) |
|
Year Ended 05/31/24 |
|
|
Year Ended 05/31/23 |
|
|
Year Ended 05/31/22 |
|
|
Period from 10/01/20 to 05/31/21 |
|
|
Year Ended 09/30/20 |
|
|
Year Ended 09/30/19 |
| ||||||||||||||||||||||||||||||||
Net asset value, beginning of period |
$ | 65.44 | $ | 47.74 | $ | 45.31 | $ | 64.81 | $ | 55.33 | $ | 32.63 | $ | 31.83 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss(a) |
(0.17 | ) | (0.23 | ) | (0.13 | ) | (0.30 | ) | (0.28 | ) | (0.22 | ) | (0.10 | ) | ||||||||||||||||||||||||||||||||||||||
Net realized and unrealized gain (loss) |
10.48 | 17.93 | 2.56 | (14.51 | ) | 12.67 | 23.43 | 1.20 | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net increase (decrease) from investment operations |
10.31 | 17.70 | 2.43 | (14.81 | ) | 12.39 | 23.21 | 1.10 | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Distributions from net realized gain(b) |
— | — | — | (4.69 | ) | (2.91 | ) | (0.51 | ) | (0.30 | ) | |||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net asset value, end of period |
$ | 75.75 | $ | 65.44 | $ | 47.74 | $ | 45.31 | $ | 64.81 | $ | 55.33 | $ | 32.63 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total Return(c) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Based on net asset value |
15.75 | %(d) | 37.08 | % | 5.36 | % | (25.09 | )% | 22.68 | %(d) | 72.07 | % | 3.63 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Ratios to Average Net Assets(e) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total expenses |
0.93 | %(f) | 0.97 | % | 0.98 | % | 0.94 | % | 0.92 | %(f) | 0.98 | % | 1.02 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total expenses after fees waived and/or reimbursed |
0.92 | %(f) | 0.92 | % | 0.92 | % | 0.92 | % | 0.92 | %(f) | 0.92 | % | 0.92 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss |
(0.47 | )%(f) | (0.41 | )% | (0.30 | )% | (0.48 | )% | (0.66 | )%(f) | (0.50 | )% | (0.32 | )% | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Supplemental Data |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Net assets, end of period (000) |
$ | 3,165,792 | $ | 2,751,350 | $ | 2,316,550 | $ | 2,943,616 | $ | 4,958,187 | $ | 3,641,519 | $ | 1,033,286 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Portfolio turnover rate |
28 | % | 21 | % | 39 | % | 29 | % | 25 | % | 27 | % | 33 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) | Based on average shares outstanding. |
(b) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(c) | Where applicable, assumes the reinvestment of distributions. |
(d) | Not annualized. |
(e) | Excludes fees and expenses incurred indirectly as a result of investments in underlying funds. |
(f) | Annualized. |
See notes to financial statements.
48 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BlackRock Technology Opportunities Fund (continued) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Service | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Six Months Ended 11/30/24 (unaudited |
) |
|
Year Ended 05/31/24 |
|
|
Year Ended 05/31/23 |
|
|
Year Ended 05/31/22 |
|
|
Period from 10/01/20 to 05/31/21 |
|
|
Year Ended 09/30/20 |
|
|
Year Ended 09/30/19 |
| ||||||||||||||||||||||||||||||||
Net asset value, beginning of period |
$ | 60.78 | $ | 44.45 | $ | 42.30 | $ | 60.86 | $ | 52.20 | $ | 30.88 | $ | 30.22 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss(a) |
(0.24 | ) | (0.34 | ) | (0.21 | ) | (0.42 | ) | (0.37 | ) | (0.30 | ) | (0.17 | ) | ||||||||||||||||||||||||||||||||||||||
Net realized and unrealized gain (loss) |
9.73 | 16.67 | 2.36 | (13.52 | ) | 11.94 | 22.13 | 1.13 | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net increase (decrease) from investment operations |
9.49 | 16.33 | 2.15 | (13.94 | ) | 11.57 | 21.83 | 0.96 | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Distributions from net realized gain(b) |
— | — | — | (4.62 | ) | (2.91 | ) | (0.51 | ) | (0.30 | ) | |||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net asset value, end of period |
$ | 70.27 | $ | 60.78 | $ | 44.45 | $ | 42.30 | $ | 60.86 | $ | 52.20 | $ | 30.88 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total Return(c) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Based on net asset value |
15.62 | %(d) | 36.74 | % | 5.08 | % | (25.28 | )% | 22.46 | %(d) | 71.68 | % | 3.36 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Ratios to Average Net Assets(e) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total expenses |
1.21 | %(f) | 1.21 | % | 1.20 | % | 1.19 | % | 1.17 | %(f) | 1.19 | % | 1.25 | %(g) | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total expenses after fees waived and/or reimbursed |
1.17 | %(f) | 1.17 | % | 1.17 | % | 1.17 | % | 1.16 | %(f) | 1.17 | % | 1.17 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss |
(0.71 | )%(f) | (0.67 | )% | (0.55 | )% | (0.73 | )% | (0.90 | )%(f) | (0.74 | )% | (0.57 | )% | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Supplemental Data |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Net assets, end of period (000) |
$ | 56,019 | $ | 46,993 | $ | 47,332 | $ | 55,439 | $ | 83,886 | $ | 50,710 | $ | 20,429 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Portfolio turnover rate |
28 | % | 21 | % | 39 | % | 29 | % | 25 | % | 27 | % | 33 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) | Based on average shares outstanding. |
(b) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(c) | Where applicable, assumes the reinvestment of distributions. |
(d) | Not annualized. |
(e) | Excludes fees and expenses incurred indirectly as a result of investments in underlying funds. |
(f) | Annualized. |
(g) | Includes recoupment of past waived and/or reimbursed fees with no financial impact to the expense ratios. |
See notes to financial statements.
F I N A N C I A L H I G H L I G H T S |
49 |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BlackRock Technology Opportunities Fund (continued) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investor A | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Six Months Ended 11/30/24 (unaudited |
) |
|
Year Ended 05/31/24 |
|
|
Year Ended 05/31/23 |
|
|
Year Ended 05/31/22 |
|
|
Period from 10/01/20 to 05/31/21 |
|
|
Year Ended 09/30/20 |
|
|
Year Ended 09/30/19 |
| ||||||||||||||||||||||||||||||||
Net asset value, beginning of period |
$ | 59.29 | $ | 43.37 | $ | 41.27 | $ | 59.47 | $ | 51.06 | $ | 30.22 | $ | 29.58 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss(a) |
(0.23 | ) | (0.33 | ) | (0.21 | ) | (0.41 | ) | (0.36 | ) | (0.29 | ) | (0.17 | ) | ||||||||||||||||||||||||||||||||||||||
Net realized and unrealized gain (loss) |
9.49 | 16.25 | 2.31 | (13.19 | ) | 11.68 | 21.64 | 1.11 | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net increase (decrease) from investment operations |
9.26 | 15.92 | 2.10 | (13.60 | ) | 11.32 | 21.35 | 0.94 | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Distributions from net realized gain(b) |
— | — | — | (4.60 | ) | (2.91 | ) | (0.51 | ) | (0.30 | ) | |||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net asset value, end of period |
$ | 68.55 | $ | 59.29 | $ | 43.37 | $ | 41.27 | $ | 59.47 | $ | 51.06 | $ | 30.22 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total Return(c) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Based on net asset value |
15.62 | %(d) | 36.71 | % | 5.09 | % | (25.28 | )% | 22.48 | %(d) | 71.65 | % | 3.36 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Ratios to Average Net Assets(e) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total expenses |
1.19 | %(f) | 1.21 | % | 1.23 | % | 1.21 | % | 1.19 | %(f) | 1.25 | % | 1.29 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total expenses after fees waived and/or reimbursed |
1.17 | %(f) | 1.17 | % | 1.17 | % | 1.17 | % | 1.17 | %(f) | 1.17 | % | 1.17 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss |
(0.72 | )%(f) | (0.66 | )% | (0.54 | )% | (0.73 | )% | (0.91 | )%(f) | (0.74 | )% | (0.58 | )% | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Supplemental Data |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Net assets, end of period (000) |
$ | 2,188,541 | $ | 1,959,752 | $ | 1,572,976 | $ | 1,695,648 | $ | 2,524,052 | $ | 1,773,399 | $ | 672,110 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Portfolio turnover rate |
28 | % | 21 | % | 39 | % | 29 | % | 25 | % | 27 | % | 33 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) | Based on average shares outstanding. |
(b) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(c) | Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions. |
(d) | Not annualized. |
(e) | Excludes fees and expenses incurred indirectly as a result of investments in underlying funds. |
(f) | Annualized. |
See notes to financial statements.
50 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BlackRock Technology Opportunities Fund (continued) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investor C | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Six Months Ended 11/30/24 (unaudited |
) |
|
Year Ended 05/31/24 |
|
|
Year Ended 05/31/23 |
|
|
Year Ended 05/31/22 |
|
|
Period from 10/01/20 to 05/31/21 |
|
|
Year Ended 09/30/20 |
|
|
Year Ended 09/30/19 |
| ||||||||||||||||||||||||||||||||
Net asset value, beginning of period |
$ | 46.92 | $ | 34.58 | $ | 33.17 | $ | 48.77 | $ | 42.52 | $ | 25.43 | $ | 25.13 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss(a) |
(0.37 | ) | (0.56 | ) | (0.40 | ) | (0.68 | ) | (0.54 | ) | (0.48 | ) | (0.32 | ) | ||||||||||||||||||||||||||||||||||||||
Net realized and unrealized gain (loss) |
7.51 | 12.90 | 1.81 | (10.52 | ) | 9.70 | 18.08 | 0.92 | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net increase (decrease) from investment operations |
7.14 | 12.34 | 1.41 | (11.20 | ) | 9.16 | 17.60 | 0.60 | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Distributions from net realized gain(b) |
— | — | — | (4.40 | ) | (2.91 | ) | (0.51 | ) | (0.30 | ) | |||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net asset value, end of period |
$ | 54.06 | $ | 46.92 | $ | 34.58 | $ | 33.17 | $ | 48.77 | $ | 42.52 | $ | 25.43 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total Return(c) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Based on net asset value |
15.22 | %(d) | 35.68 | % | 4.25 | % | (25.81 | )% | 21.89 | %(d) | 70.39 | % | 2.60 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Ratios to Average Net Assets(e) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total expenses |
1.92 | %(f) | 1.97 | % | 1.98 | % | 1.92 | % | 1.91 | %(f) | 1.98 | % | 2.02 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total expenses after fees waived and/or reimbursed |
1.91 | %(f) | 1.92 | % | 1.92 | % | 1.91 | % | 1.90 | %(f) | 1.92 | % | 1.92 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss |
(1.46 | )%(f) | (1.42 | )% | (1.30 | )% | (1.47 | )% | (1.65 | )%(f) | (1.49 | )% | (1.33 | )% | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Supplemental Data |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Net assets, end of period (000) |
$ | 312,839 | $ | 292,034 | $ | 259,247 | $ | 291,802 | $ | 427,435 | $ | 317,792 | $ | 152,505 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Portfolio turnover rate |
28 | % | 21 | % | 39 | % | 29 | % | 25 | % | 27 | % | 33 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) | Based on average shares outstanding. |
(b) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(c) | Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions. |
(d) | Not annualized. |
(e) | Excludes fees and expenses incurred indirectly as a result of investments in underlying funds. |
(f) | Annualized. |
See notes to financial statements.
F I N A N C I A L H I G H L I G H T S |
51 |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BlackRock Technology Opportunities Fund (continued) | ||||||||||||||||||||||||||||||||||||||||||||
Class K | ||||||||||||||||||||||||||||||||||||||||||||
|
Six Months Ended 11/30/24 (unaudited |
) |
|
Year Ended 05/31/24 |
|
|
Year Ended 05/31/23 |
|
|
Year Ended 05/31/22 |
|
|
Period from 10/01/20 to 05/31/21 |
|
|
Period from 12/10/19 to 09/30/20 |
(a)
| |||||||||||||||||||||||||||
Net asset value, beginning of period |
$ | 65.61 | $ | 47.83 | $ | 45.37 | $ | 64.89 | $ | 55.36 | $ | 34.59 | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
Net investment loss(b) |
(0.13 | ) | (0.19 | ) | (0.10 | ) | (0.24 | ) | (0.24 | ) | (0.16 | ) | ||||||||||||||||||||||||||||||||
Net realized and unrealized gain (loss) |
10.50 | 17.97 | 2.56 | (14.55 | ) | 12.68 | 20.93 | |||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
Net increase (decrease) from investment operations |
10.37 | 17.78 | 2.46 | (14.79 | ) | 12.44 | 20.77 | |||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
Distributions from net realized gain(c) |
— | — | — | (4.73 | ) | (2.91 | ) | — | ||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
Net asset value, end of period |
$ | 75.98 | $ | 65.61 | $ | 47.83 | $ | 45.37 | $ | 64.89 | $ | 55.36 | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
Total Return(d) |
||||||||||||||||||||||||||||||||||||||||||||
Based on net asset value |
15.81 | %(e) | 37.17 | % | 5.42 | % | (25.05 | )% | 22.77 | %(e) | 60.05 | %(e) | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
Ratios to Average Net Assets(f) |
||||||||||||||||||||||||||||||||||||||||||||
Total expenses |
0.83 | %(g) | 0.85 | % | 0.87 | % | 0.84 | % | 0.83 | %(g) | 0.87 | %(g) | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
Total expenses after fees waived and/or reimbursed |
0.83 | %(g) | 0.85 | % | 0.87 | % | 0.83 | % | 0.82 | %(g) | 0.86 | %(g) | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
Net investment loss |
(0.38 | )%(g) | (0.34 | )% | (0.24 | )% | (0.38 | )% | (0.56 | )%(g) | (0.46 | )%(g) | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
Supplemental Data |
||||||||||||||||||||||||||||||||||||||||||||
Net assets, end of period (000) |
$ | 349,269 | $ | 241,109 | $ | 157,185 | $ | 135,879 | $ | 122,568 | $ | 75,426 | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
Portfolio turnover rate |
28 | % | 21 | % | 39 | % | 29 | % | 25 | % | 27 | %(h) | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
(a) | Commencement of operations. |
(b) | Based on average shares outstanding. |
(c) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(d) | Where applicable, assumes the reinvestment of distributions. |
(e) | Not annualized. |
(f) | Excludes fees and expenses incurred indirectly as a result of investments in underlying funds. |
(g) | Annualized. |
(h) | Portfolio turnover is representative of the Fund for the entire year. |
See notes to financial statements.
52 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BlackRock Technology Opportunities Fund (continued) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Class R | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Six Months Ended 11/30/24 (unaudited |
) |
|
Year Ended 05/31/24 |
|
|
Year Ended 05/31/23 |
|
|
Year Ended 05/31/22 |
|
|
Period from 10/01/20 to 05/31/21 |
|
|
Year Ended 09/30/20 |
|
|
Year Ended 09/30/19 |
| ||||||||||||||||||||||||||||||||
Net asset value, beginning of period |
$ | 59.25 | $ | 43.44 | $ | 41.44 | $ | 59.75 | $ | 51.37 | $ | 30.48 | $ | 29.90 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss(a) |
(0.31 | ) | (0.46 | ) | (0.30 | ) | (0.56 | ) | (0.46 | ) | (0.38 | ) | (0.24 | ) | ||||||||||||||||||||||||||||||||||||||
Net realized and unrealized gain (loss) |
9.48 | 16.27 | 2.30 | (13.25 | ) | 11.75 | 21.78 | 1.12 | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net increase (decrease) from investment operations |
9.17 | 15.81 | 2.00 | (13.81 | ) | 11.29 | 21.40 | 0.88 | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Distributions from net realized gain(b) |
— | — | — | (4.50 | ) | (2.91 | ) | (0.51 | ) | (0.30 | ) | |||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net asset value, end of period |
$ | 68.42 | $ | 59.25 | $ | 43.44 | $ | 41.44 | $ | 59.75 | $ | 51.37 | $ | 30.48 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total Return(c) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Based on net asset value |
15.48 | %(d) | 36.39 | % | 4.83 | % | (25.47 | )% | 22.28 | %(d) | 71.20 | % | 3.12 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Ratios to Average Net Assets(e) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total expenses |
1.53 | %(f) | 1.55 | % | 1.58 | % | 1.54 | % | 1.50 | %(f) | 1.57 | % | 1.60 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total expenses after fees waived and/or reimbursed |
1.42 | %(f) | 1.42 | % | 1.42 | % | 1.42 | % | 1.42 | %(f) | 1.42 | % | 1.42 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Net investment loss |
(0.97 | )%(f) | (0.91 | )% | (0.79 | )% | (0.98 | )% | (1.17 | )%(f) | (0.99 | )% | (0.83 | )% | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Supplemental Data |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Net assets, end of period (000) |
$ | 49,760 | $ | 44,320 | $ | 35,771 | $ | 35,001 | $ | 50,186 | $ | 38,907 | $ | 18,799 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Portfolio turnover rate |
28 | % | 21 | % | 39 | % | 29 | % | 25 | % | 27 | % | 33 | % | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) | Based on average shares outstanding. |
(b) | Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(c) | Where applicable, assumes the reinvestment of distributions. |
(d) | Not annualized. |
(e) | Excludes fees and expenses incurred indirectly as a result of investments in underlying funds. |
(f) | Annualized. |
See notes to financial statements.
F I N A N C I A L H I G H L I G H T S |
53 |
Notes to Financial Statements (unaudited)
1. | ORGANIZATION |
BlackRock Capital Appreciation Fund, Inc. (the “Corporation”) and BlackRock FundsSM (the “Trust”) are each registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as open-end management investment companies. The Corporation is organized as a Maryland corporation. The Trust is organized as a Massachusetts business trust. BlackRock Capital Appreciation Fund, Inc. is the only series of the Corporation. BlackRock Health Sciences Opportunities Portfolio, BlackRock Infrastructure Sustainable Opportunities Fund, BlackRock Mid-Cap Growth Equity Portfolio and BlackRock Technology Opportunities Fund are series of the Trust. The following are referred to herein collectively as the “Funds” or individually as a “Fund”:
Fund Name | Herein Referred To As | Diversification Classification | ||
BlackRock Capital Appreciation Fund, Inc. |
Capital Appreciation | Diversified | ||
BlackRock Health Sciences Opportunities Portfolio |
Health Sciences Opportunities | Diversified | ||
BlackRock Infrastructure Sustainable Opportunities Fund |
Infrastructure Sustainable Opportunities | Non-Diversified | ||
BlackRock Mid-Cap Growth Equity Portfolio |
Mid-Cap Growth Equity | Diversified | ||
BlackRock Technology Opportunities Fund |
Technology Opportunities | Diversified |
Each Fund offers multiple classes of shares. All classes of shares have identical voting, dividend, liquidation and other rights and are subject to the same terms and conditions, except that certain classes bear expenses related to the shareholder servicing and distribution of such shares. Institutional, Service and Class K Shares are sold only to certain eligible investors. Service, Investor A, Investor C and Class R Shares bear certain expenses related to shareholder servicing of such shares, and Investor C and Class R Shares also bear certain expenses related to the distribution of such shares. Investor A and Investor C Shares are generally available through financial intermediaries. Class R Shares are sold only to certain employer-sponsored retirement plans. Each class has exclusive voting rights with respect to matters relating to its shareholder servicing and distribution expenditures (except that Investor C shareholders may vote on material changes to the Investor A Shares distribution and service plan).
Share Class | Initial Sales Charge | CDSC | Conversion Privilege | |||||||
Institutional, Service and Class K Shares |
No | No | None | |||||||
Investor A Shares |
Yes | No | (a) | None | ||||||
Investor C Shares |
No | Yes | (b) | To Investor A Shares after approximately 8 years |
(a) | Investor A Shares may be subject to a contingent deferred sales charge (“CDSC”) for certain redemptions where no initial sales charge was paid at the time of purchase. |
(b) | A CDSC of 1.00% is assessed on certain redemptions of Investor C Shares made within one year after purchase. |
The Board of Directors of the Corporation and the Board of Trustees of the Trust are collectively referred to throughout this report as the “Board”, and the directors/trustees thereof are collectively referred to throughout this report as “Directors”.
The Funds, together with certain other registered investment companies advised by BlackRock Advisors, LLC (the “Manager”) or its affiliates, are included in a complex of funds referred to as the BlackRock Multi-Asset Complex.
2. | SIGNIFICANT ACCOUNTING POLICIES |
The financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”), which may require management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the financial statements, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates. Each Fund is considered an investment company under U.S. GAAP and follows the accounting and reporting guidance applicable to investment companies. Below is a summary of significant accounting policies:
Investment Transactions and Income Recognition: For financial reporting purposes, investment transactions are recorded on the dates the transactions are executed. Realized gains and losses on investment transactions are determined using the specific identification method. Dividend income and capital gain distributions, if any, are recorded on the ex-dividend dates. Non-cash dividends, if any, are recorded on the ex-dividend dates at fair value. Dividends from foreign securities where the ex-dividend dates may have passed are subsequently recorded when the Funds are informed of the ex-dividend dates. Under the applicable foreign tax laws, a withholding tax at various rates may be imposed on capital gains, dividends and interest. Upon notification from issuers, a portion of the dividend income received from a real estate investment trust may be redesignated as a reduction of cost of the related investment and/or realized gain. Income, expenses and realized and unrealized gains and losses are allocated daily to each class based on its relative net assets.
Foreign Currency Translation: Each Fund’s books and records are maintained in U.S. dollars. Securities and other assets and liabilities denominated in foreign currencies are translated into U.S. dollars using exchange rates determined as of the close of trading on the New York Stock Exchange (“NYSE”). Purchases and sales of investments are recorded at the rates of exchange prevailing on the respective dates of such transactions. Generally, when the U.S. dollar rises in value against a foreign currency, the investments denominated in that currency will lose value; the opposite effect occurs if the U.S. dollar falls in relative value.
Each Fund does not isolate the effect of fluctuations in foreign exchange rates from the effect of fluctuations in the market prices of investments for financial reporting purposes. Accordingly, the effects of changes in exchange rates on investments are not segregated in the Statements of Operations from the effects of changes in market prices of those investments, but are included as a component of net realized and unrealized gain (loss) from investments. Each Fund reports realized currency gains (losses) on foreign currency related transactions as components of net realized gain (loss) for financial reporting purposes, whereas such components are generally treated as ordinary income for U.S. federal income tax purposes.
ForeignTaxes: The Funds may be subject to foreign taxes (a portion of which may be reclaimable) on income, stock dividends, capital gains on investments, or certain foreign currency transactions. All foreign taxes are recorded in accordance with the applicable foreign tax regulations and rates that exist in the foreign jurisdictions in which each Fund
54 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Notes to Financial Statements (unaudited) (continued)
invests. These foreign taxes, if any, are paid by each Fund and are reflected in its Statements of Operations as follows: foreign taxes withheld at source are presented as a reduction of income, foreign taxes on securities lending income are presented as a reduction of securities lending income, foreign taxes on stock dividends are presented as “Foreign taxes withheld”, and foreign taxes on capital gains from sales of investments and foreign taxes on foreign currency transactions are included in their respective net realized gain (loss) categories. Foreign taxes payable or deferred as of November 30, 2024, if any, are disclosed in the Statements of Assets and Liabilities.
Consistent with U.S. GAAP accrual requirements for uncertain tax positions, each Fund recognizes tax reclaims when the Fund determines that it is more likely than not that each Fund will sustain its position that it is due the reclaim.
The Funds file withholding tax reclaims in certain jurisdictions to recover a portion of amounts previously withheld. The Funds may record a reclaim receivable based on collectability, which includes factors such as the jurisdiction’s applicable laws, payment history and market convention. The Statements of Operations include tax reclaims recorded as well as professional and other fees, if any, associated with recovery of foreign withholding taxes.
Bank Overdraft: Certain Funds had outstanding cash disbursements exceeding deposited cash amounts at the custodian during the reporting period. The Funds are obligated to repay the custodian for any overdraft, including any related costs or expenses, where applicable. For financial reporting purposes, overdraft fees, if any, are included in interest expense in the Statements of Operations.
Collateralization: If required by an exchange or counterparty agreement, the Funds may be required to deliver/deposit cash and/or securities to/with an exchange, or broker-dealer or custodian as collateral for certain investments.
Distributions: Distributions paid by the Funds are recorded on the ex-dividend dates. The character and timing of distributions are determined in accordance with U.S. federal income tax regulations, which may differ from U.S. GAAP.
Indemnifications: In the normal course of business, a Fund enters into contracts that contain a variety of representations that provide general indemnification. A Fund’s maximum exposure under these arrangements is unknown because it involves future potential claims against a Fund, which cannot be predicted with any certainty.
Other: Expenses directly related to a Fund or its classes are charged to that Fund or the applicable class. Expenses directly related to the Funds and other shared expenses prorated to the Funds are allocated daily to each class based on their relative net assets or other appropriate methods. Other operating expenses shared by several funds, including other funds managed by the Manager, are prorated among those funds on the basis of relative net assets or other appropriate methods.
The Funds have an arrangement with their custodian whereby credits are earned on uninvested cash balances. For financial reporting purposes, custodian credits, if any, are included in interest income in the Statements of Operations.
3. | INVESTMENT VALUATION AND FAIR VALUE MEASUREMENTS |
Investment Valuation Policies: Each Fund’s investments are valued at fair value (also referred to as “market value” within the financial statements) each day that the Fund is open for business and, for financial reporting purposes, as of the report date. U.S. GAAP defines fair value as the price a fund would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants at the measurement date. The Board of each Fund has approved the designation of each Fund’s Manager as the valuation designee for each Fund. Each Fund determines the fair values of its financial instruments using various independent dealers or pricing services under the Manager’s policies. If a security’s market price is not readily available or does not otherwise accurately represent the fair value of the security, the security will be valued in accordance with the Manager’s policies and procedures as reflecting fair value. The Manager has formed a committee (the “Valuation Committee”) to develop pricing policies and procedures and to oversee the pricing function for all financial instruments, with assistance from other BlackRock pricing committees.
Fair Value Inputs and Methodologies: The following methods and inputs are used to establish the fair value of each Fund’s assets and liabilities:
• | Equity investments traded on a recognized securities exchange are valued at that day’s official closing price, as applicable, on the exchange where the stock is primarily traded. Equity investments traded on a recognized exchange for which there were no sales on that day may be valued at the last trade or last available bid (long positions) or ask (short positions) price. |
• | Investments in open-end U.S. mutual funds (including money market funds) are valued at that day’s net asset value (“NAV”). |
Generally, trading in foreign instruments is substantially completed each day at various times prior to the close of trading on the NYSE. Each business day, the Funds use current market factors supplied by independent pricing services to value certain foreign instruments (“Systematic Fair Value Price”). The Systematic Fair Value Price is designed to value such foreign securities at fair value as of the close of trading on the NYSE, which occurs after the close of the local markets.
If events (e.g., market volatility, company announcement or a natural disaster) occur that are expected to materially affect the value of such investment, or in the event that application of these methods of valuation results in a price for an investment that is deemed not to be representative of the market value of such investment, or if a price is not available, the investment will be valued by the Valuation Committee in accordance with the Manager’s policies and procedures as reflecting fair value (“Fair Valued Investments”). The fair valuation approaches that may be used by the Valuation Committee include market approach, income approach and cost approach. Valuation techniques such as discounted cash flow, use of market comparables and matrix pricing are types of valuation approaches and are typically used in determining fair value. When determining the price for Fair Valued Investments, the Valuation Committee seeks to determine the price that each Fund might reasonably expect to receive or pay from the current sale or purchase of that asset or liability in an arm’s-length transaction. Fair value determinations shall be based upon all available factors that the Valuation Committee deems relevant and consistent with the principles of fair value measurement as of the measurement date.
N O T E S T O F I N A N C I A L S T A T E M E N T S |
55 |
Notes to Financial Statements (unaudited) (continued)
For investments in equity or debt issued by privately held companies or funds (“Private Company” or collectively, the “Private Companies”) and other Fair Valued Investments, the fair valuation approaches that are used by the Valuation Committee and third-party pricing services utilized by the Valuation Committee include one or a combination of, but not limited to, the following inputs:
(i) recent market transactions, including secondary market transactions, merger or acquisition activity and subsequent rounds of financing in the underlying investment or comparable issuers
(ii) recapitalizations and other transactions across the capital structure
(iii) market or relevant indices multiples of comparable issuers
(iv) future cash flows discounted to present and adjusted as appropriate for liquidity, credit, and/or market risks
(v) quoted prices for similar investments or assets in active markets
(vi) other risk factors, such as interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks, recovery rates, liquidation amounts and/or default rates
(vii) audited or unaudited financial statements, investor communications and Private Company financial or operational metrics
(viii) relevant market news and other public sources.
Investments in series of preferred stock issued by Private Companies are typically valued utilizing a market approach to determine the enterprise value of the company. Such investments often contain rights and preferences that differ from other series of preferred and common stock of the same issuer. Enterprise valuation techniques such as an option pricing model (“OPM”), a probability weighted expected return model (“PWERM”), current value method or a hybrid of those techniques are used as deemed appropriate under the circumstances. The use of these valuation techniques involves a determination of the exit scenarios of the investment in order to appropriately allocate the enterprise value of the company among the various parts of its capital structure.
Private Companies are not subject to public company disclosure, timing, and reporting standards applicable to other investments held by a Fund. Certain information made available by a Private Company is as of a date that is earlier than the date a Fund is calculating its NAV. This factor may result in a difference between the value of the investment and the price a Fund could receive upon the sale of the investment.
Fair Value Hierarchy: Various inputs are used in determining the fair value of financial instruments at the measurement date. These inputs to valuation techniques are categorized into a fair value hierarchy consisting of three broad levels for financial reporting purposes as follows:
• | Level 1 – Unadjusted price quotations in active markets/exchanges that each Fund has the ability to access for identical assets or liabilities; |
• | Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly; and |
• | Level 3 – Inputs that are unobservable and significant to the entire fair value measurement for the asset or liability (including the Valuation Committee’s assumptions used in determining the fair value of financial instruments). |
The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Accordingly, the degree of judgment exercised in determining fair value is greatest for instruments categorized in Level 3. The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the fair value hierarchy classification is determined based on the lowest level input that is significant to the fair value measurement in its entirety. Investments classified within Level 3 have significant unobservable inputs used by the Valuation Committee in determining the price for Fair Valued Investments. Level 3 investments include equity or debt issued by Private Companies that may not have a secondary market and/or may have a limited number of investors. The categorization of a value determined for financial instruments is based on the pricing transparency of the financial instruments and is not necessarily an indication of the risks associated with investing in those securities.
4. | SECURITIES AND OTHER INVESTMENTS |
Preferred Stocks: Preferred stock has a preference over common stock in liquidation (and generally in receiving dividends as well), but is subordinated to the liabilities of the issuer in all respects. As a general rule, the market value of preferred stock with a fixed dividend rate and no conversion element varies inversely with interest rates and perceived credit risk, while the market price of convertible preferred stock generally also reflects some element of conversion value. Because preferred stock is junior to debt securities and other obligations of the issuer, deterioration in the credit quality of the issuer will cause greater changes in the value of a preferred stock than in a more senior debt security with similar stated yield characteristics. Unlike interest payments on debt securities, preferred stock dividends are payable only if declared by the issuer’s board of directors. Preferred stock also may be subject to optional or mandatory redemption provisions.
Warrants: Warrants entitle a fund to purchase a specified number of shares of common stock and are non-income producing. The purchase price and number of shares are subject to adjustment under certain conditions until the expiration date of the warrants, if any. If the price of the underlying stock does not rise above the strike price before the warrant expires, the warrant generally expires without any value and a fund will lose any amount it paid for the warrant. Thus, investments in warrants may involve more risk than investments in common stock. Warrants may trade in the same markets as their underlying stock; however, the price of the warrant does not necessarily move with the price of the underlying stock.
56 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Notes to Financial Statements (unaudited) (continued)
Securities Lending: The Funds may lend their securities to approved borrowers, such as brokers, dealers and other financial institutions. The borrower pledges and maintains with the Funds collateral consisting of cash, an irrevocable letter of credit issued by a bank, or securities issued or guaranteed by the U.S. Government. The initial collateral received by each Fund is required to have a value of at least 102% of the current value of the loaned securities for securities traded on U.S. exchanges and a value of at least 105% for all other securities. The collateral is maintained thereafter at a value equal to at least 100% of the current market value of the securities on loan. The market value of the loaned securities is determined at the close of each business day of the Fund and any additional required collateral is delivered to the Fund, or excess collateral returned by the Fund, on the next business day. During the term of the loan, the Funds are entitled to all distributions made on or in respect of the loaned securities, but does not receive interest income on securities received as collateral. Loans of securities are terminable at any time and the borrower, after notice, is required to return borrowed securities within the standard time period for settlement of securities transactions.
As of period end, any securities on loan were collateralized by cash and/or U.S. Government obligations. Cash collateral invested by the securities lending agent, BlackRock Investment Management, LLC (“BIM”), if any, is disclosed in the Schedules of Investments. Any non-cash collateral received cannot be sold, re-invested or pledged by the Fund, except in the event of borrower default. The securities on loan, if any, are disclosed in the Funds’ Schedules of Investments. The market value of any securities on loan and the value of related collateral, if any, are shown separately in the Statements of Assets and Liabilities as a component of investments at value – unaffiliated and collateral on securities loaned, respectively.
Securities lending transactions are entered into by the Funds under Master Securities Lending Agreements (each, an “MSLA”), which provide the right, in the event of default (including bankruptcy or insolvency), for the non-defaulting party to liquidate the collateral and calculate a net exposure to the defaulting party or request additional collateral. In the event that a borrower defaults, the Fund, as lender, would offset the market value of the collateral received against the market value of the securities loaned. When the value of the collateral is greater than that of the market value of the securities loaned, the lender is left with a net amount payable to the defaulting party. However, bankruptcy or insolvency laws of a particular jurisdiction may impose restrictions on or prohibitions against such a right of offset in the event of an MSLA counterparty’s bankruptcy or insolvency. Under the MSLA, absent an event of default, the borrower can resell or re-pledge the loaned securities, and the Funds can reinvest cash collateral received in connection with loaned securities. Upon an event of default, the parties’ obligations to return the securities or collateral to the other party are extinguished, and the parties can resell or re-pledge the loaned securities or the collateral received in connection with the loaned securities in order to satisfy the defaulting party’s net payment obligation for all transactions under the MSLA. The defaulting party remains liable for any deficiency.
As of period end, the following table is a summary of the Funds’ securities on loan by counterparty which are subject to offset under an MSLA:
Fund Name/Counterparty | Securities Loaned at Value |
Cash Collateral Received(a) |
Non-Cash Collateral Received, at Fair Value(a) |
Net Amount |
||||||||||||
Health Sciences Opportunities |
||||||||||||||||
BofA Securities, Inc. |
$ | 1,151,500 | $ | (1,151,500 | ) | $ | — | $ | — | |||||||
Citigroup Global Markets, Inc. |
9,139,796 | (9,139,796 | ) | — | — | |||||||||||
Goldman Sachs & Co. LLC |
3,934,140 | (3,845,400 | ) | — | 88,740 | (b) | ||||||||||
J.P. Morgan Securities LLC |
28,225,023 | (28,225,023 | ) | — | — | |||||||||||
Jefferies LLC |
38,099,139 | (38,099,139 | ) | — | — | |||||||||||
Morgan Stanley |
7,289,594 | (7,289,594 | ) | — | — | |||||||||||
Toronto-Dominion Bank |
2,205,026 | (2,205,026 | ) | — | — | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 90,044,218 | $ | (89,955,478 | ) | $ | — | $ | 88,740 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Infrastructure Sustainable Opportunities |
||||||||||||||||
J.P. Morgan Securities LLC |
$ | 248,531 | $ | (248,531 | ) | $ | — | $ | — | |||||||
|
|
|
|
|
|
|
|
|||||||||
Mid-Cap Growth Equity |
||||||||||||||||
Citigroup Global Markets, Inc. |
$ | 121,162,111 | $ | (121,162,111 | ) | $ | — | $ | — | |||||||
Goldman Sachs & Co. LLC |
61,382,040 | (60,790,680 | ) | — | 591,360 | |||||||||||
J.P. Morgan Securities LLC |
8,991,464 | (8,991,464 | ) | — | — | |||||||||||
Morgan Stanley |
163,575,718 | (163,575,718 | ) | — | — | |||||||||||
National Financial Services LLC |
21,981,750 | (21,981,750 | ) | — | — | |||||||||||
State Street Bank & Trust Co. |
27,640,499 | (27,640,499 | ) | — | — | |||||||||||
Toronto-Dominion Bank |
19,490,633 | (19,490,633 | ) | — | — | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 424,224,215 | $ | (423,632,855 | ) | $ | — | $ | 591,360 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Technology Opportunities |
||||||||||||||||
BofA Securities, Inc. |
$ | 16,452,856 | $ | (16,452,856 | ) | $ | — | $ | — | |||||||
Goldman Sachs & Co. LLC |
1,947,036 | (1,947,036 | ) | — | — |
N O T E S T O F I N A N C I A L S T A T E M E N T S |
57 |
Notes to Financial Statements (unaudited) (continued)
Fund Name/Counterparty | Securities Loaned at Value |
Cash Collateral Received(a) |
Non-Cash Collateral Received, at Fair Value(a) |
Net Amount |
||||||||||||
Technology Opportunities (continued) |
||||||||||||||||
J.P. Morgan Securities LLC |
$ | 5,841,615 | $ | (5,841,615 | ) | $ | — | $ | — | |||||||
Morgan Stanley |
26,578,677 | (26,578,677 | ) | — | — | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 50,820,184 | $ | (50,820,184 | ) | $ | — | $ | — | ||||||||
|
|
|
|
|
|
|
|
(a) | Collateral received, if any, in excess of the market value of securities on loan is not presented in this table. The total cash collateral received by each Fund is disclosed in the Funds’ Statements of Assets and Liabilities. |
(b) | The market value of the loaned securities is determined as of November 30, 2024. Additional collateral is delivered to the Fund on the next business day in accordance with the MSLA. The net amount would be subject to the borrower default indemnity in the event of default by the counterparty. |
The risks of securities lending include the risk that the borrower may not provide additional collateral when required or may not return the securities when due. To mitigate these risks, each Fund benefits from a borrower default indemnity provided by BIM. BIM’s indemnity allows for full replacement of the securities loaned to the extent the collateral received does not cover the value on the securities loaned in the event of borrower default. Each Fund could incur a loss if the value of an investment purchased with cash collateral falls below the market value of the loaned securities or if the value of an investment purchased with cash collateral falls below the value of the original cash collateral received. Such losses are borne entirely by each Fund.
5. | DERIVATIVE FINANCIAL INSTRUMENTS |
The Funds engage in various portfolio investment strategies using derivative contracts both to increase the returns of the Funds and/or to manage their exposure to certain risks such as credit risk, equity risk, interest rate risk, foreign currency exchange rate risk, commodity price risk or other risks (e.g., inflation risk). Derivative financial instruments categorized by risk exposure are included in the Schedules of Investments. These contracts may be transacted on an exchange or over-the-counter (“OTC”).
Swaps: Swap contracts are entered into to manage exposure to issuers, markets and securities. Such contracts are agreements between the Funds and a counterparty to make periodic net payments on a specified notional amount or a net payment upon termination. Swap agreements are privately negotiated in the OTC market and may be entered into as a bilateral contract (“OTC swaps”) or centrally cleared (“centrally cleared swaps”).
For OTC swaps, any upfront premiums paid and any upfront fees received are shown as swap premiums paid and swap premiums received, respectively, in the Statements of Assets and Liabilities and amortized over the term of the contract. The daily fluctuation in market value is recorded as unrealized appreciation (depreciation) on OTC swaps in the Statements of Assets and Liabilities. Payments received or paid are recorded in the Statements of Operations as realized gains or losses, respectively. When an OTC swap is terminated, a realized gain or loss is recorded in the Statements of Operations equal to the difference between the proceeds from (or cost of) the closing transaction and the Funds’ basis in the contract, if any. Generally, the basis of the contract is the premium received or paid.
• | Total return swaps — Total return swaps are entered into to obtain exposure to a security or market without owning such security or investing directly in such market or to exchange the risk/return of one security or market (e.g., fixed-income) with another security or market (e.g., equity or commodity prices) (equity risk, commodity price risk and/or interest rate risk). |
Total return swaps are agreements in which there is an exchange of cash flows whereby one party commits to make payments based on the total return (distributions plus capital gains/losses) of an underlying instrument, or basket of underlying instruments, in exchange for fixed or floating rate interest payments. If the total return of the instrument(s) or index underlying the transaction exceeds or falls short of the offsetting fixed or floating interest rate obligation, the Funds receive payment from or make a payment to the counterparty.
Certain total return swaps are designed to function as a portfolio of direct investments in long and short equity positions. This means that the Fund has the ability to trade in and out of these long and short positions within the swap and will receive the economic benefits and risks equivalent to direct investment in these positions, subject to certain adjustments due to events related to the counterparty. Benefits and risks include capital appreciation (depreciation), corporate actions and dividends received and paid, all of which are reflected in the swap’s market value. The market value also includes interest charges and credits (“financing fees”) related to the notional values of the long and short positions and cash balances within the swap. These interest charges and credits are based on a specified benchmark rate plus or minus a specified spread determined based upon the country and/or currency of the positions in the portfolio.
Positions within the swap and financing fees are reset periodically. During a reset, any unrealized appreciation (depreciation) on positions and accrued financing fees become available for cash settlement between the Funds and the counterparty. The amounts that are available for cash settlement are recorded as realized gains or losses in the Statements of Operations. Cash settlement in and out of the swap may occur at a reset date or any other date, at the discretion of the Funds and the counterparty, over the life of the agreement. Certain swaps have no stated expiration and can be terminated by either party at any time.
Swap transactions involve, to varying degrees, elements of interest rate, credit and market risks in excess of the amounts recognized in the Statements of Assets and Liabilities. Such risks involve the possibility that there will be no liquid market for these agreements, that the counterparty to the agreements may default on its obligation to perform or disagree as to the meaning of the contractual terms in the agreements, and that there may be unfavorable changes in interest rates and/or market values associated with these transactions.
Master Netting Arrangements: In order to define its contractual rights and to secure rights that will help it mitigate its counterparty risk, a Fund may enter into an International Swaps and Derivatives Association, Inc. Master Agreement (“ISDA Master Agreement”) or similar agreement with its derivative contract counterparties. An ISDA Master
58 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Notes to Financial Statements (unaudited) (continued)
Agreement is a bilateral agreement between a Fund and a counterparty that governs certain OTC derivatives and typically contains, among other things, collateral posting terms and netting provisions in the event of a default and/or termination event. Under an ISDA Master Agreement, a Fund may, under certain circumstances, offset with the counterparty certain derivative financial instruments’ payables and/or receivables with collateral held and/or posted and create one single net payment. The provisions of the ISDA Master Agreement typically permit a single net payment in the event of default including the bankruptcy or insolvency of the counterparty. However, bankruptcy or insolvency laws of a particular jurisdiction may impose restrictions on or prohibitions against the right of offset in bankruptcy, insolvency or other events.
Collateral Requirements: For derivatives traded under an ISDA Master Agreement, the collateral requirements are typically calculated by netting the mark-to-market amount for each transaction under such agreement and comparing that amount to the value of any collateral currently pledged by the Funds and the counterparty.
Cash collateral that has been pledged to cover obligations of the Funds and cash collateral received from the counterparty, if any, is reported separately in the Statements of Assets and Liabilities as cash pledged as collateral and cash received as collateral, respectively. Non-cash collateral pledged by the Funds, if any, is noted in the Schedules of Investments. Generally, the amount of collateral due from or to a counterparty is subject to a certain minimum transfer amount threshold before a transfer is required, which is determined at the close of business of the Funds. Any additional required collateral is delivered to/pledged by the Funds on the next business day. Typically, the counterparty is not permitted to sell, re-pledge or use cash and non-cash collateral it receives. A Fund generally agrees not to use non-cash collateral that it receives but may, absent default or certain other circumstances defined in the underlying ISDA Master Agreement, be permitted to use cash collateral received. In such cases, interest may be paid pursuant to the collateral arrangement with the counterparty. To the extent amounts due to the Funds from the counterparties are not fully collateralized, each Fund bears the risk of loss from counterparty non-performance. Likewise, to the extent the Funds have delivered collateral to a counterparty and stand ready to perform under the terms of their agreement with such counterparty, each Fund bears the risk of loss from a counterparty in the amount of the value of the collateral in the event the counterparty fails to return such collateral. Based on the terms of agreements, collateral may not be required for all derivative contracts.
For financial reporting purposes, the Funds do not offset derivative assets and derivative liabilities that are subject to netting arrangements, if any, in the Statements of Assets and Liabilities.
6. INVESTMENT ADVISORY AGREEMENT AND OTHER TRANSACTIONS WITH AFFILIATES
Investment Advisory: The Corporation, on behalf of Capital Appreciation, and the Trust, on behalf of Health Sciences Opportunities, Infrastructure Sustainable Opportunities, Mid-Cap Growth Equity and Technology Opportunities, entered into an Investment Advisory Agreement with the Manager, the Funds’ investment adviser and an indirect, wholly-owned subsidiary of BlackRock, Inc. (“BlackRock”), to provide investment advisory services and with respect to Capital Appreciation, administrative services. The Manager is responsible for the management of each Fund’s portfolio and provides the personnel, facilities, equipment and certain other services necessary to the operations of each Fund.
For such services, each Fund pays the Manager a monthly fee at an annual rate equal to the following percentages of the average daily value of each Fund’s net assets:
Investment Advisory Fees | ||||||||
Average Daily Net Assets | Capital Appreciation | |||||||
First $1 billion |
0.650 | % | ||||||
$1 billion - $1.5 billion |
0.625 | |||||||
$1.5 billion - $5 billion |
0.600 | |||||||
$5 billion - $7.5 billion |
0.575 | |||||||
Greater than $7.5 billion |
0.550 |
Investment Advisory Fees | ||||||||
Average Daily Net Assets | Health Sciences Opportunities | |||||||
First $1 billion |
0.750 | % | ||||||
$1 billion - $2 billion |
0.700 | |||||||
$2 billion - $3 billion |
0.675 | |||||||
$3 billion - $10 billion |
0.650 | |||||||
Greater than $10 billion |
0.640 |
Investment Advisory Fees |
||||||||
Average Daily Net Assets | Infrastructure Sustainable Opportunities | Technology Opportunities | ||||||
First $1 billion |
0.800 | % | 0.820 | % | ||||
$1 billion - $3 billion |
0.750 | 0.770 | ||||||
$3 billion - $5 billion |
0.720 | 0.740 | ||||||
$5 billion - $10 billion |
0.700 | 0.710 | ||||||
Greater than $10 billion |
0.680 | 0.700 |
N O T E S T O F I N A N C I A L S T A T E M E N T S |
59 |
Notes to Financial Statements (unaudited) (continued)
Investment Advisory Fees | ||||||||
Average Daily Net Assets | Mid-Cap Growth Equity | |||||||
First $1 billion |
0.700 | % | ||||||
$1 billion - $3 billion |
0.660 | |||||||
$3 billion - $5 billion |
0.630 | |||||||
$5 billion - $10 billion |
0.610 | |||||||
$10 billion - $18 billion |
0.600 | |||||||
Greater than $18 billion |
0.590 |
With respect to Infrastructure Sustainable Opportunities, the Manager entered into separate sub-advisory agreements with each of BlackRock International Limited (“BIL”) and BlackRock (Singapore) Limited (“BSL”), each an affiliate of the Manager. The Manager pays BIL and BSL for services they provide, for that portion of the Fund for which BIL and BSL, as applicable, act as sub-adviser, a monthly fee that is equal to a percentage of the investment advisory fees paid by the Fund to the Manager.
Service and Distribution Fees: The Corporation, on behalf of Capital Appreciation, and the Trust, on behalf of Health Sciences Opportunities, Infrastructure Sustainable Opportunities, Mid-Cap Growth Equity and Technology Opportunities, entered into a Distribution Agreement and a Distribution and Service Plan with BlackRock Investments, LLC (“BRIL”), an affiliate of the Manager. Pursuant to the Distribution and Service Plan and in accordance with Rule 12b-1 under the 1940 Act, each Fund pays BRIL ongoing service and distribution fees. The fees are accrued daily and paid monthly at annual rates based upon the average daily net assets of the relevant share class of each Fund as follows:
Capital Appreciation | Health Sciences Opportunities | Infrastructure Sustainable Opportunities | ||||||||||||||||||||||
Share Class | Service Fees | Distribution Fees | Service Fees | Distribution Fees | Service Fees | Distribution Fees | ||||||||||||||||||
Service |
N/A | N/A | 0.25 | % | N/A | N/A | N/A | |||||||||||||||||
Investor A |
0.25 | % | N/A | 0.25 | N/A | 0.25 | % | N/A | ||||||||||||||||
Investor C |
0.25 | 0.75 | % | 0.25 | 0.75 | % | N/A | N/A | ||||||||||||||||
Class R |
0.25 | 0.25 | 0.25 | 0.25 | N/A | N/A |
Mid-Cap Growth Equity | Technology Opportunities | |||||||||||||||||||||||
Share Class | Service Fees | Distribution Fees | Service Fees | Distribution Fees | ||||||||||||||||||||
Service |
0.25 | % | N/A | 0.25 | % | N/A | ||||||||||||||||||
Investor A |
0.25 | N/A | 0.25 | N/A | ||||||||||||||||||||
Investor C |
0.25 | 0.75 | % | 0.25 | 0.75 | % | ||||||||||||||||||
Class R |
0.25 | 0.25 | 0.25 | 0.25 |
BRIL and broker-dealers, pursuant to sub-agreements with BRIL, provide shareholder servicing and distribution services to the Funds. The ongoing service and/or distribution fee compensates BRIL and each broker-dealer for providing shareholder servicing and/or distribution related services to shareholders.
For the six months ended November 30, 2024, the following table shows the class specific service and distribution fees borne directly by each share class of each Fund:
Fund Name | Service | Investor A | Investor C | Class R | Total | |||||||||||||||
Capital Appreciation |
$ | — | $ | 2,742,539 | $ | 204,771 | $ | 61,956 | $ | 3,009,266 | ||||||||||
Health Sciences Opportunities |
38,575 | 3,625,008 | 1,504,232 | 631,382 | 5,799,197 | |||||||||||||||
Infrastructure Sustainable Opportunities |
— | 285 | — | — | 285 | |||||||||||||||
Mid-Cap Growth Equity |
71,680 | 1,987,472 | 880,404 | 211,176 | 3,150,732 | |||||||||||||||
Technology Opportunities |
62,331 | 2,604,605 | 1,526,146 | 115,500 | 4,308,582 |
Administration: The Trust, on behalf of Health Sciences Opportunities, Infrastructure Sustainable Opportunities, Mid-Cap Growth Equity and Technology Opportunities, entered into an Administration Agreement with the Manager, an indirect, wholly-owned subsidiary of BlackRock, to provide administrative services. For these services, the Manager receives an administration fee computed daily and payable monthly, based on a percentage of the average daily net assets of each Fund. The administration fee, which is shown as administration in the Statements of Operations, is paid at the annual rates below.
Average Daily Net Assets | Administration Fees | |||
First $500 million |
0.0425 | % | ||
$500 million - $1 billion |
0.0400 | |||
$1 billion - $2 billion |
0.0375 | |||
$2 billion - $4 billion |
0.0350 | |||
$4 billion - $13 billion |
0.0325 | |||
Greater than $13 billion |
0.0300 |
In addition, the Manager charges each of the share classes an administration fee, which is shown as administration — class specific in the Statements of Operations, at an annual rate of 0.02% of the average daily net assets of each respective class.
60 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Notes to Financial Statements (unaudited) (continued)
For the six months ended November 30, 2024, the following table shows the class specific administration fees borne directly by each share class of each Fund:
Fund Name | Institutional | Service | Investor A | Investor C | Class K | Class R | Total | |||||||||||||||||||||
Health Sciences Opportunities |
$ | 440,514 | $ | 3,093 | $ | 290,669 | $ | 30,155 | $ | 52,272 | $ | 25,312 | $ | 842,015 | ||||||||||||||
Infrastructure Sustainable Opportunities |
11 | — | 23 | — | 906 | — | 940 | |||||||||||||||||||||
Mid-Cap Growth Equity |
483,645 | 5,750 | 159,385 | 17,650 | 435,881 | 8,466 | 1,110,777 | |||||||||||||||||||||
Technology Opportunities |
300,458 | 4,995 | 208,693 | 30,569 | 32,890 | 4,626 | 582,231 |
Transfer Agent: Pursuant to written agreements, certain financial intermediaries, some of which may be affiliates, provide the Funds with sub-accounting, recordkeeping, sub-transfer agency and other administrative services with respect to servicing of underlying investor accounts. For these services, these entities receive an asset-based fee or an annual fee per shareholder account, which will vary depending on share class and/or net assets. For the six months ended November 30, 2024, the Funds paid the following amounts to affiliates of BlackRock in return for these services, which are included in transfer agent — class specific in the Statements of Operations:
Fund Name | Institutional | Total | ||||||
Capital Appreciation |
$ | 82,573 | $ | 82,573 |
The Manager maintains a call center that is responsible for providing certain shareholder services to the Funds. Shareholder services include responding to inquiries and processing purchases and sales based upon instructions from shareholders. For the six months ended November 30, 2024, each Fund reimbursed the Manager the following amounts for costs incurred in running the call center, which are included in transfer agent — class specific in the Statements of Operations:
Fund Name | Institutional | Service | Investor A | Investor C | Class K | Class R | Total | |||||||||||||||||||||
Capital Appreciation |
$ | 1,652 | $ | — | $ | 55,302 | $ | 4,248 | $ | 2,024 | $ | 142 | $ | 63,368 | ||||||||||||||
Health Sciences Opportunities |
9,152 | 267 | 47,717 | 6,878 | 1,277 | 655 | 65,946 | |||||||||||||||||||||
Infrastructure Sustainable Opportunities |
8 | — | 125 | — | — | — | 133 | |||||||||||||||||||||
Mid-Cap Growth Equity |
18 | 183 | 80,990 | 1,063 | 5,786 | 570 | 88,610 | |||||||||||||||||||||
Technology Opportunities |
580 | 91 | 19,876 | 3,066 | 705 | 383 | 24,701 |
For the six months ended November 30, 2024, the following table shows the class specific transfer agent fees borne directly by each share class of each Fund:
Fund Name | Institutional | Service | Investor A | Investor C | Class K | Class R | Total | |||||||||||||||||||||
Capital Appreciation |
$ | 352,493 | $ | — | $ | 917,776 | $ | 32,455 | $ | 25,912 | $ | 26,542 | $ | 1,355,178 | ||||||||||||||
Health Sciences Opportunities |
2,032,348 | 24,925 | 1,350,801 | 152,452 | 14,153 | 253,883 | 3,828,562 | |||||||||||||||||||||
Infrastructure Sustainable Opportunities |
90 | — | 341 | — | 207 | — | 638 | |||||||||||||||||||||
Mid-Cap Growth Equity |
3,112,918 | 54,127 | 1,261,090 | 95,190 | 62,650 | 94,383 | 4,680,358 | |||||||||||||||||||||
Technology Opportunities |
1,496,082 | 32,015 | 1,127,131 | 137,655 | 5,225 | 46,880 | 2,844,988 |
Other Fees: For the six months ended November 30, 2024, affiliates earned underwriting discounts, direct commissions and dealer concessions on sales of each Fund’s Investor A Shares as follows:
Fund Name | Amounts | |||
Capital Appreciation |
$ | 24,295 | ||
Health Sciences Opportunities |
25,564 | |||
Mid-Cap Growth Equity |
18,609 | |||
Technology Opportunities |
57,123 |
For the six months ended November 30, 2024, affiliates received CDSCs as follows:
Share Class | Capital Appreciation |
Health Sciences Opportunities |
Mid-Cap Growth Equity |
Technology Opportunities |
||||||||||||
Investor A |
$ | 2,512 | $ | 2,451 | $ | 4,722 | $ | 1,688 | ||||||||
Investor C |
708 | 5,614 | 2,988 | 9,251 |
Expense Limitations, Waivers, Reimbursements, and Recoupments: With respect to each Fund, the Manager contractually agreed to waive its investment advisory fees by the amount of investment advisory fees each Fund pays to the Manager indirectly through its investment in affiliated money market funds (the “affiliated money market fund waiver”) through June 30, 2026. The contractual agreement may be terminated upon 90 days’ notice by a majority of the directors who are not “interested persons” of the Corporation or the Trust, as defined in the 1940 Act (“Independent Directors”), or by a vote of a majority of the outstanding voting securities of a Fund. The amount of waivers and/or reimbursements of fees and expenses made pursuant to the expense limitation described below will be reduced by the amount of the affiliated money market fund
N O T E S T O F I N A N C I A L S T A T E M E N T S |
61 |
Notes to Financial Statements (unaudited) (continued)
waiver. These amounts are included in fees waived and/or reimbursed by the Manager in the Statements of Operations. For the six months ended November 30, 2024, the amounts waived were as follows:
Fund Name | Amounts Waived | |||
Capital Appreciation |
$ | 1,223 | ||
Health Sciences Opportunities |
58,232 | |||
Infrastructure Sustainable Opportunities |
52 | |||
Mid-Cap Growth Equity |
3,615 | |||
Technology Opportunities |
18,880 |
The Manager has contractually agreed to waive its investment advisory fee with respect to any portion of each Fund’s assets invested in affiliated equity and fixed-income mutual funds and affiliated exchange-traded funds that have a contractual management fee through June 30, 2026. The contractual agreement may be terminated upon 90 days’ notice by a majority of the Independent Directors, or by a vote of a majority of the outstanding voting securities of a Fund. For the six months ended November 30, 2024, there were no fees waived and/or reimbursed by the Manager pursuant to this arrangement.
With respect to each Fund (except Health Sciences Opportunities), the Manager contractually agreed to waive and/or reimburse fees or expenses in order to limit expenses, excluding interest expense, dividend expense, tax expense, acquired fund fees and expenses, and certain other fund expenses, which constitute extraordinary expenses not incurred in the ordinary course of each Fund’s business (“expense limitation”). The expense limitations as a percentage of average daily net assets are as follows:
Share Class | Capital Appreciation | Infrastructure Sustainable Opportunities | Mid-Cap Growth Equity | Technology Opportunities | ||||||||||||
Institutional |
N/A | 1.00 | % | 0.80 | % | 0.92 | % | |||||||||
Service |
N/A | N/A | 1.05 | 1.17 | ||||||||||||
Investor A |
N/A | 1.25 | 1.05 | 1.17 | ||||||||||||
Investor C |
1.94 | % | N/A | 1.80 | 1.92 | |||||||||||
Class K |
0.72 | 0.95 | 0.75 | 0.87 | ||||||||||||
Class R |
N/A | N/A | 1.30 | 1.42 |
The Manager has agreed not to reduce or discontinue the contractual expense limitations through June 30, 2026 (or June 30, 2035 with respect to Capital Appreciation), unless approved by the Board, including a majority of the Independent Directors, or by a vote of a majority of the outstanding voting securities of a Fund.
For the six months ended November 30, 2024, Infrastructure Sustainable Opportunities waived and/or reimbursed the Manager investment advisory fees and other expenses of $128,996, which is included in fees waived and/or reimbursed by the Manager in the Statements of Operations.
In addition, these amounts waived and/or reimbursed by the Manager are included in administration fees waived by the Manager — class specific and transfer agent fees waived and/or reimbursed by the Manager — class specific, respectively, in the Statements of Operations. For the six months ended November 30, 2024, class specific expense waivers and/or reimbursements are as follows:
Administration Fees Waived by the Manager - Class Specific | ||||||||||||||||||||||||||||
Fund Name | Institutional | Service | Investor A | Investor C | Class K | Class R | Total | |||||||||||||||||||||
Infrastructure Sustainable Opportunities |
$ | 11 | $ | — | $ | 23 | $ | — | $ | 906 | $ | — | $ | 940 | ||||||||||||||
Mid-Cap Growth Equity |
475,544 | 5,750 | 158,943 | 4,472 | — | 8,466 | 653,175 | |||||||||||||||||||||
Technology Opportunities |
140,750 | 4,995 | 165,062 | 6,919 | — | 4,626 | 322,352 |
Transfer Agent Fees Waived and/or Reimbursed by the Manager - Class Specific | ||||||||||||||||||||||||||||
Fund Name | Institutional | Service | Investor A | Investor C | Class K | Class R | Total | |||||||||||||||||||||
Infrastructure Sustainable Opportunities |
$ | 64 | $ | — | $ | 283 | $ | — | $ | 207 | $ | — | $ | 554 | ||||||||||||||
Mid-Cap Growth Equity |
128,596 | 18,462 | 270,929 | 120 | — | 41,468 | 459,575 | |||||||||||||||||||||
Technology Opportunities |
3,987 | 4,465 | 19,412 | — | — | 21,234 | 49,098 |
Infrastructure Sustainable Opportunities also had a waiver of administration fees, which are included in Administration fees waived in the Statements of Operations. For the six months ended November 30, 2024, the amount was $1,997.
With respect to the contractual expense limitation of Infrastructure Sustainable Opportunities, if during the Fund’s fiscal year the operating expenses of a share class, that at any time during the prior two fiscal years received a waiver and/or reimbursement from the Manager, are less than the current expense limitation for that share class, the Manager is entitled to be reimbursed by such share class up to the lesser of: (a) the amount of fees waived and/or expenses reimbursed during those prior two fiscal years under the agreement and (b) an amount not to exceed either the current expense limitation of that share class or the expense limitation of the share class in effect at the time that the share class received the applicable waiver and/or reimbursement, provided that:
(1) | the Fund, of which the share class is a part, has more than $50 million in assets for the fiscal year, and |
(2) | the Manager or an affiliate continues to serve as the Fund’s investment adviser or administrator. |
This repayment applies only to the contractual expense limitation on net expenses and does not apply to the contractual investment advisory fee waiver described above or any voluntary waivers that may be in effect from time to time. Effective September 30, 2028 the repayment arrangement between the Fund and the Manager pursuant to which the Fund may be required to repay amounts waived and/or reimbursed under the Fund’s contractual caps on net expenses will be terminated.
62 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Notes to Financial Statements (unaudited) (continued)
As of November 30, 2024, the fund level and class specific waivers and/or reimbursements subject to possible future recoupment under the expense limitation agreement were as follows:
Expiring May 31, | ||||||||||||
Fund Name/Fund Level/Share Class | 2025 | 2026 | 2027 | |||||||||
Infrastructure Sustainable Opportunities |
||||||||||||
Fund Level |
$ | 299,135 | $ | 301,268 | $ | 130,993 | ||||||
Institutional |
174 | 281 | 75 | |||||||||
Investor A |
40 | 640 | 306 | |||||||||
Class K |
1,854 | 2,055 | 1,113 |
Securities Lending: The U.S. Securities and Exchange Commission (“SEC”) has issued an exemptive order which permits BIM, an affiliate of the Manager, to serve as securities lending agent for the Funds, subject to applicable conditions. As securities lending agent, BIM bears all operational costs directly related to securities lending. The Funds are responsible for fees in connection with the investment of cash collateral received for securities on loan (the “collateral investment fees”). The cash collateral is invested in a money market fund, BlackRock Cash Funds: Institutional, managed by the Manager or its affiliates. However, BIM has agreed to reduce the amount of securities lending income it receives in order to effectively limit the collateral investment fees the Funds bear to an annual rate of 0.04%. The SL Agency Shares of such money market fund will not be subject to a sales load, distribution fee or service fee. The money market fund in which the cash collateral has been reinvested may impose a discretionary liquidity fee of up to 2% on all redemptions. Discretionary liquidity fees may be imposed or terminated at any time at the discretion of the board of directors of the money market fund, or its delegate, if it is determined that such fee would be, or would not be, respectively, in the best interest of the money market fund. Additionally, the money market fund will impose a mandatory liquidity fee if the money market fund’s total net redemptions on a single day exceed 5% of the money market fund’s net assets, unless the amount of the fee is less than 0.01% of the value of the shares redeemed. The money market fund will determine the size of the mandatory liquidity fee by making a good faith estimate of certain costs the money market fund would incur if it were to sell a pro rata amount of each security in the portfolio to satisfy the amount of net redemptions on that day. There is no limit to the size of a mandatory liquidity fee. If the money market fund cannot estimate the costs of selling a pro rata amount of each portfolio security in good faith and supported by data, it is required to apply a default liquidity fee of 1% on the value of shares redeemed on that day.
Securities lending income is generally equal to the total of income earned from the reinvestment of cash collateral (and excludes collateral investment fees), and any fees or other payments to and from borrowers of securities. Each Fund retains a portion of the securities lending income and remits the remaining portion to BIM as compensation for its services as securities lending agent.
Pursuant to the current securities lending agreement, Capital Appreciation, Health Sciences Opportunities, Mid-Cap Growth Equity and Technology Opportunities retains 81% of securities lending income (which excludes collateral investment fees), and this amount retained can never be less than 70% of the total of securities lending income plus the collateral investment fees. Pursuant to the current securities lending agreement, Infrastructure Sustainable Opportunities retains 82% of securities lending income (which excludes collateral investment fees), and this amount retained can never be less than 70% of the total of securities lending income plus the collateral investment fees.
In addition, commencing the business day following the date that the aggregate securities lending income earned across the BlackRock Multi-Asset Complex in a calendar year exceeds a specified threshold, Capital Appreciation, Health Sciences Opportunities, Mid-Cap Growth Equity and Technology Opportunities, pursuant to the securities lending agreement, will retain for the remainder of that calendar year securities lending income in an amount equal to 81% of securities lending income (which excludes collateral investment fees), and this amount retained can never be less than 70% of the total of securities lending income plus the collateral investment fees. Infrastructure Sustainable Opportunities, pursuant to the securities lending agreement, will retain for the remainder of that calendar year securities lending income in an amount equal to 85% of securities lending income (which excludes collateral investment fees), and this amount retained can never be less than 70% of the total of securities lending income plus the collateral investment fees.
The share of securities lending income earned by each Fund is shown as securities lending income — affiliated — net in the Statements of Operations. For the six months ended November 30, 2024, each Fund paid BIM the following amounts for securities lending agent services:
Fund Name | Amounts | |||
Health Sciences Opportunities |
$ | 49,292 | ||
Infrastructure Sustainable Opportunities |
7 | |||
Mid-Cap Growth Equity |
92,479 | |||
Technology Opportunities |
18,703 |
Interfund Lending: In accordance with an exemptive order (the “Order”) from the SEC, Capital Appreciation and Infrastructure Sustainable Opportunities may participate in a joint lending and borrowing facility for temporary purposes (the “Interfund Lending Program”), subject to compliance with the terms and conditions of the Order, and to the extent permitted by Capital Appreciation’s and Infrastructure Sustainable Opportunities’s investment policies and restrictions. Capital Appreciation is currently permitted to borrow under the Interfund Lending Program. In addition, Infrastructure Sustainable Opportunities is currently permitted to borrow and lend under the Interfund Lending Program.
A lending BlackRock fund may lend in aggregate up to 15% of its net assets but may not lend more than 5% of its net assets to any one borrowing fund through the Interfund Lending Program. A borrowing BlackRock fund may not borrow through the Interfund Lending Program or from any other source more than 33 1/3% of its total assets (or any lower threshold provided for by the fund’s investment restrictions). If a borrowing BlackRock fund’s total outstanding borrowings exceed 10% of its total assets, each of its outstanding interfund loans will be subject to collateralization of at least 102% of the outstanding principal value of the loan. All interfund loans are for temporary or emergency purposes and the interest rate to be charged will be the average of the highest current overnight repurchase agreement rate available to a lending fund and the bank loan rate, as calculated according to a formula established by the Board.
N O T E S T O F I N A N C I A L S T A T E M E N T S |
63 |
Notes to Financial Statements (unaudited) (continued)
During the six months ended November 30, 2024, Capital Appreciation and Infrastructure Sustainable Opportunities did not participate in the Interfund Lending Program.
Directors and Officers: Certain directors and/or officers of the Corporation and the Trust are directors and/or officers of BlackRock or its affiliates. The Funds reimburse the Manager for a portion of the compensation paid to the Corporation’s/Trust’s Chief Compliance Officer, which is included in Directors and Officer in the Statements of Operations.
7. | PURCHASES AND SALES |
For the six months ended November 30, 2024, purchases and sales of investments, excluding short-term securities, were as follows:
Fund Name | Purchases | Sales | ||||||
Capital Appreciation |
$ | 365,320,031 | $ | 583,990,866 | ||||
Health Sciences Opportunities |
1,344,117,260 | 1,969,147,193 | ||||||
Infrastructure Sustainable Opportunities |
5,691,082 | 5,441,085 | ||||||
Mid-Cap Growth Equity |
4,210,719,102 | 6,255,764,350 | ||||||
Technology Opportunities |
1,582,005,700 | 1,690,974,372 |
8. | INCOME TAX INFORMATION |
It is each Fund’s policy to comply with the requirements of the Internal Revenue Code of 1986, as amended, applicable to regulated investment companies, and to distribute substantially all of its taxable income to its shareholders. Therefore, no U.S. federal income tax provision is required.
Each Fund files U.S. federal and various state and local tax returns. No income tax returns are currently under examination. The statute of limitations on each Fund’s U.S. federal tax returns generally remains open for a period of three years after they are filed. The statutes of limitations on each Fund’s state and local tax returns may remain open for an additional year depending upon the jurisdiction.
Management has analyzed tax laws and regulations and their application to the Funds as of November 30, 2024, inclusive of the open tax return years, and does not believe that there are any uncertain tax positions that require recognition of a tax liability in the Funds’ financial statements. Management’s analysis is based on the tax laws and judicial and administrative interpretations thereof in effect as of date of these financial statements, all of which are subject to change, possibly with retroactive effect which may impact the Funds’ NAV.
As of May 31, 2024, the Funds had non-expiring capital loss carryforwards available to offset future realized capital gains and qualified late-year losses as follows:
Fund Name | Non-Expiring Capital Loss Carryforwards |
Qualified Late-Year Ordinary Losses |
||||||
Capital Appreciation |
$ | — | $ | (6,308,381 | ) | |||
Health Sciences Opportunities |
— | (1,657,243 | ) | |||||
Infrastructure Sustainable Opportunities |
(968,437 | ) | — | |||||
Mid-Cap Growth Equity |
(1,282,051,982 | ) | (23,606,786 | ) | ||||
Technology Opportunities |
(441,794,511 | ) | (10,030,779 | ) |
As of November 30, 2024, gross unrealized appreciation and depreciation based on cost of investments (including short positions and derivatives, if any) for U.S. federal income tax purposes were as follows:
Fund Name | Tax Cost | Gross Unrealized Appreciation |
Gross Unrealized Depreciation |
Net Unrealized Appreciation (Depreciation) |
||||||||||||
Capital Appreciation |
$ | 1,419,133,730 | $ | 2,326,859,893 | $ | (5,735,828 | ) | $ | 2,321,124,065 | |||||||
Health Sciences Opportunities |
4,760,708,205 | 3,599,572,117 | (244,763,237 | ) | 3,354,808,880 | |||||||||||
Infrastructure Sustainable Opportunities |
9,627,729 | 620,446 | (350,707 | ) | 269,739 | |||||||||||
Mid-Cap Growth Equity |
7,949,428,456 | 4,030,847,660 | (95,921,971 | ) | 3,934,925,689 | |||||||||||
Technology Opportunities |
3,100,304,688 | 3,118,718,823 | (38,813,614 | ) | 3,079,905,209 |
9. | BANK BORROWINGS |
The Corporation and the Trust, on behalf of the Funds, along with certain other funds managed by the Manager and its affiliates (“Participating Funds”), is party to a 364-day, $2.40 billion credit agreement with a group of lenders. Under this agreement, the Funds may borrow to fund shareholder redemptions. Excluding commitments designated for certain individual funds, the Participating Funds, including the Funds, can borrow up to an aggregate commitment amount of $1.75 billion at any time outstanding, subject to asset coverage and other limitations as specified in the agreement. The credit agreement has the following terms: a fee of 0.10% per annum on unused commitment amounts and interest at a rate equal to the higher of (a) Overnight Bank Funding Rate (“OBFR”) (but, in any event, not less than 0.00%) on the date the loan is made plus 0.80% per annum, (b) the Fed Funds rate (but, in any event, not less than 0.00%) in effect from time to time plus 0.80% per annum on amounts borrowed or (c) the sum of (x) Daily Simple Secured Overnight Financing Rate (“SOFR”) (but, in any event, not less than 0.00%) on the date the loan is made plus 0.10% and (y) 0.80% per annum. The agreement expires in April 2025 unless extended or renewed. These fees were allocated among such funds based upon portions of the aggregate commitment available to them and relative net assets of Participating Funds. During the six months ended November 30, 2024, the Funds did not borrow under the credit agreement.
64 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Notes to Financial Statements (unaudited) (continued)
10. | PRINCIPAL RISKS |
In the normal course of business, the Funds invest in securities or other instruments and may enter into certain transactions, and such activities subject each Fund to various risks, including among others, fluctuations in the market (market risk) or failure of an issuer to meet all of its obligations. The value of securities or other instruments may also be affected by various factors, including, without limitation: (i) the general economy; (ii) the overall market as well as local, regional or global political and/or social instability; (iii) regulation, taxation or international tax treaties between various countries; or (iv) currency, interest rate and price fluctuations. Local, regional or global events such as war, acts of terrorism, the spread of infectious illness or other public health issues, recessions, or other events could have a significant impact on the Funds and their investments. Each Fund’s prospectus provides details of the risks to which each Fund is subject.
The Funds may be exposed to additional risks when reinvesting cash collateral in money market funds that do not seek to maintain a stable NAV per share of $1.00, which may be subject to mandatory and discretionary liquidity fees under certain circumstances.
Valuation Risk: The market values of equities, such as common stocks and preferred securities or equity related investments, such as futures and options, may decline due to general market conditions which are not specifically related to a particular company. They may also decline due to factors which affect a particular industry or industries. A Fund may invest in illiquid investments. An illiquid investment is any investment that a Fund reasonably expects cannot be sold or disposed of in current market conditions in seven calendar days or less without the sale or disposition significantly changing the market value of the investment. A Fund may experience difficulty in selling illiquid investments in a timely manner at the price that it believes the investments are worth. Prices may fluctuate widely over short or extended periods in response to company, market or economic news. Markets also tend to move in cycles, with periods of rising and falling prices. This volatility may cause each Fund’s NAV to experience significant increases or decreases over short periods of time. If there is a general decline in the securities and other markets, the NAV of a Fund may lose value, regardless of the individual results of the securities and other instruments in which a Fund invests. A Fund’s ability to value its investments may also be impacted by technological issues and/or errors by pricing services or other third-party service providers.
The price a Fund could receive upon the sale of any particular portfolio investment may differ from a Fund’s valuation of the investment, particularly for securities that trade in thin or volatile markets or that are valued using a fair valuation technique or a price provided by an independent pricing service. Changes to significant unobservable inputs and assumptions (i.e., publicly traded company multiples, growth rate, time to exit) due to the lack of observable inputs may significantly impact the resulting fair value and therefore a Fund’s results of operations. As a result, the price received upon the sale of an investment may be less than the value ascribed by a Fund, and a Fund could realize a greater than expected loss or lesser than expected gain upon the sale of the investment.
Counterparty Credit Risk: The Funds may be exposed to counterparty credit risk, or the risk that an entity may fail to or be unable to perform on its commitments related to unsettled or open transactions, including making timely interest and/or principal payments or otherwise honoring its obligations. The Funds manage counterparty credit risk by entering into transactions only with counterparties that the Manager believes have the financial resources to honor their obligations and by monitoring the financial stability of those counterparties. Financial assets, which potentially expose the Funds to market, issuer and counterparty credit risks, consist principally of financial instruments and receivables due from counterparties. The extent of the Funds’ exposure to market, issuer and counterparty credit risks with respect to these financial assets is approximately their value recorded in the Statements of Assets and Liabilities, less any collateral held by the Funds.
A derivative contract may suffer a mark-to-market loss if the value of the contract decreases due to an unfavorable change in the market rates or values of the underlying instrument. Losses can also occur if the counterparty does not perform under the contract.
Geographic/Asset Class Risk: A diversified portfolio, where this is appropriate and consistent with a fund’s objectives, minimizes the risk that a price change of a particular investment will have a material impact on the NAV of a fund. The investment concentrations within the Fund’s portfolio are disclosed in its Schedule of Investments.
Certain Funds invest a significant portion of their assets in securities within a single or limited number of market sectors. When a fund concentrates its investments in this manner, it assumes the risk that economic, regulatory, political and social conditions affecting such sectors may have a significant impact on the Fund and could affect the income from, or the value or liquidity of, the Fund’s portfolio. Investment percentages in specific sectors are presented in the Schedules of Investments.
The Funds invest a significant portion of their assets in securities of issuers located in the United States. A decrease in imports or exports, changes in trade regulations, inflation and/or an economic recession in the United States may have a material adverse effect on the U.S. economy and the securities listed on U.S. exchanges. Proposed and adopted policy and legislative changes in the United States may also have a significant effect on U.S. markets generally, as well as on the value of certain securities. Governmental agencies project that the United States will continue to maintain elevated public debt levels for the foreseeable future which may constrain future economic growth. Circumstances could arise that could prevent the timely payment of interest or principal on U.S. government debt, such as reaching the legislative “debt ceiling.” Such non-payment would result in substantial negative consequences for the U.S. economy and the global financial system. If U.S. relations with certain countries deteriorate, it could adversely affect issuers that rely on the United States for trade. The United States has also experienced increased internal unrest and discord. If these trends were to continue, they may have an adverse impact on the U.S. economy and the issuers in which the Funds invest.
Significant Shareholder Redemption Risk: Certain shareholders may own or manage a substantial amount of fund shares and/or hold their fund investments for a limited period of time. Large redemptions of fund shares by these shareholders may force a fund to sell portfolio securities, which may negatively impact the fund’s NAV, increase the fund’s brokerage costs, and/or accelerate the realization of taxable income/gains and cause the fund to make additional taxable distributions to shareholders.
N O T E S T O F I N A N C I A L S T A T E M E N T S |
65 |
Notes to Financial Statements (unaudited) (continued)
11. | CAPITAL SHARE TRANSACTIONS |
Transactions in capital shares for each class were as follows:
Six Months Ended 11/30/24 | Year Ended 05/31/24 | |||||||||||||||
Fund Name/Share Class | Shares | Amount | Shares | Amount | ||||||||||||
Capital Appreciation |
||||||||||||||||
Institutional |
||||||||||||||||
Shares sold |
1,192,474 | $ | 50,481,614 | 2,375,172 | $ | 85,564,796 | ||||||||||
Shares issued in reinvestment of distributions |
1,123,280 | 46,020,787 | 607,843 | 20,849,409 | ||||||||||||
Shares redeemed |
(1,889,471 | ) | (81,337,922 | ) | (5,700,478 | ) | (206,766,629 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
426,283 | $ | 15,164,479 | (2,717,463 | ) | $ | (100,352,424 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Investor A |
||||||||||||||||
Shares sold and automatic conversion of shares |
1,330,755 | $ | 49,195,218 | 3,059,279 | $ | 95,896,183 | ||||||||||
Shares issued in reinvestment of distributions |
4,370,491 | 154,453,099 | 2,141,572 | 64,101,470 | ||||||||||||
Shares redeemed |
(4,821,545 | ) | (177,965,330 | ) | (9,329,188 | ) | (296,845,503 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
879,701 | $ | 25,682,987 | (4,128,337 | ) | $ | (136,847,850 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Investor C |
||||||||||||||||
Shares sold |
147,503 | $ | 2,789,149 | 259,279 | $ | 4,516,743 | ||||||||||
Shares issued in reinvestment of distributions |
317,610 | 5,640,757 | 150,664 | 2,462,125 | ||||||||||||
Shares redeemed and automatic conversion of shares |
(320,768 | ) | (6,007,341 | ) | (921,149 | ) | (15,736,877 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
144,345 | $ | 2,422,565 | (511,206 | ) | $ | (8,758,009 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Class K |
||||||||||||||||
Shares sold |
562,402 | $ | 24,289,193 | 1,392,489 | $ | 50,192,656 | ||||||||||
Shares issued in reinvestment of distributions |
843,365 | 35,008,091 | 625,650 | 21,705,654 | ||||||||||||
Shares redeemed |
(1,167,359 | ) | (50,363,717 | ) | (9,972,800 | ) | (372,605,778 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
238,408 | $ | 8,933,567 | (7,954,661 | ) | $ | (300,707,468 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Class R |
||||||||||||||||
Shares sold |
60,439 | $ | 1,540,379 | 149,207 | $ | 3,233,921 | ||||||||||
Shares issued in reinvestment of distributions |
112,014 | 2,688,341 | 57,317 | 1,211,907 | ||||||||||||
Shares redeemed |
(182,616 | ) | (4,606,836 | ) | (415,361 | ) | (9,306,024 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
(10,163 | ) | $ | (378,116 | ) | (208,837 | ) | $ | (4,860,196 | ) | |||||||
|
|
|
|
|
|
|
|
|||||||||
1,678,574 | $ | 51,825,482 | (15,520,504 | ) | $ | (551,525,947 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Health Sciences Opportunities |
||||||||||||||||
Institutional |
||||||||||||||||
Shares sold |
2,999,250 | $ | 228,394,797 | 8,193,691 | $ | 583,683,482 | ||||||||||
Shares issued in reinvestment of distributions |
1,832,268 | 136,485,641 | 2,283,482 | 157,422,926 | ||||||||||||
Shares redeemed |
(7,905,663 | ) | (601,033,205 | ) | (16,815,339 | ) | (1,183,104,439 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
(3,074,145 | ) | $ | (236,152,767 | ) | (6,338,166 | ) | $ | (441,998,031 | ) | |||||||
|
|
|
|
|
|
|
|
|||||||||
Service |
||||||||||||||||
Shares sold |
16,487 | $ | 1,165,942 | 41,297 | $ | 2,740,817 | ||||||||||
Shares issued in reinvestment of distributions |
14,946 | 1,042,793 | 18,476 | 1,199,629 | ||||||||||||
Shares redeemed |
(49,174 | ) | (3,499,511 | ) | (129,496 | ) | (8,549,804 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
(17,741 | ) | $ | (1,290,776 | ) | (69,723 | ) | $ | (4,609,358 | ) | |||||||
|
|
|
|
|
|
|
|
|||||||||
Investor A |
||||||||||||||||
Shares sold and automatic conversion of shares |
1,126,344 | $ | 80,147,032 | 3,148,635 | $ | 208,743,219 | ||||||||||
Shares issued in reinvestment of distributions |
1,393,987 | 96,714,809 | 1,628,677 | 105,093,179 | ||||||||||||
Shares redeemed |
(3,366,759 | ) | (238,724,728 | ) | (8,665,399 | ) | (573,000,127 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
(846,428 | ) | $ | (61,862,887 | ) | (3,888,087 | ) | $ | (259,163,729 | ) | |||||||
|
|
|
|
|
|
|
|
66 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Notes to Financial Statements (unaudited) (continued)
Six Months Ended 11/30/24 | Year Ended 05/31/24 | |||||||||||||||
Fund Name/Share Class | Shares | Amount | Shares | Amount | ||||||||||||
Health Sciences Opportunities (continued) |
||||||||||||||||
Investor C |
||||||||||||||||
Shares sold |
141,656 | $ | 8,166,627 | 340,682 | $ | 18,635,857 | ||||||||||
Shares issued in reinvestment of distributions |
228,569 | 12,854,740 | 298,034 | 15,871,867 | ||||||||||||
Shares redeemed and automatic conversion of shares |
(954,290 | ) | (55,043,192 | ) | (2,792,967 | ) | (151,349,046 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
(584,065 | ) | $ | (34,021,825 | ) | (2,154,251 | ) | $ | (116,841,322 | ) | |||||||
|
|
|
|
|
|
|
|
|||||||||
Class K |
||||||||||||||||
Shares sold |
771,062 | $ | 59,146,958 | 1,849,326 | $ | 131,524,955 | ||||||||||
Shares issued in reinvestment of distributions |
219,796 | 16,403,366 | 255,328 | 17,603,287 | ||||||||||||
Shares redeemed |
(835,440 | ) | (63,497,302 | ) | (2,585,491 | ) | (183,510,131 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
155,418 | $ | 12,053,022 | (480,837 | ) | $ | (34,381,889 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Class R |
||||||||||||||||
Shares sold |
87,554 | $ | 6,021,344 | 293,019 | $ | 18,639,450 | ||||||||||
Shares issued in reinvestment of distributions |
135,121 | 9,050,426 | 141,806 | 8,875,180 | ||||||||||||
Shares redeemed |
(260,398 | ) | (17,785,142 | ) | (663,365 | ) | (42,582,090 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
(37,723 | ) | $ | (2,713,372 | ) | (228,540 | ) | $ | (15,067,460 | ) | |||||||
|
|
|
|
|
|
|
|
|||||||||
(4,404,684 | ) | $ | (323,988,605 | ) | (13,159,604 | ) | $ | (872,061,789 | ) | |||||||
|
|
|
|
|
|
|
|
|||||||||
Infrastructure Sustainable Opportunities |
||||||||||||||||
Institutional |
||||||||||||||||
Shares sold |
215 | $ | 2,000 | 538 | $ | 4,705 | ||||||||||
Shares issued in reinvestment of distributions |
10 | 90 | 29 | 261 | ||||||||||||
Shares redeemed |
(53 | ) | (500 | ) | (262 | ) | (2,192 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
172 | $ | 1,590 | 305 | $ | 2,774 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Investor A |
||||||||||||||||
Shares sold |
95 | $ | 868 | 14,312 | $ | 123,978 | ||||||||||
Shares issued in reinvestment of distributions |
71 | 643 | 194 | 1,740 | ||||||||||||
Shares redeemed |
(4,417 | ) | (38,254 | ) | (3,167 | ) | (26,060 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
(4,251 | ) | $ | (36,743 | ) | 11,339 | $ | 99,658 | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Class K |
||||||||||||||||
Shares sold |
— | $ | — | 82 | $ | 710 | ||||||||||
Shares issued in reinvestment of distributions |
329 | 14 | 132 | |||||||||||||
Shares redeemed |
— | — | (145 | ) | (1,240 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
3 | $ | 29 | (49 | ) | $ | (398 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
(4,076 | ) | $ | (35,124 | ) | 11,595 | $ | 102,034 | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Mid-Cap Growth Equity |
||||||||||||||||
Institutional |
||||||||||||||||
Shares sold |
7,858,582 | $ | 315,741,463 | 25,774,794 | $ | 943,438,772 | ||||||||||
Shares redeemed |
(34,419,648 | ) | (1,387,284,824 | ) | (53,836,267 | ) | (1,966,094,068 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
(26,561,066 | ) | $ | (1,071,543,361 | ) | (28,061,473 | ) | $ | (1,022,655,296 | ) | |||||||
|
|
|
|
|
|
|
|
|||||||||
Service |
||||||||||||||||
Shares sold |
65,088 | $ | 2,343,039 | 218,068 | $ | 7,181,094 | ||||||||||
Shares redeemed |
(317,787 | ) | (11,501,219 | ) | (648,553 | ) | (21,108,643 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
(252,699 | ) | $ | (9,158,180 | ) | (430,485 | ) | $ | (13,927,549 | ) | |||||||
|
|
|
|
|
|
|
|
|||||||||
Investor A |
||||||||||||||||
Shares sold and automatic conversion of shares |
1,691,490 | $ | 57,965,042 | 5,192,371 | $ | 162,981,384 | ||||||||||
Shares redeemed |
(6,160,111 | ) | (210,450,398 | ) | (15,109,163 | ) | (469,268,479 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
(4,468,621 | ) | $ | (152,485,356 | ) | (9,916,792 | ) | $ | (306,287,095 | ) | |||||||
|
|
|
|
|
|
|
|
N O T E S T O F I N A N C I A L S T A T E M E N T S |
67 |
Notes to Financial Statements (unaudited) (continued)
Six Months Ended 11/30/24 | Year Ended 05/31/24 | |||||||||||||||
Fund Name/Share Class | Shares | Amount | Shares | Amount | ||||||||||||
Mid-Cap Growth Equity (continued) |
||||||||||||||||
Investor C |
||||||||||||||||
Shares sold |
117,370 | $ | 2,983,615 | 459,280 | $ | 10,686,451 | ||||||||||
Shares redeemed and automatic conversion of shares |
(1,159,582 | ) | (29,126,677 | ) | (2,320,240 | ) | (53,855,034 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
(1,042,212 | ) | $ | (26,143,062 | ) | (1,860,960 | ) | $ | (43,168,583 | ) | |||||||
|
|
|
|
|
|
|
|
|||||||||
Class K |
||||||||||||||||
Shares sold |
6,758,356 | $ | 273,175,230 | 23,280,033 | $ | 866,092,270 | ||||||||||
Shares redeemed |
(25,107,782 | ) | (1,026,245,489 | ) | (37,065,253 | ) | (1,369,957,463 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
(18,349,426 | ) | $ | (753,070,259 | ) | (13,785,220 | ) | $ | (503,865,193 | ) | |||||||
|
|
|
|
|
|
|
|
|||||||||
Class R |
||||||||||||||||
Shares sold |
167,590 | $ | 5,520,146 | 550,929 | $ | 16,719,131 | ||||||||||
Shares redeemed |
(414,182 | ) | (13,856,481 | ) | (1,350,214 | ) | (41,042,668 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
(246,592 | ) | $ | (8,336,335 | ) | (799,285 | ) | $ | (24,323,537 | ) | |||||||
|
|
|
|
|
|
|
|
|||||||||
(50,920,616 | ) | $ | (2,020,736,553 | ) | (54,854,215 | ) | $ | (1,914,227,253 | ) | |||||||
|
|
|
|
|
|
|
|
|||||||||
Technology Opportunities |
||||||||||||||||
Institutional |
||||||||||||||||
Shares sold |
5,356,705 | $ | 378,849,860 | 9,723,910 | $ | 537,366,881 | ||||||||||
Shares redeemed |
(5,607,634 | ) | (394,493,482 | ) | (16,207,338 | ) | (891,747,608 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
(250,929 | ) | $ | (15,643,622 | ) | (6,483,428 | ) | $ | (354,380,727 | ) | |||||||
|
|
|
|
|
|
|
|
|||||||||
Service |
||||||||||||||||
Shares sold |
156,783 | $ | 10,655,049 | 206,830 | $ | 10,760,963 | ||||||||||
Shares redeemed |
(132,796 | ) | (8,717,725 | ) | (498,430 | ) | (25,937,289 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
23,987 | $ | 1,937,324 | (291,600 | ) | $ | (15,176,326 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Investor A |
||||||||||||||||
Shares sold and automatic conversion of shares |
2,431,270 | $ | 156,891,497 | 5,008,601 | $ | 252,087,332 | ||||||||||
Shares redeemed |
(3,559,779 | ) | (227,958,000 | ) | (8,228,564 | ) | (416,589,841 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
(1,128,509 | ) | $ | (71,066,503 | ) | (3,219,963 | ) | $ | (164,502,509 | ) | |||||||
|
|
|
|
|
|
|
|
|||||||||
Investor C |
||||||||||||||||
Shares sold |
317,454 | $ | 16,137,924 | 731,500 | $ | 29,296,687 | ||||||||||
Shares redeemed and automatic conversion of shares |
(755,244 | ) | (38,301,363 | ) | (2,003,356 | ) | (79,620,760 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
(437,790 | ) | $ | (22,163,439 | ) | (1,271,856 | ) | $ | (50,324,073 | ) | |||||||
|
|
|
|
|
|
|
|
|||||||||
Class K |
||||||||||||||||
Shares sold |
1,686,929 | $ | 117,459,494 | 1,737,800 | $ | 95,856,044 | ||||||||||
Shares redeemed |
(764,986 | ) | (54,225,678 | ) | (1,349,293 | ) | (74,821,457 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
921,943 | $ | 63,233,816 | 388,507 | $ | 21,034,587 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Class R |
||||||||||||||||
Shares sold |
108,499 | $ | 6,938,173 | 281,736 | $ | 14,160,044 | ||||||||||
Shares redeemed |
(129,242 | ) | (8,160,614 | ) | (357,121 | ) | (17,401,063 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
(20,743 | ) | $ | (1,222,441 | ) | (75,385 | ) | $ | (3,241,019 | ) | |||||||
|
|
|
|
|
|
|
|
|||||||||
(892,041 | ) | $ | (44,924,865 | ) | (10,953,725 | ) | $ | (566,590,067 | ) | |||||||
|
|
|
|
|
|
|
|
As of November 30, 2024, shares owned by BlackRock Financial Management, Inc., an affiliate of the Funds, were as follows:
Share Class | Infrastructure Sustainable Opportunities |
Technology Opportunities |
||||||
Institutional |
10,000 | — | ||||||
Investor A |
10,000 | — | ||||||
Class K |
980,000 | 8,673 |
68 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Notes to Financial Statements (unaudited) (continued)
12. | SUBSEQUENT EVENTS |
Management has evaluated the impact of all subsequent events on the Funds through the date the financial statements were issued and has determined that there were no subsequent events requiring adjustment or additional disclosure in the financial statements.
N O T E S T O F I N A N C I A L S T A T E M E N T S |
69 |
Additional Information
Changes in and Disagreements with Accountants
Not applicable.
Proxy Results
Not applicable.
Remuneration Paid to Directors, Officers, and Others
Compensation to the independent directors/trustees of the Corporation/Trust is paid by the Corporation/Trust, on behalf of the Funds.
General Information
Quarterly performance, shareholder reports, semi-annual and annual financial statements, current net asset value and other information regarding the Funds may be found on BlackRock’s website, which can be accessed at blackrock.com. Any reference to BlackRock’s website in this report is intended to allow investors public access to information regarding the Funds and does not, and is not intended to, incorporate BlackRock’s website in this report.
Electronic Delivery
Shareholders can sign up for e-mail notifications of quarterly statements, annual and semi-annual shareholder reports and prospectuses by enrolling in the electronic delivery program.
To enroll in electronic delivery:
Shareholders Who Hold Accounts with Investment Advisors, Banks or Brokerages:
Please contact your financial advisor. Please note that not all investment advisors, banks or brokerages may offer this service.
Shareholders Who Hold Accounts Directly with BlackRock:
1. | Access the BlackRock website at blackrock.com |
2. | Select “Access Your Account” |
3. | Next, select “eDelivery” in the “Related Resources” box and follow the sign-up instructions. |
BlackRock’s Mutual Fund Family
BlackRock offers a diverse lineup of open-end mutual funds crossing all investment styles and managed by experts in equity, fixed-income and tax-exempt investing. Visit blackrock.com for more information.
Shareholder Privileges
Account Information
Call us at (800) 441-7762 from 8:00 AM to 6:00 PM ET on any business day to get information about your account balances, recent transactions and share prices. You can also visit blackrock.com for more information.
Automatic Investment Plans
Investor class shareholders who want to invest regularly can arrange to have $50 or more automatically deducted from their checking or savings account and invested in any of the BlackRock funds.
Systematic Withdrawal Plans
Investor class shareholders can establish a systematic withdrawal plan and receive periodic payments of $50 or more from their BlackRock funds, as long as their account balance is at least $10,000.
Retirement Plans
Shareholders may make investments in conjunction with Traditional, Rollover, Roth, Coverdell, Simple IRAs, SEP IRAs and 403(b) Plans.
70 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
Additional Information (continued)
Fund and Service Providers
Investment Adviser and Administrator | Independent Registered Public Accounting Firm | |
BlackRock Advisors, LLC | Deloitte & Touche LLP | |
Wilmington, DE 19809 | Boston, MA 02110 | |
Sub-Advisers(a) | Distributor | |
BlackRock International Limited | BlackRock Investments, LLC | |
Edinburgh, EH3 8BL | New York, NY 10001 | |
United Kingdom | ||
Legal Counsel | ||
BlackRock (Singapore) Limited | Sidley Austin LLP | |
079912 Singapore |
New York, NY 10019 | |
Accounting Agent and Transfer Agent | Address of the Corporation/Trust | |
BNY Mellon Investment Servicing (US) Inc. | 100 Bellevue Parkway | |
Wilmington, DE 19809 | Wilmington, DE 19809 | |
Custodian | ||
The Bank of New York Mellon | ||
New York, NY 10286 | ||
(a) For BlackRock Infrastructure Sustainable Opportunities Fund. |
A D D I T I O N A L I N F O R M A T I O N |
71 |
Glossary of Terms Used in this Report
Currency Abbreviation
CAD | Canadian Dollar | |
USD | United States Dollar |
Portfolio Abbreviation | ||
ADR | American Depositary Receipt | |
CVR | Contingent Value Rights | |
NVS | Non-Voting Shares | |
REIT | Real Estate Investment Trust |
72 | 2 0 2 4 B L A C K R O C K S E M I - A N N U A L F I N A N C I A L S T A T E M E N T S A N D A D D I T I O N A L I N F O R M A T I O N |
THIS PAGE INTENTIONALLY LEFT BLANK.
THIS PAGE INTENTIONALLY LEFT BLANK.
THIS PAGE INTENTIONALLY LEFT BLANK.
Want to know more?
blackrock.com | 800-441-7762
This report is intended for current holders. It is not authorized for use as an offer of sale or a solicitation of an offer to buy shares of the Funds unless preceded or accompanied by the Funds’ current prospectus. Past performance results shown in this report should not be considered a representation of future performance. Investment returns and principal value of shares will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Statements and other information herein are as dated and are subject to change.
|
![]() |
Item 8 – | Changes in and Disagreements with Accountants for Open-End Management Investment Companies – See Item 7 |
Item 9 – | Proxy Disclosures for Open-End Management Investment Companies – See Item 7 |
Item 10 – | Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies – See Item 7 |
Item 11 – | Statement Regarding Basis for Approval of Investment Advisory Contract – See Item 7 |
Item 12 – | Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies – Not Applicable |
Item 13 – | Portfolio Managers of Closed-End Management Investment Companies – Not Applicable |
Item 14 – | Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers – Not Applicable |
Item 15 – | Submission of Matters to a Vote of Security Holders – There have been no material changes to these procedures. |
2
Item 16 – | Controls and Procedures |
(a) The registrant’s principal executive and principal financial officers, or persons performing similar functions, have concluded that the registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940, as amended (the “1940 Act”)) are effective as of a date within 90 days of the filing date of this report based on the evaluation of these controls and procedures required by Rule 30a-3(b) under the 1940 Act and Rule 13a-15(b) or 15d-15(b) under the Securities Exchange Act of 1934, as amended.
(b) There were no changes in the registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the 1940 Act) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the registrant’s internal control over financial reporting.
Item 17 – | Disclosure of Securities Lending Activities for Closed-End Management Investment Companies – Not Applicable |
Item 18 – | Recovery of Erroneously Awarded Compensation – Not Applicable |
Item 19 – | Exhibits attached hereto |
(a)(1) Code of Ethics – Not Applicable to this semi-annual report
(a)(2) Any policy required by the listing standards adopted pursuant to Rule 10D-1 under the Exchange Act (17 CFR 240.10D-1) by the registered national securities exchange or registered national securities association upon which the registrant’s securities are listed – Not Applicable
(a)(3) Section 302 Certifications are attached.
(a)(4) Any written solicitation to purchase securities under Rule 23c-1 – Not Applicable
(a)(5) Change in registrant’s independent public accountant – Not Applicable
(b) Section 906 Certifications are attached.
3
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
BlackRock Capital Appreciation Fund, Inc.
By: |
/s/ John M. Perlowski | |||
John M. Perlowski | ||||
Chief Executive Officer (principal executive officer) of | ||||
BlackRock Capital Appreciation Fund, Inc. |
Date: January 21, 2025
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By: |
/s/ John M. Perlowski | |||
John M. Perlowski | ||||
Chief Executive Officer (principal executive officer) of | ||||
BlackRock Capital Appreciation Fund, Inc. |
Date: January 21, 2025
By: |
/s/ Trent Walker | |||
Trent Walker | ||||
Chief Financial Officer (principal financial officer) of | ||||
BlackRock Capital Appreciation Fund, Inc. |
Date: January 21, 2025
4